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Abstract 
The adult mammalian brain is a highly plastic structure capable of cellular and 
molecular remodelling in response to its interactions with the outside world. The 
addition of new neurons to the hippocampus throughout life is one of the most 
striking manifestations of this plasticity. New neurons here are generated from a 
population of stem cells that, although existing primarily in a dormant or quiescent 
state, they can become activated upon the reception of neurogenic signals. How stem 
cells integrate these signals from the environment to ultimately control neuronal 
production is currently under investigation. 
During embryonic development, transcription factors of the basic helix-loop-
helix family promote progenitor proliferation and differentiation to ensure the 
production of neurons in correct numbers and at the correct positions. We found 
Ascl1, a proneural factor in this family, to be expressed by stem cells of the adult 
hippocampus when in an active state. Here we used pharmacological and genetic 
approaches to show that Ascl1 expression is rapidly induced in response to 
neurogenic stimuli, and that deletion of this factor with a conditional inactivation 
approach results in an inability of stem cells to respond to signals and exit their 
quiescent state. Moreover, by examining the genes deregulated in Ascl1-deleted stem 
cells, we show that Ascl1 promotes the proliferation of hippocampal stem cells by 
directly regulating cell cycle regulatory genes, among which the cyclin D genes are 
of great importance. 
 The data presented here supports a model whereby Ascl1 acts as a central 
factor in adult hippocampal stem cells to integrate both stimulatory and inhibitory 
signals and translate them into a transcriptional programme that controls stem cell 
activity. With this work we also highlight that understanding how Ascl1 is regulated 
will contribute, in the future, to the development of stem cell therapies for the 
treatment of neurological disorders. 
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Adult mammalian brains were long believed to be post-mitotic structures with little 
or no regeneration ability. However, the identification of neural stem cells (NSCs) 
that are able to self-renew and differentiate to give rise to all major neural lineages 
has shown adult brains to be highly plastic systems (Temple, 2001). Two main 
germinal zones have been identified where new neurons are born throughout 
adulthood: the subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) and 
the subventricular zone (SVZ) of the walls of the lateral ventricles (Zhao et al., 
2008). The ability of NSCs in these regions to promote the generation of new 
neurons throughout life depends on a tight balance of stem cell maintenance and 
proliferation (Schwarz et al., 2012). The control of this balance is achieved through 
the combinatorial activity of complex intrinsic programmes that regulate stem cell 
activity, and of extrinsic neurogenic signals that arise in the specialized 
microenvironment these cells are embedded in and with which they form a functional 
unit (Suh et al., 2009, Doetsch, 2003).  
 In this chapter I will summarise the present knowledge in the field of adult 
neurogenesis. I do not intend to be exhaustive, but to present those ideas that will be 
relevant for the analysis and understanding of the original work that I will present in 
the following chapters. I will start this section by presenting a general introduction of 
the topic and how it fits within a social and scientific context. Next I will move on to 
describe, in more detail, the process of neurogenesis in the hippocampus and how it 
is regulated by the environment. This will be followed by a description of the 
mechanisms that control the neurogenic programme, what will be the main focus of 
the chapter. Finally, I will present a short synopsis of the proneural factor Ascl1, why 
we think it might be important in the process of neurogenesis and how it might fit 
into the picture. The main goal in this section is to show a picture of a process that is 
intricately complex and that is influenced by an innumerable number of factors. 
Moreover, I aim to show a picture where all these factors remarkably come together 
to perform precise functions, and where the failure to do so results in devastating 
neurological disorders. 
Introduction 
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1.1 An introduction to the field 
1.1.1 Brief historical perspective 
If asked to think of a mammalian tissue with regenerative capacity, the brain would 
certainly not be our first choice. Blood, skin or intestines would most likely pop into 
our heads instead (Poss, 2010). Why this is the case can probably be briefly 
summarised in this quote from the early nineties by Santiago Ramón y Cajal: 
“Una vez que el desarrollo ha concluido, las fuentes de la regeneración 
de los axones y dendritas se agotan irrevocablemente. Preciso es 
reconocer que, en los centros adultos, las vías nerviosas son algo fijo, 
acabado, inmutable. Todo puede morir, nada renacer.” (Once development 
has ended, the sources of growth and regeneration of the axons and dendrites 
dry up irrevocably. In the adult centres, the nerve paths are something fixed, 
finished, immutable: everything may die, nothing may be regenerated.) 
(Ramón y Cajal, 1928) 
The brain, as described in this quote from the father of modern neuroscience, 
was believed to be a stable and “immutable” structure until not long ago. Neurons, 
the main cellular constitution of the brain, are post-mitotic, and therefore unable to 
divide. This, added to the failure to recognise the existence of NSCs in adult brains, 
led to the inevitable conclusion that neurons are incapable of regenerating. 
The first mention of neurogenesis in the rodent adult hippocampus came from 
Joseph Altman in 1963 (Altman, 1963), when he labelled cells in adult rats with a 
thymidine analogue to show that indeed there were regions of proliferative activity 
and therefore, the possibility of new neurons being formed in adult structures. Later 
studies by Michael Kaplan in the adult olfactory bulb (Kaplan and Hinds, 1977) and 
by Fernando Nottebohm in brains of songbirds (Paton and Nottebohm, 1984) 
supported this notion. These were, however, discoveries made ahead of their time. 
The scientific community was not ready to believe this to be a true phenomenon. It 
was only after the discovery of NSCs in the SVZ (Reynolds and Weiss, 1992), and in 
the hippocampus (Palmer et al., 1995), as well as after the demonstration of 
neurogenesis taking place in adult human brains (Eriksson et al., 1998), that the idea 
of “new neurons for old brains” (Kempermann, 2011a) was finally accepted. 
Introduction 
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Adult neurogenesis research gained momentum from this time, with 
publications concerning adult NSCs growing exponentially in the last 20 years. The 
increasing need of new brain cells for the treatment of numerous neurological 
disorders, together with the finding that NSCs, especially in the hippocampus, are 
regulated by physical and cognitive activities and that therefore have biological and 
functional relevance (see below for details), made this a very promising area of 
research. Understanding the cellular and molecular mechanisms that regulate 
endogenous neurogenesis opens the doors to the exciting possibility of using the 
brain’s own reservoir of stem cells as a potential therapeutic strategy (Taylor et al., 
2013, Einstein and Ben-Hur, 2008). 
1.1.2 Definitions: What is adult neurogenesis?  
Adult neurogenesis, in its most general definition, is the production of new 
functional neurons in the adult brain (Kempermann, 2011a). A neurogenic region is, 
therefore, an area in the brain where new neurons are generated; and it normally 
implies 1) that precursor cells are present, and 2) that these precursors are surrounded 
by a special microenvironment or neurogenic niche that is permissive, i.e. that allows 
neurogenesis to take place. In the adult brain two main neurogenic regions exist: the 
hippocampus and the olfactory system. These are populated by a subset of 
undifferentiated precursors, the NSCs, that retain the ability to proliferate and self-
renew, and are capable of giving rise to both neuronal and glial lineages (Shi et al., 
2008) 
 While the precursors contributing new neurons to the olfactory system reside 
in the subventricular or subependymal zone (SVZ or SEZ) in the walls of the lateral 
ventricles, precursors generating the neurons that will contribute to the hippocampal 
formation are located in the subgranular zone (SGZ) of the dentate gyrus (DG, 
Figure 1-1). In both cases, a population of NSCs or radial glia-like cells (RGLs) will 
enter the cell cycle, from a relatively quiescent state, to proliferate and, if dividing 
asymmetrically, give rise to more committed progenitors that will rapidly divide to 
amplify the number of neurons produced (Zhao et al., 2008). Note that I will be using 
the term neural precursor when referring to all dividing cells in the lineage with some 
capacity for differentiation, including the primitive NSCs, while I will make use of 
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the term progenitors, instead, when only referring to the more committed population 
of cells that is derived from NSCs.  
 Despite sharing important features during the process of neurogenesis, a 
phenomenon that grants them the allocation into the same category, numerous 
differences between the SVZ and the SGZ exist. To begin with, at least in rodents, 
there is a dramatic difference in the number of neurons generated in each region, 
with the SVZ having a many-fold higher production compared to the DG 
(Kempermann, 2011a). Moreover, while precursors in the hippocampus generate 
excitatory granule cells that remain in the vicinity of their birthplace (Kempermann 
et al., 2004), those of the SVZ generate various types of interneurons that migrate 
over a long distance along the rostral migratory stream (RMS) to the olfactory bulb 
(Lledo et al., 2008). Consequently, the newly generated neurons in these regions play 
rather dissimilar roles, and respond differently to the various physiological demands 
of the organism and to threatening pathological insults. 
 
Figure 1-1 Neurogenic regions in the adult mouse brain 
Sagittal view of the adult mouse brain showing, in blue, the two main regions where neurogenesis 
occurs throughout life: the dentate gyrus (DG) of the hippocampus, and the subventricular zone 
(SVZ). In the hippocampus, stem cells (green) reside in the subgranular zone (SGZ), at the base of the 
DG facing the hilus, and they extend radial processes along the granule layer or granule cell layer 
(GCL). Upon division, stem cells give rise to intermediate progenitors (light blue), which will in turn 
divide and generate first neuroblasts (blue) and finally immature (purple) and mature neurons (pink). 
Mature granule cell neurons extend their dendrites to the molecular layer to receive cortical input.  In 
the SVZ, stem cells (green) reside in the wall of the lateral ventricles underneath the ependymal layer 
(grey). These also give rise to intermediate progenitors (light blue) and neuroblasts (purple). 
Neuroblasts migrate out of the SVZ, and they do so in chains that reach the olfactory bulb (OB) along 
the rostral migratory stream (RMS). In the OB, neuroblasts mature into functionally distinct neurons 
(red and peach). (Figure reproduced with permission from Johnson et al., 2009) 
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 Excluding the hippocampus and the SVZ, the rest of the adult brain is 
considered non-neurogenic under physiological conditions, and this is because, even 
if dividing cells are found in other areas of the brain in large numbers, these do not 
give rise to functional neurons. Numerous reports, however, have claimed 
neurogenesis to be a more widespread phenomenon, and to take place also in other 
areas like the neocortex, the striatum and the hypothalamus (Dayer et al., 2005, 
Gould, 2007, Kokoeva et al., 2005). Furthermore, multiple studies have suggested 
that in response to pathological stimuli, otherwise “non-neurogenic” areas can 
become neurogenic (Magavi et al., 2000). Hypoxia and ischemia appear to be two 
insults that trigger this response (Arvidsson et al., 2002, Ohira et al., 2010). 
1.1.3 Neurogenesis in the adult human brain 
The discovery that new neurons are generated in the adult brains of humans by Peter 
Eriksson’s analysis of tissue from deceased cancer patients in the late nineties 
(Eriksson et al., 1998), indeed helped overcome the scepticism with which adult 
neurogenesis was met and certainly facilitated the huge advancement in the field. 
The lack of techniques to study neurogenesis in the human brain, however, meant 
that the knowledge regarding the extent and the relevance of this process in humans 
was not extensive. In recent years, nonetheless, a few novel techniques have been 
introduced that have allowed for a better understanding of human neurogenesis in 
adult brains. 
 One of the approaches brought forward for measuring levels of neurogenesis 
in the human brain in vivo was the use of non-invasive imaging strategies, like that 
shown by Manganas and colleagues (2007), which used magnetic resonance 
spectroscopy to measure a biomarker associated with neurogenesis in the 
hippocampus. Another more recent and innovative approach used carbon dating to 
measure neurogenesis in humans relying on elevated levels of 14C in genomic DNA 
following terrestrial nuclear bomb testing. With this technique, the group led by 
Jonas Frisén, was able to show that in adult humans there is a significant turnover of 
hippocampal neurons, with 700 of them being generated per day (Spalding et al., 
2013).  
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Therefore, it is now clear that new neurons are born in the human 
hippocampus and that they may contribute to brain function. However, the evidence 
supporting neurogenesis in the adult human SVZ is less conclusive. Some groups 
report the presence of neurogenesis in this area in humans as well as the existence of 
a chain of migratory neuroblasts as seen in the rodent RMS (Curtis et al., 2007), 
while others find no detectable addition of neurons in the olfactory bulb and show 
that this is almost completely absent after childhood (Sanai et al., 2011). In view of 
this controversy, Frisén’s group has used the carbon dating technique to investigate 
the presence of neuron-producing progenitors in the lateral ventricles of humans. 
What they found is that while there are neuronal precursors present in the SVZ of 
humans, neuroblasts generated here appear to migrate, in their majority, to the 
striatum. Moreover, they find that, very interestingly, these adult-generated striatal 
neurons are preferentially depleted in Huntington’s disease patients (Ernst et al., 
2014; see also section 1.3.6).  
 No doubt new in vivo approaches to study neurogenesis in adult human brains 
will clarify a lot of the questions that remain regarding the relevance of the newly 
born neurons. These, however, will likely be complemented with novel in vitro tools 
that facilitate the manipulation of neuronal progenitors. The use of human pluripotent 
embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), for 
example, have revolutionised our understanding of the mechanisms governing stem 
cell maintenance and subsequent differentiation (Jessberger and Gage, 2014, Yu et 
al., 2014, Yu et al., 2013). In the near future, the use of cerebral organoids derived 
from human cells will also allow for the study of integration and functional 
connectivity within live neuronal networks (Lancaster et al., 2013, Pasca et al., 
2014).  
1.1.4 An evolutionary view of adult neurogenesis 
In order to understand adult neurogenesis in a general context, it is important to very 
briefly consider how this trait might have evolved. Two main ideas have been 
postulated to answer this question. The first, and possibly the most widespread of 
these is based on the idea that neurogenesis in adult organisms was gradually lost 
during the course of evolution (Kaslin et al., 2008, Lindsey and Tropepe, 2006). 
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While in mammals adult neurogenesis is restricted to two telencephalic active 
regions, in non-mammalian vertebrates (fish, amphibians, birds and reptiles) 
proliferation and neuron generation occur extensively (Barker et al., 2011). The 
neuroscientist Pasko Rakic (2004) has suggested that this decrease in the extent of 
adult neurogenesis in mammals, and in particular in humans, might be due to a 
resistance to incorporate new neurons into an already established and mature 
network, and that strong suppressors of neurogenesis have evolved to restrain the 
potential of progenitors in the brain. 
 The alternative idea proposed by Gerd Kempermann (2012) is that 
neurogenesis in the adult DG might be instead a late-evolved trait, and that the 
plasticity conferred to the hippocampus by the addition of new neurons might have 
provided mammalian species with the ability to adapt to new and challenging 
environments. A number of arguments support this idea. First, even though the 
hippocampus is an ancient part of the brain, lower vertebrates do not have a DG and 
therefore lack a comparable functional structure (Treves et al., 2008). Moreover, 
when considering the proposed function of adult neurogenesis in rodents (see below), 
it becomes apparent that the flexibility to contextualise important pieces of 
information can provide a beneficial advantage to conquer new ecological niches 
(Glasper et al., 2012, Kempermann, 2008). Quantitative analysis of adult 
neurogenesis in more species, together with computational models that factor 
adaptation in will provide further evidence to prove or disprove these theories. 
1.2 Neurogenic niches in the adult brain 
Increasing understanding of the mechanisms controlling self-renewal and 
differentiation have made it apparent that stem cell function, and particularly cell fate 
decisions are under the influence of the microenvironmental niche the stem cells 
reside in. This role is highlighted by transplantation experiments where, for example, 
both DG-derived progenitors and neonatal cerebellar astrocytes are able to generate 
olfactory interneurons when grafted into the SVZ, while progenitors derived from the 
SVZ differentiate into glial cells if transplanted into non-neurogenic regions of the 
brain (Seidenfaden et al., 2006, Suhonen et al., 1996, Zheng et al., 2006). In the adult 
brain, some common components of the neurogenic niches that are known to 
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regulate stem cell function are blood vessels, mature residing astrocytes, the 
extracellular matrix, and several innervating neurotransmitter systems, among others 
(Doetsch, 2003). Understanding how each of these components regulates adult stem 
cells will be critical for better comprehending the mechanisms by which these cells 
are kept in a tight balance between self-renewal and differentiation and, ultimately, 
for the exploration of therapeutic applications. 
1.2.1 The SVZ neurogenic niche 
The neurogenic niche lining the lateral ventricles, the SVZ, has been extensively 
studied in past years and some defining features have started to emerge (Figure 1-2; 
Ihrie and Alvarez-Buylla, 2011). The SVZ, as the DG of the hippocampus, consists 
of three populations of lineage-related progenitors. The slowly dividing population 
of NSCs (B cells) lines the ventricle and gives rise to C cells, which correspond to 
transit amplifying progenitors that in turn divide to generate neuroblasts (A cells). 
These will migrate along the rostral migratory stream (RMS) to reach the olfactory 
bulb and integrate into the circuitry (Zhao et al., 2008).  
B cells in the SVZ contact the ventricles through specialized apical processes 
that contain a primary cilium, while at the same time contacting blood vessels 
through long basal processes. In this way, B cells are exposed to both cerebrospinal 
fluid and blood-borne factors (Mirzadeh et al., 2008, Shen et al., 2008, Tavazoie et 
al., 2008). The influence of blood vessels on B cells is not restricted to vasculature-
secreted soluble factors, though. Direct cell-cell contact between blood vessels and 
SVZ NSCs has been shown to maintain these in a quiescent state. Endothelial 
receptors ephrinB2 and Jagged1 work together to regulate stem cell behaviour by 
suppressing cell cycle entry and inhibiting differentiation, respectively (Ottone et al., 
2014). This data suggests a model where contact with the vasculature keeps stem 
cells quiescent, while loss of this anchorage makes NSCs prone to differentiation in 
response to soluble factors released in the niche, and highlights a possible 
mechanism by which the neurogenic niche is able to promote opposite biological 
outcomes. 
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Figure 1-2 Schematic of the SVZ neurogenic niche 
Stem cells in the SVZ (B1, dark blue) reside just beneath the ependymal layer that lines the lateral 
ventricles. Ependymal cells (E1 and E2, brown) are multicilliated cells that form pinwheel structures 
on the ventricle surface. B cells contact the ventricle with an apical process that extends through the 
ependymal pinwheel structure. B cells also contact blood vessels (Endo, red) through basal processes. 
Once activated, B1 cells (B1a, light blue) give rise to transit-amplifying C cells (green), which, in turn, 
generate A cells or neuroblasts (red, shown here as a migrating chain). The SVZ receives innervation 
from a number of different neurotransmitter systems (e.g. serotonin, 5HT; dopamine, DAt; 
acetylcholine, ChAT). (Figure reproduced with permission from Lim and Alvarez-Buylla, 2014) 
Another component that, also in relation with the blood vessels, has been 
shown to be important in maintaining stem cell function in the SVZ, is the astrocytes. 
Astrocytic processes contact all cell types in the SVZ niche. End-feet within these 
processes are closely associated to the walls of blood vessels, and regulate, like this, 
the induction and maintenance of the blood-brain barrier (BBB, Abbott et al., 2006). 
At sites where NSCs’ basal processes contact the vessels, however, astrocytic end-
feet are absent, thus modifying the BBB and exposing NSCs to blood-derived factors 
(Tavazoie et al., 2008). Moreover, clusters of proliferating B and C cells appear to be 
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associated with blood vessels at these sites where the BBB is leaky (Tavazoie et al., 
2008), pointing at the regulation of progenitor cells of the SVZ by molecules in the 
circulation. 
And finally, NSCs of the SVZ are found intercalated within ependymal cells, 
a single layer of multi-ciliated cells adjacent to the ventricle that form pinwheel-like 
structures around the apical processes of B cells (Mirzadeh et al., 2008). Ependymal 
cells synthesize molecules such as noggin, a bone morphogenetic protein (BMP) 
inhibitor, and platelet-derived growth factor (PDGF) that maintain the mitogenic 
character of stem cells (Jackson et al., 2006, Lim et al., 2000). All of these examples 
show the close connection that exists between stem cells and their niches, and how 
these associations are not merely anatomical, but that they also create functional 
links. 
1.2.2 The DG neurogenic niche 
In the case of the DG, the nature of the stem cell-niche interactions is less well 
understood, but some examples of their associations are increasingly coming to light. 
Progenitors in the SGZ have also been shown to bare close associations with blood 
vessels, the extracellular matrix and post-mitotic cells like neurons, astrocytes and 
microglia (Figure 1-3). 
Astrocytes in the hippocampus represent one of the major contributors to the 
niche, as they appear to play a number of important and apparently opposite roles. 
For example, they have been shown to promote both progenitor proliferation and 
neuronal fate commitment by, in part, the secretion of Wnt molecules (Song et al., 
2002, Lie et al., 2005; see also section 1.4.2.1), as well as the expression of ephrinB2 
on their surface (Ashton et al., 2012). At the same time, astrocytes have been 
involved in the negative regulation of neurogenesis in vitro via a mechanism 
involving Jagged1 and Notch signalling (Wilhelmsson et al., 2012). 
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Figure 1-3 Schematic of the neurogenic niche in the DG 
Stem cells in the DG (NSCs, dark and light blue), which can be in an active or quiescent state, reside 
in the subgranular zone. Horizontal astrocytes and intermediate progenitors (type II a and type II b, 
dark green) also reside here, while neuroblasts (type III, light green) and granule neurons (yellow) 
reside in the granule cell layer. Intermediate progenitors and NSCs are in physical contact with blood 
vessels in the DG. Astrocytes (purple) and interneurons (red) are located either in the hilus or granule 
cell layer and they are important constituents of the niche. (Figure reproduced with permission from 
Urbán and Guillemot, 2014) 
Microglial cells are another cell type present in the niche that is important in 
DG neurogenesis. Microglia are the primary immune cells of the brain, and with 
their dynamic processes they interact with neurons, astrocytes and endothelial cells, 
among others, to constantly survey the local environment (Nimmerjahn et al., 2005). 
Phagocytosis of new-born DG cells by microglia provides a mechanism for 
maintaining a basal level of neurogenic output, and therefore maintaining 
hippocampal homeostasis (Sierra et al., 2010). Not only this, but microglial function 
in the niche also depends on the secretion of cytokines and chemokines that 
contributes to the balance of pro- and anti-inflammatory signalling that will either 
positively or negatively regulate neurogenesis (Carpentier and Palmer, 2009, Battista 
et al., 2006, Monje et al., 2003). 
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A few important examples also exist when considering physical contacts 
between neuronal precursors in the SGZ and components of the niche. The most 
significant of these is the intimate association of neuronal precursors and blood 
vessel endothelial cells. In a study carried out by Palmer and colleagues (2000), 
progenitors in the DG were found to be, as those in the SVZ niche, forming dense 
clusters adjacent to or surrounding small capillaries. Moreover, when studying the 
phenotype of cells incorporating 5-bromo-2’deoxyuridine (BrdU) after 2 hours of 
injection, they found 37% of BrdU immunoreactive cells to be of endothelial lineage, 
a discovery that led to the suggestion that neurogenesis is uniquely associated with 
the process of angiogenesis in the DG. The intriguing possibility of an intricate 
functional cross-talk between components of the nervous and vascular systems in the 
adult DG makes for an appealing hypothesis but has yet to be confirmed, as the 
finding of angiogenesis in this region of the adult brain has not yet been replicated 
(see Appendix 2 for a brief characterisation of angiogenesis in the DG, also 
performed as part of my doctoral work). 
1.3 The adult mouse hippocampus 
The hippocampus, or hippocampal formation, is a bilateral structure situated within 
the temporal lobes of the brain. It consists of four parts: the dentate gyrus, the cornu 
ammonis (or CA), the parasubiculum and the subiculum. The simple laminar pattern 
into which it is organised has made the hippocampus a central model system to 
record synaptic events, and as that, one of the most studied areas of the mammalian 
central nervous system (CNS; Li et al., 2009b, Neves et al., 2008). It is generally 
accepted that the hippocampus serves a crucial role in some forms of learning and 
memory. Lesions of the hippocampus in humans results in an inability to form new 
episodic memories, as was the case for the famous patient H.M., who underwent 
surgery to remove the medial temporal lobes as a way to treat intractable epilepsy 
(Scoville and Milner, 1957). Further studies using animal models have strengthen 
this understanding. Loss of hippocampal function both by controlled lesions and 
pharmacological or genetic inactivation of specific neuronal circuits have led to 
results involving a failure to learn or a loss of spatial or temporal memory, and have 
suggested to fit a model where the role of the hippocampus is to establish a spatio-
temporal organization of memories (Eichenbaum, 2013). 
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1.3.1 Neuronal circuits in the adult hippocampus 
The mammalian hippocampus consists of a trisynaptic core circuit that is organised 
in a unidirectional progression of excitatory pathways that links the DG, the CA3 and 
the CA1 (Figure 1-4; Li et al., 2009b, Kempermann, 2011a). The starting point of the 
trisynaptic hippocampal circuit is the entorhinal cortex (EC), from where, via the 
perforant path, most of the sensory information reaches the hippocampus. Afferents 
from layer II of the EC project through the subiculum to the dendrites of the granule 
cells in the outer molecular layer of the DG. Here, the axons of the granule cells form 
the mossy fibre tracts that will terminate on the dendrites of CA3 pyramidal cells.  
The last synapse in the circuit consists of a projection, termed Schaffer collateral 
projection, between the pyramidal neurons of CA3 to those in CA1. CA1 neurons 
finally return, through the subiculum, to convey sensory information to the EC, the 
cortical region of origin. Other pathways exist that add complexity to the concept of 
the trisynaptic circuit. The EC, for example, can bypass the DG and directly project 
to CA3 and CA1. Moreover, numerous types of local inhibitory interneurons 
modulate the neuronal activity of the DG mossy fibres; while a number of 
neurotransmitter systems project to the hippocampus from the rest of the brain. The 
hippocampus is, therefore, under the control of an extensive input system, which will 
undoubtedly have a profound influence on the regulation of neurogenesis in this 
region of the adult brain. 
 
Figure 1-4 Schematic of the hippocampal network (legend next page) 
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Figure 1-4 Schematic of the hippocampal network 
Sensory information reaches the hippocampus through the entorhinal cortex (EC). The EC axons then 
project through the subiculum (SUB) to the DG, and from here to the CA3. Finally, CA3 neurons 
project to CA1, from where sensory information returns to the EC (see text for more details). (Figure 
reproduced with permission from Li et al., 2009b)  
1.3.2 Developmental origin of the hippocampal DG  
Within the hippocampal formation, it is only in the DG that neural progenitors are 
found and new neurons are generated throughout life. A developmental point of view 
might give us a clue as to why the DG of the hippocampus is different from other 
regions of the adult brain. For this reason, here I would like to very briefly address 
how is the DG generated and where do stem cells in the adult originate from. 
 The neuroepithelium that gives rise to the hippocampal formation is a part of 
the dorso-medial region of the telencephalon and it consists of three different 
components, each unique in terms of morphology and molecular markers (Sugiyama 
et al., 2013). These are the hippocampal neuroepithelium (HNE), the dentate 
neuroepithelium (DNE) and the cortical hem (CH). The DNE, also called primary 
matrix, represents the first proliferative zone from where the first granule cells are 
generated at embryonic day 14.5 (E14.5). At late gestational stages (E17.5) 
progenitors migrate out of the DNE into the nascent DG, and they do so along a 
primordial radial glial scaffold that extends from the CH to the pial surface. Around 
birth, the main proliferative zone switches to the dentate area, including the hilar 
region and the blades of the granule cell layer, which are starting to be formed (Li et 
al., 2009a). At this time the primordial radial glial scaffold disappears, with a 
secondary scaffold developing approximately a week after birth (Brunne et al., 
2010). From the second postnatal week, proliferation becomes limited to the SGZ of 
the DG, where it continues into adult life (For further information on each of the 
developmental steps and genetic regulators see Li and Pleasure, 2005). 
 The origin of the NSCs that will inhabit the SGZ of the adult hippocampus is 
still under examination. The prevalent hypothesis is that RGLs originate from hilar 
progenitors in the tertiary matrix that is formed at peri-natal stages (Brunne et al., 
2010, Namba et al., 2005, Seki et al., 2014). What the relationship between the 
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progenitors in the tertiary matrix and those in the primary and secondary ones is not 
completely understood, though. A recent study reported that the stem cells 
responsible for persistent neurogenesis in the adult DG are derived during late 
gestation from sonic hedgehog (Shh)-responsive cells from a restricted region in the 
ventral hippocampus (Li et al., 2013). With this data a number of questions arise. For 
example, is there more than one pool of progenitors that give rise to adult NSCs? 
And if so, do they respond differently to different signals in the environment? 
Answers to these questions will also have implications in the search for stem cell 
heterogeneity during adulthood, but further studies will be needed to answer them. 
1.3.3 Neuronal development in the adult DG 
The formation of new neurons in the SGZ of the adult hippocampus is characterised 
by the progression of a multi-potent, self-renewing population of stem cells to 
mature functional neurons through a number of different stages, where cells are 
identified by their proliferative ability, their morphology and position in the DG, and 
by the expression of specific markers (Figure 1-5; Kempermann et al., 2004, Ming 
and Song, 2011).  
The stem cell of the adult DG (type 1 cell or RGL) is a radial-glia-like cell, 
with its soma positioned in the SGZ and a single apical process that extends through 
the granule cell layer (GL). They share several features with astrocytes, such as 
electrophysiological properties, vascular end-feet, and the expression of the markers 
glial fibrillary acidic protein (GFAP), brain lipid-binding protein (BLBP) and 
glutamate aspartate transporter (GLAST). They can, however, be distinguished from 
astrocytes by their expression of Nestin, and their lack of the mature astrocytic 
marker S100β (Seri et al., 2001, Filippov et al., 2003, Kempermann et al., 2004, 
Brunne et al., 2010). Recently, a second type of type 1 cells, with short horizontal 
processes and higher proliferative ability, has been described. The lineage 
relationship of these cells and radial type 1 cells remains to be determined (Lugert et 
al., 2010). 
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Figure 1-5 Neurogenic lineage and markers used to study neurogenesis in the adult DG 
Stem cells or radial glia-like cells (RGLs, green) are positioned in the subgranular zone (SGZ) of the 
DG and have radial processes that extend along the granule layer (GL). They express the astrocytic 
markers GFAP and GLAST, but they do not express more mature astrocytic markers like S100β 
(mature astrocyte in dark blue). RGLs are found mainly in a quiescent state, but they will activate to 
give rise to the rest of the lineage. Intermediate progenitors (IPCs) are generated when RGLs divide 
asymmetrically. IPCs divide rapidly to amplify the lineage, and they are characterised by Ascl1 
expression first (purple), and Tbr2 expression after (orange). Cell division can be detected using 
antibodies against Ki67 and MCM2, or by BrdU incorporation (red nuclei). All precursor cells express 
Sox2. IPCs generate neuroblasts (light blue), and finally mature neurons (light brown). These express 
the markers doublecortin (DCX) and NeuN, respectively, and can be found in the GL.  
 In a young adult murine brain, thousands of RGLs exist, but only a small 
proportion of them (1-5%) undergo cell division at one time, with the majority of 
them being in a relatively quiescent state (Kronenberg et al., 2003, Seri et al., 2001). 
At present, a number of models exist to explain the long-term potential and self-
renewal capabilities of adult RGLs (Figure 1-6). Using population analysis, Encinas 
et al. (2011) came to the conclusion that RGLs undergo activation-dependent 
depletion throughout adulthood, and therefore do not possess long-term maintenance. 
According to this study, when RGLs exit quiescence and enter the cell cycle, they 
divide asymmetrically, three times on average, to generate new neurons before 
terminally differentiating into astrocytes. In conflict with this model, Bonaguidi et al. 
(2011) showed, by performing clonal analysis, that RGLs undergo several rounds of 
division to produce both neurons and astrocytes over a long period of time, and that 
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therefore RGLs are capable of self-renewal and multilineage differentiation. Yet 
another study by Dranovsky et al. (2011) has reported that RGLs in the adult 
hippocampus can accumulate, and that the lineage outcome is dictated by the 
animal’s environment. In this model, an enriched environment can shift the RGL 
lineage toward a terminal neuronal population, while social isolation and irradiation 
result in an accumulating RGL population. The idea behind this form of neuronal 
plasticity is that accumulation of RGLs under deprived conditions would lead to 
increased neurogenesis in ameliorating conditions. The differences observed in the 
properties of RGLs in these studies have been attributed to differences in 
experimental designs, and particularly in the targeting and labelling of divergent 
RGL populations (Bonaguidi et al., 2012, Encinas and Sierra, 2012), pointing at a 
potential heterogeneity between apparently similar precursor populations. 
 
Figure 1-6 Models for stem cell behaviour in the adult hippocampus 
Two main models have been proposed to explain RGL behaviour in the DG. Bonaguidi et al., 2011 
propose a model where RGLs can divide symmetrically to generate additional RGLs, as well as 
asymmetrically to generate neuronal and astroglial lineages. Stem cells can, therefore, cycle between 
quiescent (G0) and active states (G1èM). Similarly, Dranovsky et al., 2011 have proposed that RGLs 
are able to divide symmetrically and accumulate, but that the environment dictates this behaviour 
(opposed to a terminal neurogenic behaviour). In contrast, in the disposable RGL model proposed by 
Encinas et al., 2011, once activated, RGLs only divide a number of times before they terminally 
differentiate into astrocytes. In this model, therefore, activated RGLs cannot return to a quiescent 
state. (Figure adapted and reproduced with permission from Bonaguidi et al., 2012) 
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 It is generally accepted, nevertheless, that once RGLs enter the cell cycle to 
undergo an asymmetric division, they give rise to transit-amplifying progenitor cells, 
type 2 cells or intermediate progenitors (IPCs). Morphologically, IPCs are small with 
short, tangentially-oriented processes, and they are normally located in clusters 
exclusively in the SGZ. One defining property of these cells is their highly 
proliferative ability, which accounts for the bulk of mitotic activity in the DG and for 
the large amplification observed in the lineage (Kronenberg et al., 2003). Two 
subgroups of type 2 cells can be distinguished: type 2a, or early IPCs, still express 
Nestin and also express the bHLH factor Ascl1; type 2b, or late IPCs, on the other 
hand, do not express Nestin and start expressing markers characteristic of neuronal 
commitment, namely, the T-box transcription factor Tbr2 and the bHLH 
transcription factor neurogenin 2 (Neurog2; Kempermann et al., 2004). Another 
characteristic marker expressed in all precursor cells, including RGLs, is Sox2, an 
HMG-containing transcription factor that is also broadly expressed by astrocytes 
throughout the nervous system (Suh et al., 2007). 
 Transition of IPCs into neuroblasts or type 3 cells involves great 
morphological changes and shows of functional differentiation. These cells are 
further advanced in the expression of neuronal features and express the immature 
neuronal markers prospero homeobox-1 (Prox1) and doublecortin (DCX) and the 
polysialylated neural cell adhesion molecule (PSA-NCAM, Lavado et al., 2010, 
Kempermann et al., 2004). At this stage, neuroblasts migrate to the GL and show a 
rounded nucleus with an apical dendrite, and whereas some of them retain the ability 
to proliferate, most of them become post-mitotic. Also, it is at this point when 
network connections are established and the selection for long-term survival occurs 
(Kempermann et al., 2004).  
Finally, as neuroblasts migrate into the GL, they down-regulate DCX 
expression and up-regulate expression of more mature neuronal markers, such as 
NeuN and calretinin (Kempermann et al., 2004, Brandt et al., 2003). Features of 
mature neurons, like the expression of calbindin, are displayed at about 4 weeks of 
age, but new-born cells will continue to physiologically and morphologically change 
until up to 6-7 weeks of age, when they will become functionally indistinguishable 
from older granule cells (Jessberger and Kempermann, 2003, van Praag et al., 2002).  
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Retrovirus-mediated GFP-labelling of dividing cells has allowed for accurate 
morphological and electrophysiological analysis of adult-born neurons (Figure 1-7; 
van Praag et al., 2002, Zhao et al., 2006, Esposito et al., 2005). Such studies have 
shown that it is from an early post-mitotic stage, between 3 days post injection (dpi) 
and 14 dpi, during the phase of calretinin expression, that the largest part of the 
dendritic tree is built. During this time dendritic processes reach the outer edge of the 
molecular layer, while the axon fibres reach the CA3. Spine formation and growth 
starts taking place only once the first stage of dendritic and axonal growth is 
completed. It is also from this time that the major synaptic connections are generated 
(Zhao et al., 2006). In terms of functional maturation, it appears that neuronal 
differentiation in the adult hippocampus resembles that of its development. During 
the first week post-injection the cells are synaptically silent, and it is only after 2 
weeks that the first γ–aminobutyric acid (GABA)-ergic synaptic inputs appear 
(Esposito et al., 2005). This first GABAergic input is excitatory and it drives further 
maturation and integration of the new-born neurons (Ge et al., 2006). By the fourth 
week glutamatergic input becomes detectable, coinciding with the display of mature 
characteristics like the presence of mature dendritic spines and the increased synaptic 
plasticity. Maturation is completed with the inhibitory response to GABA at 
approximately four weeks in neurons already possessing functional glutamatergic 
inputs (Esposito et al., 2005).  
 
Figure 1-7 Time course of neuronal development in the adult DG (legend next page) 
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Figure 1-7 Time course of neuronal development in the adult DG 
Progression of neuronal development from 0 days (RGL division) to functional integration of a 
mature granule neuron (28 days). After the IPC stage, the dendritic tree starts to be built, being mainly 
formed by day 14. It is also during this time that the first GABAergic excitatory input appears. 
Glutamatergic input is only detected after this. At 28 days, newly born cells show mature features, 
with spiny dendrites reaching the molecular layer, an axonal projection extending towards CA3, and 
with the appearance of glutamatergic inputs and GABAergic inhibitory inputs (see text for more 
details). (Figure reproduced with permission from Li et al., 2009b) 
1.3.4 Regulation of adult neurogenesis in the hippocampus 
One of the main characteristics of neural precursors in the hippocampus, and 
probably one of the main reasons that makes neurogenesis in the adult DG such an 
intriguing and captivating topic is their being regulated by an ever-increasing number 
of physiological and pathological stimuli. Importantly, many of the stimuli that have 
been shown to influence neurogenesis in the hippocampus, have also been shown to 
cause a corresponding change in cognitive performance (Table 1-1; Li et al., 2009b), 
emphasising its influence in every-day behaviour and therefore giving the matter 
even more significance. 
Now, what does regulation actually refer to when talking about regulation of 
adult neurogenesis? And how is regulation different from control in this context? To 
answer these questions it is useful to go back in time and look at neuronal 
development in an embryonic context. During embryonic development, when 
describing the intrinsic and specific genetic programmes that determine the fate of a 
cell at a specific time, we refer to the control of neurogenesis. During adulthood, 
these genetic programmes are still in place, but here, as an obvious confirmation of 
the interaction of the hippocampal neurogenic niche with the outer world, it is 
instead the regulation by extrinsic factors that plays a bigger part in the formation of 
new neurons (Kempermann, 2011b). This distinction between control and regulation, 
even though blurred at times, makes adult neurogenesis a very unique process, where 
development is not the final goal, but plasticity and adaptation are. Only the fine-
tuned balance between intrinsic control and extrinsic regulation, as well as the 
careful and relevant integration of these inputs, allows for the correct response to 
take place and for, in the last instance, the normal function of hippocampal circuits 
(Kempermann, 2011b).  
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Another important point to bring forward at this stage is the idea that 
regulation can occur at many different levels during neuronal development. Not only 
precursor proliferation can be the target of regulatory mechanisms, but also neuronal 
survival or integration of new neurons into pre-existing circuits can be affected in 
response to certain stimuli (Figure 1-8; Aimone et al., 2014). This inevitably adds a 
further level of complexity to an already complex system.  
 
Figure 1-8 Regulatory events in the neurogenic lineage 
Neurogenesis in the hippocampus can be regulated at multiple stages during the course of neuronal 
development, and the possible outcomes of this regulation are limited by decisions made at previous 
stages. Each step from stem cell maintenance, to IPC proliferation and expansion, neuroblast 
migration, and neuronal maturation are subjected to external regulation. (Figure reproduced with 
permission from Kempermann, 2011b) 
Here I do not aim to extensively describe each of the stimuli that have been 
shown to regulate neurogenesis (see Table 1-1 for a list of stimuli that influence adult 
neurogenesis), but only to briefly illustrate the concept of regulation and mention 
those environmental factors that will be relevant for this work.  
 
Introduction 
 
 41 
Table 1-1 Environmental stimuli known to regulate hippocampal neurogenesis 
Regulator Effects on 
neurogenesis 
Effects on 
cognition 
References 
Physical activity 
Voluntary running 
 
Increased proliferation 
 
Improved learning 
and memory 
 
van Praag et al., 
1999 
Enrichment Increased neuronal 
survival 
 
Improved learning 
and memory 
Kempermann et al., 
1997 
Young et al., 1999 
Kronenberg et al., 
2003 
Learning Increased and decreased 
neuronal survival 
(depending on stage of 
neurogenesis) 
Improved learning 
and memory 
Dobrossy et al., 2003 
Sleep 
Acute sleep 
deprivation 
 
Chronic sleep 
deprivation 
 
Increased proliferation 
and neuronal survival 
 
Decreased proliferation 
 
NA 
 
 
NA 
 
Grassi Zucconi et al., 
2006 
 
Mirescu et al., 2006 
Stress 
Physical stress 
 
Psychosocial stress 
 
Decreased proliferation 
 
Decreased proliferation 
 
NA 
 
Impaired contextual 
memory 
 
Malberg and 
Dunman, 2003 
Gould et al., 1998 
Dong et al., 2004 
Ageing Decreased proliferation Correlated 
impairment in 
learning and memory 
Kuhn et al., 1996 
Driscoll et al., 2006 
 
The first reports of environmental factors as positive regulators of adult 
neurogenesis came from experiments showing that mice that lived in an enriched 
environment had more new neurons in the DG than littermates living in standard 
cages (Kempermann et al., 1997). It is now generally believed that environmental 
enrichment is predominantly a survival-promoting stimulus, and that it acts mainly 
on new-born neurons (Kronenberg et al., 2003, Young et al., 1999), although it can 
also promote survival of precursors in long-term experiments (Kempermann and 
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Gage, 1999). There are, however, reports that show different responses to 
environmental enrichment in different strains of mice (Kempermann et al., 1998a), 
highlighting the importance of genetic factors in these responses. It is voluntary 
running that has mainly a positive effect on precursor cell divisions (van Praag et al., 
1999), in particular in the proliferation of type 2 IPCs (Kronenberg et al., 2003, 
Steiner et al., 2008). Interestingly, the effects of these two pro-neurogenic stimuli, 
which mainly act through different mechanisms, have been shown to be additive, as 
physical activity together with an enriched environment exerted a larger effect on 
adult neurogenesis than any one stimulus alone (Fabel et al., 2009). 
A number of factors have been linked to environmental enrichment and 
physical activity and are thought to, at least in part, mediate their survival and 
proliferative effects. One of these is vascular endothelial growth factor (VEGF). 
VEGF was first identified as an angiogenic protein, but it is now known to also 
promote neurogenesis by acting on progenitor cells to increase their proliferation. 
VEGF is expressed by granule cells of the hippocampus (Lee et al., 2009), while 
VEGF receptor 2 (VEGFR2 or Flk1) is present on DCX-expressing cells (Jin et al., 
2002), a pattern of expression that would correspond with the suggested function. 
Indeed, blockade of peripheral VEGF abolished the induction of neurogenesis in 
response to physical activity (Fabel et al., 2003). Similar results were shown for the 
action of Insulin-Like Growth Factor-1 (IGF-1) in mediating some of the effects of 
the exercise-induced neurogenic response in rats. This systemically-acting factor was 
shown to accumulate in neurons during physical activity (Trejo et al., 2001).  
Another factor that has been extensively studied with a focus on adult 
neurogenesis is the brain-derived neurotrophic factor (BDNF). Here, BDNF is 
regarded as a survival and maturation factor. Chronic infusion of BDNF in the adult 
DG of rats resulted in an increase of the number of newly born granule cells 
(Scharfman et al., 2005). Moreover, both physical activity and environmental 
enrichment lead to increased BDNF expression (Zajac et al., 2010), and lower BDNF 
levels in heterozygous BDNF knockout mice or impaired TrkB neurotrophin receptor 
activation, are able to abolish the survival-promoting effect of an enriched 
environment (Rossi et al., 2006, Sairanen et al., 2005).  
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Both growth factors, like VEGF and IGF-1, and neurotrophic factors, like 
BDNF, share a common signal transduction mechanism: ligand binding to one of the 
tyrosine kinase family of receptors results in its autophosphorylation and later 
activation of downstream signalling pathways, of which the PI3K/Akt and the 
MAPK/Erk pathways stand out. IGF-1’s proliferative effect on adult hippocampal 
progenitors has been shown to be dependent on the activation of the MAPK pathway 
in vitro (Aberg et al., 2003). Another study showed inhibition of the PI-3K/Akt 
signalling pathway by infusion of the inhibitor LY294002 to abolish the increased 
exercise-induced survival of newly generated neurons, but had no effect on the 
upregulation of precursor proliferation (Bruel-Jungerman et al., 2009). These results 
suggest that different trophic factors might have divergent functions by activating 
different signalling pathways. 
In addition to these positive regulators of adult neurogenesis, namely physical 
activity and environmental enrichment, there are a number of factors that appear to 
decrease neurogenesis either by directly reducing the number of proliferating 
precursors and/or by decreasing the number of functional integrating neurons. One of 
the most studied of these is stress. Stress, both acute and chronic, regulates 
neurogenesis by decreasing the proliferation of progenitor cells in the DG (reviewed 
in Mirescu and Gould, 2006). This effect appears to be common among species and 
stressors, including both physical (e.g. foot shock; Malberg and Duman, 2003), and 
psychological stressors (e.g. resident-intruder stress and isolation; Dong et al., 2004, 
Gould et al., 1998). The effects of stress on the production of new neurons are still 
being investigated, with studies showing contradictory results; some show a 
suppression of neuron generation and others show periods of enhanced cell survival 
that follow the decrease in precursor divisions (Mirescu and Gould, 2006). 
Even though the understanding of the signalling pathways involved in the 
anti-neurogenic response following stress is far from clear, substantial evidence now 
suggests that hormones play an important role in this process. An elevation of 
glucocorticoid levels is thought to be one of the main mechanisms involved in the 
stress-mediated suppression of proliferation, since the removal of circulating adrenal 
steroids by adrenalectomy increased neurogenesis, and the increase of exogenous 
corticosterone had the opposite effect (Cameron and Gould, 1994). 
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While a number of physiological stimuli appear to influence the activity of 
cell types late in the lineage (i.e. type 2, type 3), few of these have been shown to 
regulate the activity of type 1 RGLs. Whether this is due to a lack of stem cell 
markers that would allow for a direct investigation of their responses, or whether it 
reflects a real propensity of stem cells to be partly excluded from external 
stimulation to avoid their exhaustion, is something it is not known. So far, only 
epileptic seizures are known to alter RGL’s activity. Seizures result from 
synchronized hyperactivity of excitatory synapses, and they robustly increase 
precursor cell proliferation (including type 1, type 2 and type 3 cells; Steiner et al., 
2008, Parent et al., 1997). Contrary to what would be expected from an increase in 
proliferation, and possibly due to damage to the neurogenic permissiveness in the 
niche, the survival of newly generated neurons after chronic or severe seizures is 
reduced (Mohapel et al., 2004). 
1.3.4.1 Adult hippocampal neurogenesis and ageing 
The generation of new neurons in the adult DG sees a progressive reduction with 
increasing age, with a peak during early adulthood and a quick decrease thereafter. 
This reduction has been shown to be due to a decline in precursor cell proliferation 
(Kuhn et al., 1996, Kempermann et al., 1998b). I have included this negative 
regulator of neurogenesis separate from the rest because age can be considered 
special in a number of ways. Ageing is unavoidable and a fundamental determinant 
of life, and the reduction of neurogenesis in old age could be seen as a by-product of 
other age-related systemic and structural changes. Ageing, therefore, might be 
considered as a default regulatory factor to take into account when studying baseline 
levels of adult neurogenesis (Klempin and Kempermann, 2007). What is interesting 
in an ageing context is that physiological regulation of the baseline is still in place, so 
that both environmental enrichment and physical activity are able to stimulate adult 
neurogenesis to increase the number of new neurons produced (Kempermann et al., 
1998b, van Praag et al., 2005, Kempermann et al., 2002). Moreover, it seems that 
even though the baseline level in old age is lower, the relative regulation that is 
possible is larger, as it was shown that the effect of enrichment was, in relative terms, 
stronger in old animals compared to young ones (Kempermann et al., 1998b). 
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Despite a general agreement on the idea of loss of neurogenesis with age, the 
nature of the age-associated decline is still controversial. In the recent model 
proposed by Encinas and colleagues (2011), where the quiescent stem cell population 
suffers an activation-dependent deforestation, NSCs lose their stem cell properties 
and differentiate into astrocytes, making the reduced number of stem cells 
accountable for the reduced neurogenesis during ageing. This “disposable stem cell” 
model, as it became known, proposes that, under normal conditions, stem cells are 
used only once in the adult life; their activation is followed by a series of asymmetric 
divisions that eventually leads to their final differentiation into an astrocyte (Encinas 
and Sierra, 2012). 
Another model of the force driving age-related neurogenesis decline 
proposes, instead, that NSCs shift into a predominantly quiescent state, and thus 
preserve the potential to be activated by external stimuli (Bonaguidi et al., 2011, 
Bouab et al., 2011, Lugert et al., 2010, Hattiangady and Shetty, 2008). In this case, 
both a loss of neurogenic signals in the environment or a reduced potential of stem 
cells to respond to normal signalling could account for the decline in neurogenesis. A 
number of growth factors, like VEGF, FGF2 and IGF-1, have indeed been shown to 
decline with age (Shetty et al., 2005); stem cells, nonetheless, appear to maintain the 
capacity to respond to the neurogenic effects of growth factors. Restoration of IGF-1 
levels by intracerebroventricular infusion in aged rats, restored neurogenesis in the 
hippocampus (Lichtenwalner et al., 2001).  
It is likely that both mechanisms are in place in the adult DG, and that their 
relative contribution depends on other factors acting on stem cells throughout the 
animals’ lifespan. Elucidating the mechanisms underlying age-dependent impairment 
of neurogenesis and its ultimate impact on hippocampal function will be of great use 
in understanding the deleterious effects of ageing. 
1.3.5 Functional significance of adult hippocampal neurogenesis  
The primary function that has mostly been attributed to the adult DG is that of being 
responsible for the pattern separation of cortical inputs to the hippocampus. Despite 
extensive characterisation, however, the exact functional significance of newly 
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formed neurons still remains unclear.  The addition of new neurons to an otherwise 
stable circuit represents quite a unique challenge, especially since we know that the 
hippocampal neuronal networks undergo such dynamic regulation. Nonetheless, 
theoretical approaches using computational modelling have suggested that the 
presence, at any given time, of neurons at different stages of maturation, with each of 
them presenting distinct properties, could be an advantage, since their contribution at 
each of these stages could be different from that of mature granule cells (Aimone et 
al., 2010, Aimone et al., 2014, Marin-Burgin and Schinder, 2012).  
 A few major hypotheses are being considered when searching for the 
function of neurons born in the adult hippocampus. Importantly, these do not need to 
function exclusively from one another. The first couple of these hypotheses are 
related to pattern separation. Pattern separation is the distinct representation of very 
similar inputs: two different situations can be composed of many of the same objects 
or spatial features, yet they might still be stored as distinct non-overlapping 
memories. Several behavioural studies in mice and rats that performed spatial 
discrimination tasks, including radial-arm maze and fear context discrimination 
tasks, have validated this hypothesis (Clelland et al., 2009, Sahay et al., 2011). 
Related to this idea, is that of immature neurons being important for enhancing 
pattern separation for events separated in time, and therefore function as pattern 
integrators of temporally adjacent events (Aimone et al., 2010). These functions 
would be able to be carried out, as mentioned above, thanks to neuronal activity in 
the hippocampus being able to undergo differential decoding by a heterogeneous 
population of hippocampal granule neurons born at different times. Immature 
neurons have a low activation threshold and are, therefore, highly responsive and 
integrative, allowing them to encode memories derived from very similar stimuli 
(Clelland et al., 2009, Marin-Burgin et al., 2012). 
 More recently, a new and highly controversial hypothesis has been postulated 
to explain the function of new-born neurons in the adult DG. Based on computational 
models that predict that neurogenesis during adulthood would lead to the degradation 
of already established memories, as well as observations that infantile amnesia (or 
infantile forgetting) is correlated with high levels of hippocampal neurogenesis, a 
group led by Paul Frankland hypothesised that DG neurogenesis in the postnatal and 
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adult brains can modulate changes in memory persistence (Akers et al., 2014, 
Frankland et al., 2013). Using a contextual fear conditioning behavioural paradigm, 
this group was able to show that increasing neurogenesis after memory formation is 
sufficient to induce forgetting in adult mice, while decreasing the generation of new 
neurons, again after the memory has formed, has the opposite effect. These 
surprising results would suggest that neurogenesis in adult brains promotes the 
degradation of hippocampus-dependent memories. Further studies will have to 
confirm these findings and try to reconcile them with other studies in the field. 
1.3.6 Adult neurogenesis and neurological disorders 
 Interest in adult neurogenesis was heightened not only by the recognition that 
new neurons play specific roles during physiological brain function, but also by 
reports that suggested an association between arrested or altered neurogenesis and 
rodent models of both neuropsychiatric and neurodegenerative diseases. In this 
context, however, it became difficult to establish what is the cause and what the 
consequence: does pathology affect neuronal precursors and their ability to generate 
new neurons, or is it a failure of the neurogenic process that might contribute to 
disease progression? In an expansion of the latter idea, it has been proposed that 
neurodegeneration, rather than an increase in degeneration, could be the consequence 
of a lack of plasticity and regeneration, and thus reduced levels of neurogenesis 
could be underlying a pathogenic process (Steiner et al., 2006). Even though such 
idea probably only holds true for very specific aspects of disease, it sets the ground 
to explore the evidence for and against it. 
 Much of the evidence comes from studies of major depression, where it has 
been suggested that impaired adult neurogenesis might contribute to the development 
of the disorder (Jacobs et al., 2000). In models of stress and depression in mice, 
reduced neurogenesis appears to be one of the prominent features. Moreover, all 
known antidepressants enhance the number of neurons born in the adult DG, while 
some of those actually require neurogenesis here to be effective. In humans, patients 
with chronic depression show a loss of hippocampal volume as well as impairments 
in hippocampal-dependent functions (reviewed in Jacobs et al., 2000, Sahay and 
Hen, 2007). Similar findings have been presented for schizophrenia, a severe chronic 
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mental disorder with complex cognitive and affective symptoms; and these have also 
led to an adult neurogenesis theory of the disease. Schizophrenic patients have a 
reduced hippocampal volume, and post-mortem samples show decreased cell 
proliferation in the DG (reviewed in Reif et al., 2007). 
 Links between impaired adult neurogenesis and a number of 
neurodegenerative diseases have also been found. Evidence appears inconsistent at 
times with both positive and negative modulation of neurogenesis reported. Such 
inconsistencies can be reconciled if acute and chronic states are distinguished: while 
acute pathology tends to cause a transient increase of proliferation, a lasting 
reduction of adult neurogenesis is in general seen after chronic damage (Steiner et 
al., 2006). In Alzheimer’s disease (AD), for example, it has been noted that, during 
the course of the disease, post-mitotic neurons in the hippocampus are induced to 
enter the cell cycle, and this attempt normally fails and leads to their death (Nagy, 
2000). Of interest is that AD pathology, with β-amyloid (Aβ) plaque accumulation, 
begins in close proximity to precursor cells in the hippocampus, and presence of Aβ 
peptide in neuronal progenitor cell cultures has been shown to disrupt neuronal 
differentiation (Haughey et al., 2002).  
Associations to adult neurogenesis also exist with Parkinson disease (PD), which is 
characterised by dopaminergic cell loss and intracellular deposition of α-synuclein, 
and Huntington’s disease (HD), an autosomal-dominant disorder that leads to striatal 
degeneration. Data from post-mortem PD samples showed reduced numbers of 
precursor cells in the DG, a result that was also seen after dopaminergic 
deafferentiation to the DG in mice (Hoglinger et al., 2004). As for HD, while it had 
already been recognised that animal models of the disease show reductions in 
hippocampal neurogenesis, a recent report that showed that new neurons integrate 
into the striatum throughout life in humans, also showed that these adult-generated 
striatal neurons are preferentially depleted in HD patients (Ernst et al., 2014). 
Altogether, these findings open up the doors to an emerging potential to use 
endogenous neuronal precursors for clinically relevant therapies. 
Introduction 
 
 49 
1.4 Mechanisms involved in the control of adult hippocampal neurogenesis 
In contrast to the highly proliferative capacity of NSCs in the embryonic nervous 
system, NSCs in the adult hippocampus exist primarily in a quiescent state. And, 
unlike senescent or terminally differentiated cells, quiescent cells are able to re-enter 
the cell cycle and selectively respond to changing physiological demands as well as 
to aberrant pathological states (Bonaguidi et al., 2011, Encinas et al., 2011, Lugert et 
al., 2010). Here stem cells are required to continuously receive and integrate external 
inputs to generate an appropriate response, which for them it will primarily mean: to 
exit the cell cycle and remain in a dormant or quiescent state, to proliferate and 
promote neurogenic lineage progression, or to terminally differentiate (Figure 1-9; 
Beukelaers et al., 2012, Suh et al., 2009). It is the signals received from the niche, 
together with the mechanisms that intrinsically control the self-renewal and 
maintenance of the stem cell state that are critical for the correct response to stimuli 
and for preventing the exhaustion of the progenitor population during adulthood 
(Morrison and Spradling, 2008, Nakada et al., 2011, He et al., 2009, Schwarz et al., 
2012).  
 
Figure 1-9 The balance between quiescence and activation of stem cells is controlled by 
a number of extrinsic and intrinsic factors 
This scheme shows an RGL and the different extrinsic signals and intrinsic factors known to regulate 
their activity. The challenge for the future is to understand how all these signals are interpreted and 
integrated by RGLs (see text for details). (Figure reproduced with permission from Urbán and 
Guillemot, 2014) 
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In this section I will describe the mechanisms that are responsible for 
controlling that the tight balance between stem cell quiescence and self-renewal is 
under place. Despite all mechanisms working towards the same goal of normal adult 
hippocampal function and tissue homeostasis, I have divided the text into those 
mechanisms involved in the maintenance of quiescence, and those important for stem 
cell proliferation. These are themselves subdivided into extrinsic and intrinsic 
factors. 
1.4.1 Mechanisms involved in the maintenance of quiescence 
1.4.1.1 Extrinsic factors 
A common mechanism to prevent exhaustion of the progenitor pool is the active 
suppression of proliferation. For example, IPCs in the SGZ, through Notch ligands in 
their surface, activate Notch signalling in type 1 stem cells and like this provide a 
negative feedback regulatory mechanism that maintains the balance between 
dormant stem cells and activated progenitors. Indeed, conditional ablation of Notch1 
or of a downstream effector of Notch activity, RBPJ-κ, in type 1 NSCs resulted in a 
transient and rapid activation of progenitor proliferation, accompanied by a later 
depletion of the stem cell pool (Ables et al., 2010, Ehm et al., 2010, Imayoshi et al., 
2010). Interestingly, Ehm et al. (2010) found RBPJ-κ to be acting through the 
transcription factor Sox2 to control stem cell maintenance, which is in accordance 
with results showing that conditional deletion of Sox2 leads to a loss of RGLs and 
neurogenesis (Favaro et al., 2009). 
Similar to Notch1, BMP signalling was also shown to be essential in 
regulating the equilibrium between maintenance and proliferation of stem cells. 
BMPR-1A is expressed by adult hippocampal NSCs, and blockade or inactivation of 
the BMP pathway in the hippocampus results in an initial stimulation of proliferation 
and thus an increase in new-born neurons followed by an exhaustion of the stem cell 
population (Mira et al., 2010). Following this study, Guo et al. (2011) uncovered a 
mechanism by which BMP signalling is modulated in the DG. Loss of the RNA-
binding protein fragile X relative protein 2 (FXR2) resulted in enhanced BMP 
signalling and therefore increased stem cell proliferation and neurogenesis. FXR2 is 
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expressed by type 1 DG stem cells, where it colocalises and binds to noggin mRNA. 
Binding of FXR2 to noggin, a BMP antagonist, leads to reduced mRNA stability and 
therefore upregulated BMP signalling. 
 The role of neurotransmitters in controlling stem cell fate has gained 
momentum in recent years. In particular, the role that GABAergic transmission 
exerts during adult neurogenesis has received special attention (reviewed in Pallotto 
and Deprez, 2014). A number of studies have investigated the role of GABA 
signalling in the adult DG, and all of them are in agreement that GABA action on 
RGLs is important for promoting their quiescence in response to neuronal activity. 
Song et al. (2012) provided evidence for a role of γ2-subunit-containing GABAA 
receptors in dictating the stem cells’ choice between quiescence and activation. 
GABA is released by parvalbumin-expressing interneurons found in close proximity 
to RGLs in the SGZ. Similarly, deletion of the α4-containing GABAA receptor 
showed increases in precursor proliferation in the DG of adult mice (Duveau et al., 
2011). Giachino et al. (2014), on their part, found the metabotropic GABAB 
receptors to respond to GABA to inhibit neurogenesis, although it is yet to be 
confirmed whether this effect is direct on type 1 cells. 
1.4.1.2 Intrinsic factors 
A number of transcription factors have been proposed to mediate the activity 
of these extrinsic signals by inducing quiescence-promoting transcriptional 
programmes. One of these is FoxO3, a member of a gene family known to extend 
lifespan in invertebrates. FoxO transcription factors are regulated by Akt-dependent 
phosphorylation in response to growth factor and insulin stimulation. 
Phosphorylation of FoxO factors promotes their nuclear export, and thus represses 
their transcriptional function (Salih and Brunet, 2008).  Similar to the phenotypes of 
Notch and BMP conditional deletions, constitutive ablation of FoxO3 leads to a 
depletion of the NSC pool in adult mice. This transcription factor is thought to 
prevent premature exhaustion of NSCs by regulating genes controlling cell cycle re-
entry, differentiation, and oxygen and glucose metabolism (Renault et al., 2009). 
Another of such factors is the zinc finger repressor protein REST, which, by 
restraining the neurogenic programme, it maintains adult NSCs in a quiescent state; 
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and this is shown by the depletion of the progenitor pool and the decrease in granule 
neurons after conditional deletion of REST in SGZ NSCs (Gao et al., 2011). In the 
postnatal brain, the transcription factor nuclear factor 1/X (NFIX) has also been 
shown to control the quiescent state of RGLs (Martynoga et al., 2013). NFIX was 
identified using epigenomic profiling to establish enhancers associated with the 
quiescent state in BMP4-treated NSC cultures, which, also in this study, were 
demonstrated to acquire characteristic features of quiescent cells. NFIX gain and loss 
of function analyses in quiescent NSCs, as well as analysis of NFIX mutant mice 
suggested that this transcription factor might be controlling, among other aspects of 
the quiescent phenotype, some important cell adhesion properties, and thus the 
interaction of NSCs with their environment.  
While regulation of transcription is undeniably important in the intrinsic 
control of stem cell fate, mechanisms acting outside of the transcriptional level have 
also been identified. The RNA-binding protein fragile X mental retardation protein 
(FMRP), another member of the family of fragile X mental retardation proteins, was 
shown to bind to, and inhibit the translation of, Ccnd1, CDK4 and GSK3β mRNAs. 
Loss of FMRP resulted in increased stem cell proliferation, through Ccnd1 and 
CDK4 expression, as well as increased astrocyte differentiation at the expense of 
neuronal differentiation, through downregulation of Wnt signalling and Neurog1 
expression induced by increased GSK3β-dependent β-catenin inhibition (Luo et al., 
2010). 
1.4.2 Mechanisms involved in stem cell and progenitor proliferation 
1.4.2.1 Extrinsic factors 
One of the most studied extrinsic regulators that has been associated with precursor 
proliferation in the adult hippocampus is Wnt. The canonical Wnt/β-catenin 
signalling pathway plays important roles during development, and, notably, it is 
fundamental for the formation of the hippocampus. Several Wnt proteins, as well as 
multiple BMPs, are secreted by the CH in the dorsal telencephalon, the hippocampal 
organizer (Lee et al., 2000). In the adult brain, Wnt signalling has been shown to be 
required for different aspects of hippocampal neurogenesis, from precursor 
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proliferation, to neuronal differentiation and neurite maturation (reviewed in Varela-
Nallar and Inestrosa, 2013). The first indication pointing at a role in proliferation 
came from a study showing that inhibition of Wnt signalling almost completely 
abolished neurogenesis in vivo, while overexpression of Wnt3a was sufficient to 
promote precursor cell activity (Lie et al., 2005). Further studies showed, consistent 
with this idea, that the blockade of neurogenesis observed after Wnt inhibition 
resulted in hippocampus-dependent learning deficits (Jessberger et al., 2009, Mao et 
al., 2009). In embryonic hippocampal progenitor cell cultures, Wnt3a promoted cell 
proliferation by shortening the duration of the cell cycle (Yoshinaga et al., 2010). It 
has previously been proposed that the length of G1 can directly influence the cellular 
output of neural progenitor cells, and control the balance between proliferative and 
neurogenic divisions. This “cell cycle length hypothesis”, as it became known, 
indicates that shortening the cell cycle of NSCs during development is sufficient to 
increase their proliferative potential (Salomoni and Calegari, 2010). This idea was 
later expanded to also include stem cells in the adult brain. Overexpression of Cdk4 
and Ccnd1 in the hippocampus, two factors essential for G1 progression, resulted in a 
shorter cell cycle and an expansion of the NSC pool at the expense of neurogenesis 
(Artegiani et al., 2011). Keeping this in mind, Yoshinaga et al. (2010), suggest that 
Wnt in the developing hippocampus could be acting by regulating Ccnd1 expression, 
a well-known Wnt target, to shorten the cell cycle and promote proliferation. Further 
studies will be required to establish whether this might also be true for the adult 
brain.  
 Wnt signalling in the adult hippocampus has also been implicated in the 
regulation of neurogenesis in a number of physiological and pathological conditions, 
and ageing is a good example of this. Secretion of Wnt3a by astrocytes was shown to 
reduce with age, and to act to decrease hippocampal neurogenesis (Miranda et al., 
2012, Okamoto et al., 2011). Interestingly, however, this decline was found to be 
reversible. Exercise was able to restore the expression levels of Wnt3a and thereby 
rescue impaired neurogenesis in aged animals (Okamoto et al., 2011). Modulation of 
Wnt signalling with inhibitors secreted in the niche is also an important mechanism 
involved in the age-dependent reduction of neurogenesis. The expression of the 
inhibitor dickkopf-related protein 1 (Dkk1), for example, was reported to increase 
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with age to negatively modulate neurogenesis (Seib et al., 2013). A similar 
mechanism was proposed for the observed activity-dependent increase in precursor 
proliferation. Neuronal activity is proposed to decrease the expression of the granule 
neuron-produced Wnt inhibitor secreted frizzled-related protein 3 (sFRP3) to, in this 
case, positively regulate neurogenesis (Jang et al., 2013).  
Despite the undisputed importance of Wnt in regulating neurogenesis in the 
adult brain, some questions still remain. For example, it will be important to 
ascertain specifically which cells respond to Wnt, as well as to discriminate Wnt 
action on stem cells versus progenitors. A study looking at NSCs in the SVZ, for 
instance, has reported Wnt signalling only to be upregulated in stem cells dividing 
symmetrically, as it is the case in response to stroke or regeneration, but to be absent 
in stem cells dividing asymmetrically (Piccin and Morshead, 2011). 
Another extrinsic factor that has been studied and was shown to be important 
for precursor proliferation in the context of adult neurogenesis is Shh. Enhancement 
of Shh signalling with an agonist resulted in increased proliferation in both the DG 
and SVZ (Machold et al., 2003). What the sources of Shh are in the hippocampus is 
still unclear. However, both quiescent RGLs and IPCs were shown to respond to 
Shh, and these Shh-responsive cells were shown to contribute to on-going 
neurogenesis (Ahn and Joyner, 2005). Moreover, RGLs in the DG possess primary 
cilia. Conditional ablation of these primary cilia resulted in a reduction in the number 
of IPCs (Amador-Arjona et al., 2011), corroborating the idea that Shh signalling is 
important for precursor proliferation.    
1.4.2.2 Intrinsic factors 
The activation of NSCs requires a switch in the transcription factor programme, so 
that quiescent type 1 cells re-enter the cell cycle and promote lineage progression. 
The nature of this switch is currently not known, but a few clues are starting to 
emerge. Recent work described the nuclear receptor TLX to control NSC activation 
in postnatal mice, and thus ensure the proliferative ability of these cells, as well as to 
contribute to spatial learning and memory circuits. TLX loss leads to non-
proliferative NSCs that can be re-activated upon TLX reintroduction (Niu et al., 
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2011, Zhang et al., 2008). A number of factors have been proposed to collaborate 
with TLX to maintain stem cell self-renewal. For example, recruitment of histone 
deacetylases (HDACs) by TLX to target genes like p21 and PTEN, which normally 
supress proliferation, was reported to repress gene expression to maintain RGLs’ in 
an undifferentiated and proliferative state (Sun et al., 2007). Similarly, TLX 
cooperates with HDACs to inhibit transcription of microRNA 9 (miR-9) in 
proliferating cells, and thus supress neuronal differentiation (Zhao et al., 2009). In 
the SVZ, TLX was also shown to activate Wnt/β-catenin signalling, contributing to 
the stimulation of precursor proliferation (Qu et al., 2010) 
Different factors are involved in the maintenance of proliferation of the 
intermediate population of progenitors. This stage in the neurogenic process is 
marked by the up-regulation of the transcription factors Neurog2 and Tbr2. Absence 
of Neurog2 resulted in a reduction of hippocampal granule neurons of juvenile 
animals, suggesting a role for Neurog2 on the maintenance of the progenitor state 
and thus for the lineage amplification that takes place during this stage (Roybon et 
al., 2009). In the case of the transcription factor Tbr2, its conditional deletion leads to 
a depletion of both IPCs and neuroblasts, also implicating Tbr2 in the generation and 
maintenance of late progenitors in the adult SGZ (Hodge et al., 2012). Here, 
progression of the lineage into IPCs is proposed to take place by Tbr2-mediated 
repression of Sox2. 
Interestingly, the loss of type 2 proliferating progenitors in the Tbr2 mutant 
impacts on the type 1 population. Tbr2 is suggested to exert a negative feedback onto 
the NSC pool (Hodge et al., 2012). Such non-cell autonomous regulatory feedback 
mechanism controlling NSC proliferation has also been shown for Prox1 and 
Jagged1 mutants, where conditional inactivation of these genes leads to a transient 
expansion and later exhaustion of the NSC pool. This process has been proposed to 
be mediated by the loss of active Notch signalling in adult NSCs, which, in turn, is a 
consequence of an absence of IPCs, the Notch ligand-expressing cells in the 
hippocampal DG (Lavado et al., 2010, Lavado and Oliver, 2014). This mechanism is 
also important as an example of the link between stem cell maintenance and the 
generation of appropriate numbers of progeny in the SGZ. 
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1.5 The proneural factor Ascl1 in neurogenesis 
1.5.1 Proneural factors and their mechanism of action 
During embryonic brain development combinations of transcription factors control 
the generation of cell diversity in the nervous system in a spatio-temporal manner 
(Guillemot, 2007). Proneural proteins are key regulators of this process, coordinating 
the acquisition of a neuronal fate and promoting the generation of neuronal cell types 
(reviewed in Bertrand et al., 2002, Ross et al., 2003). The main mouse proneural 
proteins are Ascl1 (Mash1), neurogenin 1-3 (Neurog1-3) and Math1 or Atoh1 
(Figure 1-10).  
 
Figure 1-10 bHLH factors in cortical development 
Phylogenetic tree showing the relationship between different bHLH factors, and table showing their 
related factors in Drosophila, their function during cortical development and the DNA element they 
bind to. (Figure reproduced with permission from Ross et al., 2003) 
Proneural proteins are basic helix-loop-helix (bHLH) transcription factors. 
Proteins in this family share a bHLH motif that is evolutionary conserved from yeast 
to plants and metazoans, including mammas. The common motif is a ≈60 base pairs 
(bp)-long DNA-binding motif that consists of a basic domain followed by two alpha 
helices that are connected by a flexible loop (helix-loop-helix domain). The basic 
region of this domain fits in the main groove of the DNA, where most of the bHLH 
residues that contact DNA (7 out of 10) are located, while the HLH region is 
responsible for the dimerization with other bHLH proteins (Figure 1-11; Bertrand et 
al., 2002). 
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Figure 1-11 Structure of bHLH proteins 
(A) Sequence of the bHLH domain of the mouse proneural protein neurogenin 2 (Ngn2 or Neurog2) 
showing the different regions forming it. The basic domain is followed by two alpha helices 
connected by a flexible loop. Colour coding indicates the degree of amino-acid conservation between 
different bHLH proteins (red = residues common to all neural bHLH proteins). Asterisks mark the 
residues that make direct contact with DNA. (B) Representation of the structure of a bHLH dimer 
complexed to DNA. The basic region fits in the main groove of DNA. (Figure reproduced with 
permission from Bertrand et al., 2002) 
Proneural factors were first discovered as regulators of the early steps of 
neural development in Drosophila melanogaster. In vertebrates, their isolation was 
possible on the basis of sequence conservation with their fly counterparts (Figure 1-
10; Bertrand et al., 2002). As transcription factors, their function is to regulate target 
gene transcription, and they do so by binding specific hexa-nucleotide sequences of 
DNA of the type CANNTG called E boxes. They usually do so as homo- or 
heterodimeric complexes that are formed with ubiquitously expressed E-proteins, 
including the alternative splice variants of the E2A gene, E12 and E47 (Murre et al., 
1989, Johnson et al., 1992). Dimerization is a requisite for DNA binding, and factors 
interfering with this step will act as repressors of proneural gene activity. Proteins of 
the Inhibitor of differentiation (Id) family are an example of this; despite having a 
HLH domain, they lack the basic domain for DNA binding and can, therefore, act as 
molecular bait to sequester other bHLH factors (Massari and Murre, 2000). 
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 Proneural proteins act mainly as transcriptional activators, with only a few of 
them, including Olig2, shown to act as repressors (See Figure 1-10). Regulation of 
target gene expression by transcription factors depends on transcriptional protein 
complexes, which include both other transcription factors and cofactors. Activation 
of gene expression, in the case of the Neurog proteins, for example, was shown to be 
mediated through the recruitment of cofactors such as p300, CREB-binding protein 
(CBP) and p300/CBP-associated factor (PCAF; Koyano-Nakagawa et al., 1999). 
Moreover, interactions between different transcription factors are thought to be 
essential for the specificity towards different target genes at subsequent stages of 
development or in different cell types. Castro et al. (2006), for example, have shown 
that the regulation of the gene encoding the Notch ligand, Delta1, involves 
cooperative binding of Ascl1 and the POU proteins Brn1 and Brn2. These 
transcription factors bind adjacent motifs on the Delta1 promoter, and this interaction 
is required for transcriptional activation. In addition, through a screen for conserved 
Ascl1-Brn motifs in silico, they found additional candidate target genes that are 
recognised by these factors and that regulate multiple steps of neurogenesis, 
providing an example of transcription factor interactions coordinating different 
neurogenic programmes.  
An essential role of proneural proteins in the developing brain is to restrict 
their own activity to single progenitor cells. In this way, they inhibit differentiation 
of adjacent cells and ensure the generation of the appropriate number of neurons and 
glia. This process, named “lateral inhibition” is achieved through activation of the 
Notch signalling pathway. Proneural genes directly activate the transcription of 
Notch ligands, namely Delta and Jagged, which will go on to activate the Notch 
signalling cascade in neighbouring cells, ultimately resulting in the expression of 
proneural gene repressors like the Hes genes (Imayoshi and Kageyama, 2014). 
1.5.2 Ascl1 during cortical development 
The proneural protein achaete-scute complex homolog-like 1 (Ascl1; also known as 
Mash1) directly regulates different steps in the neurogenic programme in the 
embryonic telencephalon. Expression of Ascl1 in this region of the developing brain 
is observed in both dorsal and ventral domains. While in the dorsal telencephalon, 
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where progenitors of the cerebral cortex reside, Ascl1 is co-expressed with Neurog1 
and Neurog2, Ascl1 is the only known proneural gene to be expressed in the ventral 
telencephalon (Figure 1-12; Nieto et al., 2001, Britz et al., 2006, Casarosa et al., 
1999). In this ventral region Ascl1 plays a critical role in the generation of cortical 
GABAergic interneurons, which are generated in the medial ganglionic eminence 
(MGE) to then migrate into the neocortex. In mice null for Ascl1, the MGE is 
completely absent, while the lateral ganglionic eminence, where striatal projection 
neurons are produced, is severely reduced in size (Nieto et al., 2001, Fogarty et al., 
2007). Moreover, in the absence of neurogenins, Ascl1 is upregulated in the dorsal 
telencephalon and induces the expression of ventral GABAergic markers (Parras et 
al., 2002).  
 
Figure 1-12 Ascl1 and Neurog2 expression in the developing telencephalon 
Diagram showing the E13 developing telencephalon. Neurog2 (green) is expressed in the dorsal 
telencephalon, where the neocortex (NCx) progenitors reside. Ascl1 (red) is expressed in the ventral 
telencephalon, and here it is important for the generation of GABAergic interneurons. These are 
generated in the medial ganglionic eminence (MGE) and migrate up into the cortex. Ascl1 also 
colocalises with Neurog2 in the dorsal telencephalon (not shown). LGE = lateral ganglionic eminence. 
A role for Ascl1 in later stages of neuronal development has also been 
uncovered. Ascl1 promotes neuronal migration in the cortex through regulation of 
the Rho GTPase Rnd3, and in this way integrates the process of neuronal migration 
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with other events in the neurogenic programme (Pacary et al., 2013, Pacary et al., 
2011, Azzarelli et al., 2014).   
Analysis of Ascl1’s transcriptional targets in NSC cultures and in the 
embryonic brain on a genome-wide scale unravelled a novel and unexpected function 
for this proneural factor. The cellular processes represented among the targets 
identified suggested Ascl1 to be involved in diverse functions during the neurogenic 
programme. Some of these included the control of neural progenitor specification, 
neuronal differentiation and neurite outgrowth, as expected from previous functional 
studies. However, a large number of genes involved in cell cycle progression were 
also identified, and loss of function analysis confirmed that Ascl1 is indeed required 
for normal progenitor divisions (Castro et al., 2011). All together, this data highlights 
that Ascl1 plays multiple and crucial roles during early and late phases of 
development of the brain.  
1.5.3 Ascl1 in the adult brain  
Despite the importance of this factor during embryonic neurogenesis, little was 
known about the role that Ascl1 played during adulthood. In the DG, it was initially 
believed that Ascl1 expression corresponded with a transition state between NSCs 
and IPCs (Lugert et al., 2010, Lugert et al., 2012). New reports, however, 
demonstrated that Ascl1 was not restricted to early IPCs but also expressed in a 
subset of radial, type 1 NSCs (Kim et al., 2011, Breunig et al., 2007). Kim and 
colleagues traced Ascl1 lineage cells in the adult brain using an Ascl1-CreERT2 
mouse line and showed that this factor is expressed in a subset of self-renewing and 
neuron-generating cells in both neurogenic regions in the adult brain. More 
specifically, they found that Ascl1 was expressed at low levels in a subpopulation of 
NSCs in the SGZ and SVZ and that these levels increased as the cells transited to an 
intermediate progenitor stage. Yet the function of Ascl1 in these cells during 
neurogenesis remained unknown. 
Interest in Ascl1 and its expression in the adult brain has also grown in the 
past years due to the finding that ectopic expression of this gene can reprogram 
various cell types into neurons (Berninger et al., 2007, Yang et al., 2011). Moreover, 
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depending on the presence or absence of other factors, as well as the starting cell 
type or the time of expression, Ascl1 can induce the generation of several different 
neuronal fates, from glutamatergic to dopaminergic neurons (reviewed in Arlotta and 
Berninger, 2014, Yang et al., 2011). In the adult brain, Notch signalling was shown 
to be reduced in astrocytes after stroke, and this reduction was necessary for striatal 
astrocytes to enter a neurogenic programme. Blockade of Notch signalling in 
astrocytes triggered their activation even in the absence of stroke, and this activation 
was accompanied by Ascl1 expression (Magnusson et al., 2014). Whether Ascl1 
expression was required for astrocyte activation was not addressed. However, 
preliminary results from our collaborator Masato Nakafuku point to this possibility. 
Ectopic overexpression of Ascl1 using Glast-CreERT2 mice crossed to TetO-Ascl1-
IRES-EGFP resulted in the generation of DCX+ neurons from parenchymal 
astrocytes, providing them with a neurogenic capacity (Simic, M. and Nakafuku, M., 
personal communication). 
1.6 Aims of the present work 
The discovery of the existence of neurogenic niches in the adult brain of mammals, 
where new neurons are generated throughout life, opened the doors to a new era in 
the study of the brain. The presence of neural precursors that respond to 
environmental regulation inspired new research avenues aimed at understanding the 
molecular mechanisms that control the different steps in the neurogenic programme, 
as well as how external regulation, of both physiological and pathological nature, is 
integrated by the precursor pools to maintain tissue homeostasis.  
The clinical relevance of these approaches becomes apparent when realising 
that failure of neurogenesis in the adult brain of both rodents and humans has been 
associated with a number of neuropsychiatric and neurodegenerative diseases. 
Understanding how the basic mechanisms underlying neurogenesis can go wrong in 
the progression of these diseases, might highlight possible treatments to reverse at 
least some of the symptoms in the pathogenic process. And ultimately, loss of 
neurons in these neurological diseases might be counteracted by the development of 
stem-cell-based transplantation therapies, or even by relying on the stimulation and 
recruitment of endogenous stem cells (Lindvall and Kokaia, 2006). 
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 The adult hippocampus is quite an extraordinary system where new neurons 
that contribute to behaviour are formed in response to the needs of the organism. 
Despite knowledge of the mechanisms involved in the control and regulation of this 
process having grown exponentially in the past couple of years, a number of 
questions remain. One question that is of particular interest is how stem cells are able 
to respond to signals from the environment. We know of a number of transcription 
factors that are important for promoting the proliferation of precursor cells, but how 
these integrate extrinsic stimuli and how this is translated into a response has not yet 
been addressed.  
The proneural transcription factor Ascl1 plays key functions in the 
developing brain and appears to also be a potent neurogenic factor in vitro. This 
knowledge, together with the finding that Ascl1 is also expressed in a subset of self-
renewing cells in neurogenic regions in the adult brain led me to formulate the 
hypothesis that Ascl1 is involved in the process of neurogenesis in the adult murine 
hippocampus. The overall aim of this PhD work is, therefore, to investigate the role 
that Ascl1 plays in the neurogenic programme in this area of the adult brain. For this 
overall aim, a number of sub-aims are outlined: 
a) Determine where Ascl1 is expressed in the adult hippocampus, i.e. which 
cells in the neurogenic lineage express Ascl1 
b) Study the function of Ascl1 in the specified cells by following a deletion 
approach, i.e. what is the outcome of deleting Ascl1 in the adult 
hippocampus 
c) Study Ascl1’s expression in response to defined neurogenic stimuli d) Determine the molecular mechanism by which Ascl1 performs its function 
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2.1 Animals 
All procedures were performed in accordance with a UK Home Office Project 
Licence and approved by the local ethics committee. Mice were housed in standard 
cages (31cm L, 13.5cm W, 11.5cm H) under a 12 h light/dark cycle, and had ad 
libitum access to food and water. Glast-CreERT2 mice, which allow for tamoxifen 
(TAM)-inducible expression of cre recombinase under the astrocyte-specific 
glutamate aspartate transporter promoter (Glast; Mori et al., 2006), were crossed with 
Ascl1neoflox/neoflox mice (Pacary et al., 2011), in which exon 1 of the Ascl1 gene is 
flanked by loxP sites, and with Rosa26-floxed stop-YFP reporter mice (R26 YFP; 
Srinivas et al., 2001) to generate Glast-CreERT2 / Ascl1neoflox/ R26 YFP mice. In 
order to remove the PGK promoter-neo cassette from the Ascl1 locus, Ascl1neoflox 
animals were crossed with an actβ-Flp mouse line (The Jackson Laboratories, 
Maine). RBPJkloxp/loxp brains were kindly provided by Christian Göritz and Jonas 
Frisén (Department of Cell and Molecular Biology, Karolinska Institute, Sweden) 
and were generated as previously described (Han et al., 2002). These were crossed 
with GLAST::CreERT2 mice (Slezak et al., 2007) to delete RBPJk in an astrocyte-
dependent manner. RBPJkloxp/+ animals were used as controls. The Ascl1Δ/Δ line was 
generated as described previously (Guillemot et al., 1993). Nestin-CreERT2 animals 
(Lagace et al., 2007) were purchased from The Jackson Laboratories (Maine), and 
crossed with MF1 wild-type (WT) mice. Both male and female transgenic mice were 
included in the analyses, unless otherwise stated. 
2.2 Genotyping 
All animals were genotyped using genomic DNA extracted from ear biopsies. 
Samples were incubated overnight in 1M Tris pH 8.5, 0.5M EDTA, 10% SDS, 4M 
NaCl, 100mg/ml proteinase K at 55°C, and DNA was precipitated by centrifugation 
(13,000 rpm, 10 minutes) with one volume of isopropanol. Genomic DNA was 
resuspended in 100μl of water. Polymerase chain reaction (PCR) for Ascl1neoflox, 
Ascl1flox, Ascl1 Δ and R26 YFP was performed using REDTaq DNA Polymerase mix 
(Sigma-Aldrich), following the manufacturer’s instructions. PCR for cre was 
performed using 500mM KCL, 100mM Tris-HCL pH 8.3, 20mM MgCl2, 1.5mM 
dNTPs, 22.5ng of each reverse and forward primer and 1.25 units of Thermoprime 
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DNA polymerase (Thermo Scientific ABgene), or GoTaq Green Master Mix 
(Promega), following the manufacturer’s instructions. All PCR programs consisted 
of: an initialization of 5 minutes at 94°C; a repeated amplification cycle (number of 
cycles specified below) consisting of a denaturation step of 1 minute at 94°C, an 
annealing step of 1 minute (temperature specified above), and an extension of 1 
minute at 72°C, and a final extension step of 10 minutes at 72°C. The primers used 
and the PCR temperatures and number of amplification cycles used for each allele 
genotyped are shown in Table 2-1. 
Table 2-1 PCR primers and conditions 
Primer Sequence Annealing 
Temp (°C) 
Amp 
cycles 
Ascl1 WT 
Ascl1neoflox 
Ascl1flox 
5’ - CTA CTG TCC AAA CGC AAA GTG G - 3’ 
3’ - GCT CCC ACA ATC CTC GTA AAG A - 5’ 
3’ - TAG ACG TTG TGG CTG TTG TAG T - 5’ 
64 35 
Cre 5’ - ATC CGA AAA GAA AAC GTT GA - 3’ 
3’ - ATC CAG GTT ACG GAT ATA GT - 5’ 
55 28 
RYFP 5’ - AAA GTC GCT CTG AGT TGT TAT - 3’ 
5’ - AAG ACC GCG AAG AGT TTG TC - 3’ 
3’ - GGA GCG GGA GAA ATG GAT ATG - 5’ 
58 35 
Ascl1 Δ 5’ - GCAGCGCATCGCCTTCTATC - 3’ 
3’ - CCAGGACTCAATACGCAGGG - 5’ 
64 40 
 
2.3 In vivo studies: 
2.3.1 Tamoxifen and BrdU administration 
For activation of the CreERT2 recombinase, postnatal day 60 (P60) animals were 
administered 4-Hydroxytamoxifen (TAM, Sigma-Aldrich) for five consecutive days 
(intraperitoneally, i.p.; 2 mg/day, stock solution 10 mg/ml dissolved in 20% 
EtOH/80% sunflower oil). For mosaic experiments, P60 animals received a single 
TAM injection at the same concentration (based on preliminary studies with a range 
of concentrations that showed a single injection to produce adequate mosaic 
recombination). All WT and experimental animals received TAM injections to avoid 
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injection-related differences. To examine progenitor proliferation, mice were given a 
single bromodeoxyuridine (BrdU, Sigma-Aldrich) i.p. injection (2 mg, stock solution 
10 mg/ml dissolved in 0.9% saline) 2 hours prior tissue collection. In order to 
examine label-retaining cells a long-term BrdU paradigm was performed. Mice 
received five daily i.p. BrdU injections (2 mg/day) followed by five consecutive days 
of BrdU-containing drinking water (1 mg/ml). Mice were sacrificed 20 days after the 
last day of receiving BrdU in the drinking water. 
2.3.2 Voluntary running 
To study the activation of stem cells under physiological conditions we used a 
voluntary running paradigm. Eight to nine week-old female MF1 mice were exposed 
to a running wheel for 12 days. Two mice were placed per cage, and daily checks 
were performed to ensure both of them exercised. Control mice were littermates of 
experimental mice, and they were also housed two per cage. Cages with the running 
wheel were bigger (34.5cm L, 18cm W, 14cm H) than standard cages for controls 
(31cm L, 13.5cm W, 11.5cm H).   
2.3.3 Social isolation 
In order to test the effect of an anti-neurogenic stimulus on stem cell activity we 
performed a social isolation paradigm. Eight to nine week-old male MF1 mice were 
initially housed in big cages (45.5cm L, 32.5cm W, 15.5cm H) with 6-8 littermates 
per cage. These cages also contained chewable toys and at least two red 
polycarbonate mouse houses. On Day 0 of the experiment animals were placed one 
per cage in standard cages with no enrichment (31cm L, 13.5cm W, 11.5cm H). 
Animals were sacrificed one or two days after isolation and processed as described 
below. 
2.3.4 Kainic acid administration 
In order to study stem cell activation, we also made use of the activating activity of 
the seizure-inducing agent kainic acid (KA). Eight to nine week-old MF1 or P86 
Ascl1 WT and Ascl1neocKO male mice received KA (Sigma-Aldrich) as a single i.p. 
injection at 19 mg/kg dissolved in 0.9% saline (sub-seizure concentration based on 
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preliminary studies showing that progenitor proliferation is induced without animals 
undergoing observable convulsions). Animals were monitored for 90 minutes after 
KA injection, and their behaviour was scored every 10 minutes from 0 to 7 based on 
Monory et al., (2006) (0- no response, 1- immobility and staring, 2- forelimb and/or 
tail extension, rigid posture, 3- repetitive movements, 4- rearing and falling, 5- 
continuous rearing and falling, 6- severe clonic-tonic seizures, 7- death). Animals 
reaching stage 4 were immediately killed and were not used for the experiment. 
Around 15% of all animals receiving KA reached stage 4. Remaining animals were 
then sacrificed 1, 2 or 4 days after KA injection, and processed as described below. 
2.4 Expression pattern analysis 
2.4.1 RNA probes  
The riboprobe used to visualize Ascl1 mRNA expression was previously described 
(Guillemot and Joyner, 1993). The riboprobe for Neurog2 was prepared by attaching 
T7 (5’ - TAATACGACTCACTATAGGGAGA - 3’) and SP6 (5’ - 
ATTTAGGTGACACTATAGAAGNG - 3') promoters to the probe-specific forward 
and reverse primers, respectively. E14.5 cDNA from the telencephalon (prepared by 
Noelia Urbán) was used as template to identify the appropriate sequences with the 
following primers: forward 5’ - GCAACTGGTCCCTGTGATC - 3’ and reverse 5’ - 
ATGAAGCAATCCTCCCTCC - 3’. Labelled complementary RNAs were 
synthesised by in vitro transcription. Briefly, sequences amplified by PCR were 
transcribed in the presence of digoxigenin (DIG)-marked nucleotides (Roche) under 
standard reaction conditions together with T7 or SP6 RNA polymerases for 
generation of anti-sense and sense probes, respectively. 
2.4.2 Tissue preparation 
For immunohistochemistry, animals were anesthetized and transcardially perfused 
with 0.9% saline for 3 minutes followed by 4% paraformaldehyde (PFA) in 
phosphate buffered saline (PBS) for 12 minutes. Brains were post-fixed with 4% 
PFA for 2 hours at 4°C and sectioned coronally at 40µm using a vibratome (Leica). 
Sections were kept at 4°C on 0.02% azide until used. For p57 immunostaining, 
brains were cryo-protected in sucrose overnight (30% sucrose in PBS) before being 
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embedded in gelatin and sucrose (7.5 and 15%, respectively, in PBS) and frozen in 
isopentane. Frozen brains were cut in a Microm Cryostat (Zeiss) at 30µm and kept at 
minus 20°C until used. To avoid degradation of the RNA for in situ hybridization, 
the perfusion was performed using diethylpyrocarbonate (DEPC)-treated PBS 
(1/1,000), and PFA also prepared in DEPC-treated PBS. Dissected brains were cut in 
half before overnight post-fixation with 4% PFA. Each half was cryo-protected by 
placing it in 20% sucrose overnight, and then frozen on dry ice in OCT compound 
(VWR Chemicals) using a plastic mould. Brains were cut in a cryostat (CM3050S, 
Leica) at 14µm and kept at minus 20°C until used. 
2.4.3 Immunohistochemistry 
To visualise protein expression in the adult DG, we performed 
immunohistochemistry. Free-floating sections were blocked in 10% normal donkey 
serum and 1% Triton X-100 for 2 hours. Sections were then incubated overnight at 
4°C with primary antibodies diluted at appropriate concentrations in incubation 
solution (10% normal donkey serum and 0.1% Triton X-100). See Table 2-2 for a list 
of primary antibodies and the concentrations they were used at. After 3 washes with 
PBT (PBS + 0.1% Triton X-100), sections were incubated in incubation solution 
with corresponding secondary antibodies for 2 hours at a dilution of 1/1000. 
Secondary antibodies used were conjugated to Alexa-488, Alexa-568 (Invitrogen 
Life Technologies), Cy3 or Cy5 (The Jackson Laboratory). Following 3 washes with 
PBT, sections were incubated with 6-diamidino-2-phenylindole (DAPI, 1/10000, 
Sigma-Aldrich) for 20 minutes to obtain nuclear staining, and finally mounted in 
Aqua PolyMount (Polysciences).  
For staining with rabbit anti-Tbr2, brain sections underwent an antigen 
retrieval treatment. For this, sections were incubated in sodium citrate buffer (10 mM 
trisodium citrate, pH 6.0) at 90°C for 20 minutes. Following incubation, sections 
were left to cool down, rinsed with PBS, and immunostaining procedure was 
continued as normal. For BrdU immunohistochemistry, staining for other markers 
was performed first as explained above. Sections were then fixed for 30 minutes with 
4% PFA, washed 3 times with PBS and then pre-treated with pre-warmed 2N HCL 
for 30 minutes. BrdU primary antibody was then added after two 15-minute borate 
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buffer (0.1 M sodium tetraborate, pH 8.5 in PBS) washes to continue 
immunostaining as normal. 
Table 2-2 Details of the primary antibodies used in this study 
Antibody Species Concentration 
used 
Manufacturer Catalogue 
number 
Ascl1 Mouse 1/100 BD Pharmingen 556604 
BrdU Rat 1/1000 AbD Serotec OBT0030CX 
CD31 Rabbit 1/200 Abcam ab28365 
Doublecortin Goat 1/50 Santa Cruz Biotechnology sc-8066 
GFAP Rabbit 1/1000 Dako Z033401 
GFAP Rat 1/1000 Invitrogen Life 
Technologies 
13-0300 
GFP Rabbit 1/1000 Invitrogen Life 
Technologies 
A11122 
GFP Rat 1/1000 Fine Chemicals 04404-84 
GFP Sheep 1/1000 AbD Serotec 4745-1051 
Ki67 Rabbit 1/200 Leica NCL-Ki67p 
MCM2 Goat 1/100 Santa Cruz Biotechnology sc-9839 
Nestin Mouse 1/200 Millipore MAB353 
NeuN Mouse 1/500 Millipore MAB377 
Olig2 Rabbit 1/200 Millipore AB9610 
p57 Rabbit 1/200 Sigma P0357 
S100β Rabbit 1/200 Dako Z0311 
Sox2 Goat 1/200 Acris Antibodies GT15098 
Tbr2 Rabbit 1/500 Abcam ab23345 
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2.4.4 Microscopic analysis and quantification 
The total number of single, double or triple antigen-positive cells was counted in 
every ninth 40µm section through the entire rostrocaudal length of the DG (-0.82 mm 
to -4.24 mm from bregma). Images were acquired using an SP5 confocal microscope 
(Leica). 15 to 20 z-plane images separated by a 1µm step were obtained per section. 
To present total numbers per dentate gyrus, cells counted were divided by the 
number of z-planes counted to obtain the number of cells per 1µm, and then 
multiplied by the total length of the dentate gyrus.  
Quantification of antigen-positive RGLs within the total population of RGLs 
was performed by calculating the percentage of antigen-positive GFAP+ RGLs 
among the total number of RGLs counted (between 60 and 150). For these counts, 
cells were deemed to be radial if the cell body, clearly associated with a DAPI-
positive nucleus, was located in the SGZ and had a single radial GFAP+ process 
extending through the GL (for at least two extra DAPI+ nuclei parallel to the SGZ 
base).  
The total number of stem cells in the DG was calculated by counting the 
number of GFP+ GFAP+ Nestin+ radial cells within a defined area in z-projections of 
three z-planes that were 1µm apart. At least two separate areas were quantified per 
DG, and the same total area was counted per animal. 
In each experiment the DG of 3 or more mice per group were used for 
quantification. In all figures, the cell numbers counted in WT, Ascl1neocKO and 
Ascl1cKO mice are numbers of YFP+ marker+ double-labelled cells, while the 
numbers counted in Ascl1neoflox and Ascl1flox mice are for marker+ cells only since 
YFP is not expressed in these mice. 
2.4.5 In situ hybridisation  
Visualization of mRNA expression on brain sections was carried out by in situ 
hybridisation (ISH). Sections, following rehydration with PBT (0.1% Tween, Sigma-
Aldrich, in DEPC-treated PBS), were treated with triethanolamine and 0.25% acetic 
anhydride to acetylate the amino groups on the proteins and reduce the background. 
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After a 15-minute pre-hybridisation step with hybridisation solution (50% 
formamide, 25% SSC, 10% Denhardt’s solution, 500 μg/ml herring sperm DNA, 250 μg/ml torula yeast RNA) at room temperature, sections were incubated with the 
DIG-labelled RNA probes diluted in hybridisation solution (1/100) in a humidified 
chamber at 70°C overnight. To detect the riboprobes hybridised to the target RNAs, 
sections were incubated with an anti-DIG antibody conjugated with alkaline 
phosphatase. To reveal the signal, nitro blue tetrazolium 5-bromo 4-chloro 3 indolyl 
phosphate (BCIP/NBT, Sigma-Aldrich) was used. 
2.5 Fluorescence-activated sell sorting 
In order to determine possible Ascl1 target genes playing a role in the adult 
hippocampus, we sorted stem cells from Ascl1 WT and Ascl1neocKO mice. TAM was 
administered for 5 consecutive days at P60, and DGs were dissected 4 days after the 
last injection. The protocol used was as described by Walker et al., 2013. Dissected 
DG were enzymatically digested using The Neural Tissue Dissection Kit (Miltenyi), 
and following the manufacturer’s instructions. After the last wash, the unstained 
pellet was resuspended in 1ml of DMEM:F12 without phenol red and filtered 
through a 40μm sieve. The YFP+ cells were analyzed using a FACS Aria Cell Sorter 
(BD Biosciences). DGs of animals not carrying the Glast-CreERT2 allele were used 
for YFP gating and dead cells were excluded by propidium iodide staining (1ug/ml). 
Three to five animals of the same genotype were pooled for each sorting and 
considered as one n. 3000-cell samples were collected in DMEM:F12 + 1% BSA, 
pelleted down by centrifugation (2,800 rpm, 5 minutes) and 100μl of lysis buffer 
from the PicoPure RNA Isolation Kit (Life Technologies) was added for further 
processing (see below). 
2.6 Laser capture microdissection  
For laser capture microdissection (LCM) tissue collection, brains were removed after 
sacrifice, rapidly frozen in OCT on dry ice and stored at -80°C until further use. 
14µm coronal sections spanning the length of the DG were cut in a cryostat 
(CM3050S, Leica) and placed on MembraneSlides (Zeiss). The SGZ of WT, 
Ascl1neoflox and Ascl1neocKO animals was excised by a PLAM laser-capture 
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microdissection system (Zeiss) and manually collected in an adhesive cap 
(AdhesiveCap 200, ZEISS). 100μl of PicoPure RNA Isolation Kit lysis buffer (Life 
Technologies) was then added for further processing (see below). 
2.7 Gene expression assays 
2.7.1 RNA isolation  
For studying gene expression after FACS or LCM sample collection, RNA was 
isolated after sample lysis was completed by incubating in the buffer mentioned 
above for 30 minutes at 42°C. If the procedure was not carried out immediately after, 
samples were kept at -80°C. In the case of FACS-sorted cells, the RNeasy Kit 
(Qiagen) was used to extract the RNA, and this was done as advised by the 
manufacturer. Each 3000-cell sample was eluted with 22μl of water. For LCM 
isolated samples, RNA was, instead, extracted using the PicoPure RNA Isolation Kit 
(Life Technologies), but also eluted with 22μl of water. Samples were immediately 
used for cDNA production or otherwise kept at -80°C until used. 
2.7.2 cDNA production 
RNA was reverse-transcribed using the High Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems). RNA from each 3000-cell sample was pooled, and 20μl 
reactions were prepared with 9μl of RNA in each. The thermal programme used 
consisted of 60 minutes at 37°C and 5 minutes at 95°C. The cDNA from each 
independent sample was also pooled after generation.  
2.7.3 Quantitative-PCR 
Gene expression was detected using TaqMan Gene expression assays (Applied 
Biosystems) as described by the manufacturer and performed on a 7500 real time 
PCR system (Applied Biosystems). Data were analysed using standard protocols to 
calculate relative expression with the dCT method with Gapdh serving as an 
endogenous control. Each probe was performed in duplicates for at least 3 
independent samples per group. 
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2.8 Statistical and bioinformatics analyses 
Statistical analysis was conducted using a two-sample t test with equal variance 
using Prism software. A p-value of <0.05 was considered significant. All values 
represent mean values, and error bars represent the standard error of the mean 
(SEM).  
 GO analysis was conducted with Database for Annotation, Visualization, and 
Integrated Discovery (DAVID) using functional annotation clustering. 
Representative terms from the top-ranking clusters of GO terms are reported, all with 
p-value < 0.05 and false discovery rate (FDR) < 5%. See Andersen et al., 2014 for a 
description of ChIP-seq data generation and processing. 
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The proneural transcription factor Ascl1 is an essential regulator of neurogenesis in 
the embryonic brain, playing important roles in progenitor proliferation, specification 
and differentiation (Casarosa et al., 1999, Castro et al., 2011). Recent work has also 
established Ascl1 to be expressed in precursor cells of the neurogenic regions of the 
adult brain: the hippocampus and the SVZ. Importantly, lineage tracing experiments 
have shown Ascl1 to be expressed in a subset of self-renewing cells in these areas 
(Kim et al., 2011). Having in mind the aim of this work, which is that of studying the 
role of Ascl1 in the DG of the hippocampus in adult mice, I will start this chapter by 
describing the expression of Ascl1 in this region. Next, I will move on to describe 
the conditional deletion of this factor in the DG, which is the main strategy used to 
understand its function in the adult brain. I will introduce the different mouse lines 
that I used to investigate the loss of Ascl1 and briefly explain their advantages and 
disadvantages. I will then describe the main phenotype that arises from deleting 
Ascl1 in self-renewing cells, and I will do this for the different mouse lines 
presented. And finally, in this chapter I will investigate the cell autonomy of the 
phenotype observed, since Ascl1 is expressed in more than one cell type. 
3.1 Ascl1 is expressed in intermediate progenitors  
Previous reports on the expression of Ascl1 in the adult DG have focused on its 
expression in IPCs, which comprise the majority of the cycling population in the 
SGZ, and are characterised by their SGZ localisation, their proliferative state and 
their lack of GFAP expression. Labelling of two month-old brains with a monoclonal 
antibody against Ascl1 together with the proliferation and activation markers Ki67 
and MCM2 revealed that, indeed, the expression of this transcription factor, mostly 
confined to the SGZ, corresponds to proliferating cells (Figures 3-1A and 3-1B). Of 
all cells positive for Ascl1 94.32% ± 2.96% are also positive for MCM2. The same is 
not true for MCM2+ cells, with only a small proportion of them being Ascl1+ 
(15.65% ± 4.36). 
Tbr2 is a well-characterised marker for late IPCs. Immunolabeling for Tbr2 
and Ascl1 showed that Tbr2+ cells are indeed localised to the SGZ and lack GFAP 
expression (Figure 3-1C). Among Tbr2+ cells, there are two populations: one that co-
expresses Ascl1 and another one that is negative for Ascl1 (Figure 3-1C, yellow 
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arrowhead and white arrow, respectively). Quantification of the Ascl1 population 
revealed that only a small fraction of them was positive for Tbr2 as well (8.91% ± 
3.25%, Figure 3-1D), and none of them express markers of more mature cells in the 
lineage, including DCX and NeuN (Figure 3-1E and not shown). Therefore, it is 
likely that an early population of IPCs express Ascl1, together with Tbr2, and that as 
Tbr2+ IPCs initiate the process of differentiation they lose expression of Ascl1. 
 
Figure 3-1 Ascl1 expression in intermediate progenitors in the SGZ of adult mice 
(A and B) Labelling of Ascl1 shows that Ascl1 is expressed in the SGZ of the DG and that here it is 
colocalised with the proliferation marker Ki67 (A) as well as the activation marker MCM2 (B). Note 
the broader expression of MCM2 compared to Ki67 highlighting the earlier onset of expression of this 
marker. IPCs are the major cycling population in the DG, suggesting that Ascl1 is expressed in this 
population of cells. (C and D) Labelling for Ascl1 and the IPC marker Tbr2 and quantification of the 
percentage of Ascl1 cells that are Tbr2+ confirms that Ascl1 is expressed by a subpopulation of IPCs. 
Only a small proportion of Ascl1+ cells also expressed Tbr2 (yellow arrowhead in C), while a big 
majority of them are Tbr2-. Most Tbr2- Ascl1+ cells are also GFAP-, indicating they are not stem cells 
(white arrow in C). (E) Staining for Ascl1 and DCX shows that Ascl1 is not expressed by immature 
neurons. n = 3 (C). Scale bars = 20μm (A, B, C and E). 
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3.2 Ascl1 is expressed in a subset of stem cells 
Double labelling for Ascl1 and the stem cell marker GFAP revealed that a proportion 
of the total Ascl1-expressing cells have characteristics of RGLs (13.60% ± 0.42%). 
RGLs are characterised by the presence of a GFAP+ radial process extending along 
the GL, and by the position of their cell bodies in the SGZ (see Figure 3-2A for an 
example of an RGL). Another important feature of stem cells in the hippocampus is 
that they are found mostly in a quiescent state. A small proportion of them, 
nevertheless, can be found to be active at any one time. Because Ascl1 is expressed, 
in its majority, in proliferating cells, I set to examine the population of Ascl1+ RGLs 
in relation to those expressing either MCM2, Ki67 or BrdU after a 2-hour pulse. 
Only cells in S phase will have incorporated BrdU, while cells expressing Ki67 will 
correspond to a bigger population of cells from a late G1 stage, and MCM2-
expressing ones to an even bigger population, since this marker is expressed from an 
earlier G1. Figure 3-2B shows the quantification for this experiment, and illustrates 
the increasing proportion of RGL cells that are positive for these three markers. As 
for Ascl1, I find it to be expressed in about 2% of the total RGL population, with a 
minimal proportion of them not expressing a proliferation marker. Together, these 
results show that there are 3 main populations of Ascl1+ cells: a subpopulation of 
RGLs, which are mainly in an active state, a population of early IPCs that is negative 
for the later IPC marker Tbr2 and a small population of IPCs that also co-expresses 
Tbr2. 
3.3 Ascl1 deletion in stem cells of the adult hippocampus 
3.3.1 Mouse lines used for deleting Ascl1 
Mice carrying homozygous null alleles for Ascl1 die at birth due to breathing defects, 
making the analysis of Ascl1 function at adult stages not feasible (Guillemot et al., 
1993). To circumvent the lethality of these mice, a previous member of the 
laboratory generated transgenic mice carrying conditional mutant alleles for Ascl1 
(Pacary et al., 2011). We called these animals Ascl1neoflox, for carrying a PGK 
promoter-neo cassette adjacent to the Ascl1 locus (Figures 3-3C and 3-3D).  
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Figure 3-2 Ascl1 expression in hippocampal stem cells in the SGZ of adult mice 
(A) Immonostaining for Ascl1 and the stem cell marker GFAP reveals that Ascl1 is expressed by 
radial GFAP-expressing RGLs in the DG. Colocalisation with MCM2 revealed that Ascl1+ RGLs are 
in an active state. (B) Quantification showing the percentage of radial GFAP+ cells expressing Ascl1 
and the cell cycle markers MCM2 and Ki67 or incorporation of BrdU after a 2-hour pulse (marker). 
Ascl1 is expressed in approximately 2% of the total RGL population (dark orange and black bars), 
and most of these cells also express a cell cycle marker or were in the S phase at the time of BrdU 
administration (dark orange bars). Note the difference in the percentage of marker+ populations. 
MCM2 is expressed from early G1, while Ki67 is expressed later in G1. BrdU will only mark cells in S 
phase at the time of BrdU injection. n = 3 for MCM2, Ki67 and BrdU. Scale bar = 10μm (A). 
In order to delete Ascl1 specifically in stem cells we made use of Glast-
CreERT2 mice, where TAM-inducible cre recombinase will be driven by the Glast 
promoter in RGLs and a proportion of IPCs (Mori et al., 2006). We also used mice 
carrying the Rosa26-floxed stop-YFP reporter transgene to follow the fate of 
recombined cells (Srinivas et al., 2001). 
Tamoxifen administration for five consecutive days to two month-old mice 
and immunohistochemical analysis on the last day of injection revealed that a 
majority of GFAP+ Nestin+ radial cells (91.43% ± 3.48%) in a WT background 
induce the expression of YFP, indicating that cre has been activated and they have 
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therefore undergone recombination (Figures 3-3A and 3-3B). In animals carrying the 
Ascl1neoflox alleles this recombination results in the deletion of Ascl1 (Ascl1neocKO). 
 Due to concerns regarding the Ascl1neoflox animals (see next section), I 
generated a new line where the neo cassette, flanked by FRT sites, was removed by 
FLP-induced recombination (Figure 3-3D). We called these animals Ascl1flox; and as 
it was the case for the Ascl1neoflox mice, administration of TAM to these animals leads 
to the loss of Ascl1 from the genome (Ascl1cKO; see Figures 3-3C and 3-3D for 
exact genotypes and treatment of each line and the relationship between them).  
 
Figure 3-3 Depiction of mouse lines used for Ascl1 deletion in the study (legend next 
page) 
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Figure 3-3 Depiction of mouse lines used for Ascl1 deletion in the study 
(A) Labelling for YFP and GFAP to illustrate the recombination efficiency in RGLs after 
administration of TAM for five consecutive days in in P60 Glast-CreERT2 animals crossed with 
animals carrying the Rosa26-floxed stop-YFP reporter transgene. (B) Quantification of the 
recombination efficiency in these animals shows that a majority of RGLs, considered as GFAP+ 
Nestin+ radial cells, have undergone recombination and thus are YFP+ after TAM injections at P60-
P64. (C) Presentation of the main mouse lines used to study the effect of Ascl1 deletion in the adult 
hippocampus showing their names (first column), the Ascl1 allele they carry (WT, flox or neoflox, 
second column), the Rosa26-floxed stop-YFP (R26) reporter transgene they all carry (+, third 
column), whether they carry (+) or not carry (-) the Glast-CreERT2 deleter allele (CreER, fourth 
column), and whether the TAM treatment they all received (TAM, +) results in recombination events 
leading to Ascl1 deletion and expression of YFP (Rec, Yes or no, fifth column). (D) Scheme showing 
how the different mutant alleles for Ascl1 were generated. The Ascl1neoflox was created by inserting a 
first loxP site at the start codon of Ascl1 and a second one after the polyA signal at the 3’ end of the 
Ascl1 transcript. A PGK promoter-neo cassette flanked by FRT sites was also inserted at the 3’ end 
(Pacary et al., 2011). TAM-induced cre activation results in recombination at the Ascl1neoflox allele to 
generate Ascl1neocKO mice. FLP-induced recombination of Ascl1neoflox mice was used to generate 
Ascl1flox mice, which after TAM-induced recombination and deletion of the PGK promoter-neo 
cassette generate the Ascl1cKO mice. n = 3 (B). Scale bar = 40μm (A). 
3.3.2 Ascl1neoflox animals show a hypomorphic phenotype 
Expression analysis one month after TAM administration showed that, in WT 
animals, both recombined RGLs and their progeny express Ascl1. This expression is 
absent in Ascl1neocKO mice (Figure 3-4A). Moreover, this analysis showed that 
animals that carry the Ascl1neoflox alleles, but do not have the cre recombinase in their 
genome, and are therefore unable to induce recombination, have lower levels of 
Ascl1 protein (Figure 3-4A, central panel).  
Because the finding of lower levels of Ascl1 protein in animals carrying the 
Ascl1neoflox allele was unexpected, we went on to investigate the phenomenon further, 
and examined whether it might be due to reduced transcription of Ascl1 at the locus. 
For this we made use of the laser capture microdissection (LCM) technique to dissect 
the SGZ of WT, Ascl1neoflox and Ascl1neocKO animals (Figure 3-4B). We were then 
able to extract mRNA from these fragments and measure expression of Ascl1 
transcripts by RT-qPCR. This analysis confirmed that Ascl1neoflox animals have 
significantly reduced levels of Ascl1 expression at the transcript level compared with 
WT mice. Ascl1 expression is undetectable in Ascl1neocKO mice, as expected (Figure 
3-4C). These results suggest that the Ascl1neoflox is a hypomorphic allele, showing a 
reduction of gene activity (Nagy et al., 1998). These results bring about concerns 
regarding developmental defects in animals carrying this allele. We know that Ascl1 
is crucial for embryonic development; hence the necessity to generate a conditional 
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line where expression of cre recombinase can be driven in an inducible manner and 
Ascl1 can be deleted specifically at adult stages. Ascl1neocKO mice undergo 
development with defective Ascl1 expression (i.e. they carry two Ascl1neoflox alleles), 
and any phenotype that we see during adulthood might be a consequence of 
abnormal development. For this reason, the rest of the analysis will include 
Ascl1neoflox mice as an additional experimental condition. 
 
Figure 3-4 Ascl1neoflox mice show reduced levels of Ascl1 expression and Ascl1 protein 
(legend next page)   
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Figure 3-4 Ascl1neoflox mice show reduced levels of Ascl1 expression and Ascl1 protein 
(A) Immunostaining showing Ascl1 expression one month after TAM administration in WT, 
Ascl1neoflox and Ascl1neocKO mice. WT animals show expression of Ascl1 in YFP+ IPCs and RGLs, and 
this is absent in Ascl1neocKO mice. Ascl1 expression in Ascl1neoflox mice is very weak or undetectable. 
(B) Image showing a laser capture microdissected SGZ (green rectangle) in the hippocampal DG 
(dashed line) of P90 animals that received TAM and P60. (C) Analysis of Ascl1 transcripts by qPCR 
of laser capture microsidessected SGZ tissue shows that Ascl1 expression is strongly and significantly 
reduced in Ascl1neoflox mice compared to WT mice, and it is eliminated in Ascl1neocKO mice. 
Expression levels are normalized to Gapdh and are relative to Ascl1 expression in WT. n = 3 for WT, 
Ascl1neoflox and Ascl1neocKO. (C and D) Performed by Ayako Ito. * p<0.05. Scale bar = 20μm (A). 
3.3.3 Ascl1cKO animals fail to completely delete Ascl1 
We hypothesised that it was the PGK promoter-neo cassette that remained inserted 
on the 3’ side of the Ascl1 locus that was having an effect on the expression of this 
gene, since it has already been shown to be the case for others (Nagy et al., 1998, 
Meyers et al., 1998). For this reason I went on to cross Ascl1neoflox and actβ-Flp 
animals to induce the excision of the FRT-flanked cassette (see Figure 3-3D). Ascl1 
protein expression in the resulting Ascl1flox animals was back to levels comparable to 
WT animals, demonstrating that it was, indeed, the flanking PGK promoter-neo 
sequence that was disrupting normal Ascl1 expression (Figure 3-5, central panel). 
Further analysis of these animals revealed, however, that Ascl1 expression is 
still present in Ascl1cKO animals in a proportion of cells that express YFP and have 
therefore recombined (Figure 3-5, bottom panel). This shows that there is an 
uncoupling between Ascl1 deletion and YFP expression. Because the Ascl1 
conditional mutant allele and the Rosa26-floxed stop-YFP reporter transgene are in 
different chromosomes in the genome, cre-induced recombination of Ascl1 and YFP 
are independent events. Moreover, for Ascl1 deletion to be complete both alleles 
need to be deleted (see Figure 3-8, showing that heterozygous Ascl1 mutant animals 
are comparable to WT), while having only one Rosa26-floxed stop-YFP allele 
undergoing recombination is enough for YFP to be expressed. Therefore, if the cre 
recombinase is not 100% efficient, it is possible for YFP to be expressed without 
Ascl1 being deleted. Interestingly, we did not detect any uncoupling in the 
Ascl1neocKO mice (and the striking phenotype observed in these animals suggest that 
it is not a common event, see results below). This might be due to the fact that Ascl1 
expression in Ascl1neoflox animals is already significantly lower compared to WT 
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mice, and recombination of only one of the alleles might be enough to abolish Ascl1 
function. 
 
Figure 3-5 Incomplete Ascl1 deletion in Ascl1cKO mice 
Labelling for Ascl1, the stem cell marker GFAP and the recombination reporter YFP in P90 animals 
that received TAM at P60. Ascl1flox mice, which do no longer have the PGK promoter-neo cassette, 
show comparable levels of Ascl1 expression to WT mice. In Ascl1cKO animals, Ascl1+ cells that are 
also YFP+ can be found indicating that recombination of the Ascl1flox allele is not complete. 
3.4 Ascl1 deletion results in a loss of proliferation in Ascl1neocKO mice 
3.4.1 Effect on progenitor proliferation  
Since, as described in the previous chapter, I found a majority of Ascl1-expressing 
cells to be in a proliferative state, the first thing to do after removing Ascl1 from the 
genome was to check for the presence of proliferation. Strikingly, TAM i.p. injection 
for 5 days at P60 and analysis at P90 showed that deletion of Ascl1 in Ascl1neocKO    
mice   results  in   a   complete  loss   of   dividing   cells  in   the  DG  (Figure 3-6A), 
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Figure 3-6 Block of proliferation and activation by conditional deletion of Ascl1 
(A and B) Animals received TAM from P60 for five consecutive days and analysis was performed at 
P90 to examine proliferation after Ascl1 deletion. Labelling for the proliferation marker Ki67 and 
quantification of the total number of Ki67+ cells in the DG revealed that proliferation here is blocked. 
Ascl1neocKO animals show a complete absence of Ki67+ cells, while Ascl1neoflox animals, where Ascl1 
expression is reduced, show, accordingly, a reduction in the number of proliferating cells compared to 
WT mice. (C and D) The same result was observed after a 2-hour pulse of BrdU, and with 
immunolabeling for the activation marker MCM2. n = 3 (C), 4 (B) and 5 (D) for WT; 3 (C) and 4 (B, 
D) for Ascl1neoflox; 3 (B, C)  and 4 (D) for Ascl1neocKO. * p<0.05, ** p<0.01, *** p<0.001. Scale bar = 
40μm (A).  
as shown by the absence of Ki67+ and BrdU-incorporating cells after a 2 hour pulse 
(Figures 3-6B and 3-6C). Moreover, by quantifying the number of proliferating cells 
in Ascl1neoflox animals I found that reduced Ascl1 levels is also translated into a 
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reduced number of dividing cells compared to WT animals (WT versus Ascl1neoflox 
versus Ascl1neocKO, 2875 ± 815 versus 1225 ± 297 versus 0 Ki67+ cells; 471 ± 115 
versus 142 ± 10.2 versus 9.78 ± 4.90 BrdU+ cells; Figures 3-6B and 3-6C). 
Next, to discard the possibility that cells were halted at an early stage of the 
cell cycle that is not marked by Ki67, I performed immunostaining against MCM2, 
which marks cells from an early stage of the G1 phase of the cycle (Niu et al., 2011, 
Stoeber et al., 2001)). This staining showed that there are no cells entering the cell 
cycle, since I find again a complete loss of MCM2+ cells. Similarly, I find less cells 
expressing MCM2 in Ascl1neoflox animals (WT versus Ascl1neoflox versus Ascl1neocKO, 
4635 ± 921 versus 2233 ± 632 versus 19.65 ± 19.65 MCM2+ cells; Figure 3-6D). 
3.4.2 Effect on RGL proliferation 
Having observed a loss of the dividing population in the adult DG after deleting 
Ascl1, I then went on to look specifically at the proliferative state of RGLs. The 
majority of the cycling cells at one time will correspond to IPCs and only between 
5% and 10% of these represent the stem cells. For analysis purposes, I defined an 
RGL as a YFP+ cell that has a GFAP+ radial process extending along the GL and 
whose cell body is positioned on the SGZ (Figure 3-7A). Ascl1 deletion following 
the same protocol as described in the previous section, revealed a total block in RGL 
proliferation. Both Ki67 and the earlier marker MCM2 were absent from RGLs (WT 
versus Ascl1neoflox versus Ascl1neocKO, 161 ± 48.5 versus 66.0 ± 29.6 versus 0 Ki67+ 
RGLs; 281 ± 70.1 versus 126 ± 26.3 versus 0 MCM2+ RGLs; Figures 3-7B and 3-
7C). This suggests that the loss of the cycling population in the DG stems from an 
inability of RGLs to enter the cell cycle and proliferate. 
Finally, to confirm that the absence of Ki67+ and MCM2+ cells is not due to a 
failure in detection due to cells dividing slower or more infrequently, I carried out a 
long-term BrdU retention paradigm. This paradigm is designed to label rarely 
dividing RGLs that are capable of retaining BrdU, administered for 10 consecutive 
days, after a 20 day chase period (Figure 3-7D). BrdU-label retaining cells were 
present in WT and, albeit in reduced numbers, in Ascl1neoflox mice, but they were 
again completely absent in Ascl1neocKO mice (WT versus Ascl1neoflox versus 
Results 3 
 
 86 
Ascl1neocKO, 43.8 ± 6.2 versus 9.7 ± 4.9 versus 0 label-retaining RGLs; Figure 3-
7D). This result shows that Ascl1-deleted RGLs are unable to incorporate BrdU, and 
thus confirms that RGLs do not enter the cell cycle in the absence of Ascl1. 
 
Figure 3-7 Block of hippocampal stem cell proliferation and activation by conditional 
deletion of Ascl1 (legend next page) 
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Figure 3-7 Block of hippocampal stem cell proliferation and activation by conditional 
deletion of Ascl1 
(A) Animals received TAM from P60 for five consecutive days and analysis was performed at P90 to 
examine stem cell proliferation after Ascl1 deletion. Stem cells are considered those cells that possess 
a GFAP+ radial process extending along the GL. Proliferating stem cells are considered those with a 
proliferation marker-positive nucleus. (B) Quantification of the total number of Ki67+ GFAP+ radial 
cells in the DG showed that stem cells that have inactivated Ascl1 in Ascl1neocKO animals do not 
proliferate. Similarly, mice that have reduced levels of Ascl1 expression show a reduction in the total 
number of Ki67+ stem cells. (C) Immunostaining and quantification for the activation marker MCM2 
also showed that stem cells in Ascl1neocKO mice fail to activate, and that in Ascl1neoflox mice, compared 
to WT animals, there are significantly less active RGLs. (D) Administration of BrdU for 10 days 
followed by a three-week chase period shows there are no BrdU-label retaining RGLs in Ascl1neocKO 
mice confirming that stem cells in these animals do not divide. n = 4 (B) and 5 (C, D) for WT; 3 (D) 
and 4 (B, C) for Ascl1neoflox; 3 (B, D) and 4 (C) for Ascl1neocKO. * p<0.05, ** p<0.01. Scale bar = 
10μm (A). 
3.4.3 Changes in Ascl1 expression levels affect proliferation 
The results shown so far suggest that Ascl1 is essential for RGLs to proliferate. They 
also suggest, however, that it is not just its presence that is important, but also the 
level of expression it is present at. Ascl1neoflox animals show significantly lower levels 
of Ascl1 mRNA and protein expression, and this is translated into reduced 
proliferation (see Figure 3-7). To further explore this idea, I crossed Ascl1neoflox 
animals with animals carrying a null Ascl1 allele (Ascl1 Δ; Guillemot et al., 1993). In 
this way I generated two more lines (WT/Δ and Ascl1neoflox/Δ) that have intermediate 
levels of Ascl1 expression between a WT and an Ascl1neoflox and between the 
Ascl1neoflox and the Ascl1neocKO, respectively (see Figure 3-8A for a table with 
genotypes). This approach could give me more evidence on the importance of Ascl1 
expression levels. 
Analysis of the number of Ki67+ cells in the DG of these animals one month 
after TAM administration showed that indeed, the level of Ascl1 expression is 
correlated with the level of proliferation (Figure 3-8B). Reducing the level of Ascl1 
by the use of the different transgenic mice lines reduced the number of dividing cells. 
Interestingly, having at least one untouched Ascl1 allele is enough for having normal 
proliferation, since I saw no significant difference between the number of Ki67+ cells 
in WT and WT/Δ	   animals (WT versus WT/Δ versus Ascl1neoflox versus Ascl1neoflox/Δ 
versus Ascl1neocKO, 2875 ± 815 versus 2032 ± 475 versus 1225 ± 297 versus 384 ± 
147 versus 0 Ki67+ cells; Figure 3-8B).  This suggests that there is a threshold effect: 
a  minimal  level of Ascl1 expression is required for proliferation to go on	  as  normal,	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Figure 3-8 Correlation of Ascl1 expression levels and proliferation in the DG 
(A) Presentation of the mouse lines used to study the results of reducing Ascl1 levels on proliferation 
showing their names (first column), the Ascl1 allele they carry (WT, Δ, or neoflox, second column), 
the Rosa26-floxed stop-YFP (R26) reporter transgene they all carry (+, third column), whether they 
carry (+) or not carry (-) the Glast-CreERT2 deleter allele (CreER, fourth column), and whether the 
TAM treatment they all received (TAM, +) results in recombination events leading to Ascl1 deletion 
and expression of YFP (Rec, Yes or no, fifth column). The lines are ordered from top to bottom in 
relation to their expected levels of Ascl1 expression. (B and C) TAM administration at P60 and 
analysis one month later showed that Ascl1 levels correlate with the total number of Ki67+ cells and 
Ki67+ RGLs in the DG. No difference is observed in the number of cells between two or one WT 
Ascl1 alleles (WT and WT/ Δ), indicating that one normal allele is enough for correct proliferation. 
However, a bigger reduction in Ascl1 levels is translated into a bigger reduction in proliferation. n = 3 
for WT/ Δ and 4 for WT, Ascl1neoflox, Ascl1neoflox/Δ and Ascl1neocKO. * p<0.05. 
below this threshold of Ascl1 expression, which we reach with our Ascl1neoflox 
animals, proliferation is disrupted, and this is amplified as expression continues to 
decrease. The same is true for the number of Ki67+ RGLs in the DG of these 
different lines (WT versus WT/Δ versus Ascl1neoflox versus Ascl1neoflox/Δ	   versus 
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Ascl1neocKO, 161 ± 48.5 versus 160 ± 84.7 versus 66.0 ± 29.6 versus 24.0 ± 13.9 
versus 0 Ki67+ RGLs; Figure 3-8C). 
3.5 Ascl1 deletion results in a loss of proliferation in Ascl1cKO mice 
3.5.1 Effect on progenitor proliferation 
Next I went on to analyse the phenotype of the Ascl1cKO mice, which do not carry 
the PGK promoter-neo sequence and have therefore levels of Ascl1 that are 
comparable to WT animals until they undergo cre-induced recombination. The 
phenotype in Ascl1neocKO animals appears to be very clear; however, because of 
concerns regarding the development of Ascl1neoflox animals with reduced Ascl1 levels, 
it is important to also study Ascl1 deletion in animals that have normal Ascl1 
expression during development. For this I followed the same procedure than before, 
and I quantified the number of Ki67+ or MCM2+ cells present in the DG of WT, 
Ascl1flox and Ascl1cKO mice.  I found, in a similar manner, a very significant 
reduction in the number of cells that are dividing with both Ki67 and MCM2 in 
Ascl1cKO animals when compared to WT and Ascl1flox mice (WT versus Ascl1flox 
versus Ascl1cKO, 1713 ± 205 versus 2651 ± 129 versus 316 ± 87.9 Ki67+ cells; 2656 
± 42.3 versus 6048 ± 1130 versus 480 ± 33.9 MCM2+ cells; Figures 3-9A and 3-9B). 
The reduction in this case is not as striking as it was in the case of the Ascl1neocKO 
mice, and this is no surprise, considering that I had seen an uncoupling of Ascl1 and 
YFP recombination in these animals (see Figure 3-5).  
As expected, the number of proliferating cells in Ascl1flox animals, which 
carry neo-less Ascl1 floxed alleles but no cre recombinase, is not reduced, 
confirming that Ascl1 expression in them is back to normal. Surprisingly, however, I 
found the number of cells in these animals to be actually significantly increased 
when compared to WT mice (Figures 3-9A and 3-9B). The only difference between 
these two lines is the presence or absence of the cre recombinase, suggesting that 
having an active cre can affect proliferation. 
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Figure 3-9 Block of proliferation and activation in Ascl1cKO mice 
(A and B) Administration of TAM for five days and analysis one month later to animals that have 
undergone Flp-induced recombination and have therefore deleted the PGK promoter-neo cassette that 
was disrupting Ascl1 expression shows that deletion of Ascl1 in these animals also results in a block 
of proliferation and activation. The quantification of the total number of Ki67+ (A) and MCM2+ (B) 
per DG is shown. Ascl1cKO animals have significantly reduced numbers of both Ki67+ and MCM2+ 
cells compared to WT and Ascl1flox, whose Ascl1 levels are back to normal. Ascl1flox animals also show 
an increased number of dividing cells compared to WT mice. n = 3 for WT and Ascl1flox; 5 for 
Ascl1cKO. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. 
3.5.2 Effect on RGL proliferation 
When studying the presence of proliferation specifically in RGLs in Ascl1cKO 
animals I found, again, that RGLs that have deleted Ascl1 fail to enter the cell cycle, 
and this is shown both by Ki67 and MCM2 expression (WT versus Ascl1flox versus 
Ascl1cKO, 125 ± 39.6 versus 165 ± 47.4 versus 9.6 ± 9.6 Ki67+ RGLs; 112 ± 16.0 
versus 224 ± 57.7 versus 28.8 ± 19.2 MCM2+ RGLs; Figures 3-10A and 3-10B). As 
it was the case for total proliferation, the reduction in Ascl1cKO mice is not 
complete.  
Due to this uncoupling in the recombination between the Ascl1flox and RYFP 
alleles, and because no developmental defects were observed (Andersen et al., 2014; 
and see Discussion, chapter 7), I will be using the Ascl1neocKO animals for most of 
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the analysis. In experiments where the use of Ascl1neocKO animals risks biasing the 
results, the analysis will be performed with both lines. 
 
Figure 3-10 Block of proliferation and activation in hippocampal stem cells in 
Ascl1cKO mice 
(A and B) Administration of TAM for five days to adult mice and analysis one month later showed 
that the total number of Ki67+ and MCM2+ RGLs is greatly reduced in Ascl1cKO mice. No significant 
difference is found in RGL numbers between WT and Ascl1flox animals. n = 3 for WT and Ascl1flox; 5 
for Ascl1cKO. * p<0.05, ** p<0.01. 
3.6 Ascl1 acts in a cell-autonomous manner 
3.6.1 Ascl1-deleted cells do not proliferate from an early time-point 
The data in this chapter strongly indicate that Ascl1 is an essential factor required for 
the RGLs to enter the cell cycle and divide to generate more committed progeny. We 
know, nonetheless, that Ascl1 is expressed by IPCs as well as RGLs. There is a 
possibility, therefore, that the loss of RGL proliferation is a secondary consequence 
of an effect of Ascl1 on IPCs. To investigate this possibility I first performed a short-
term analysis, where RGL proliferation was quantified after the last TAM injection. 
In this way, by carrying out the analysis straight after TAM administration, non-
recombined proliferating IPCs will still be present (Figure 3-11A), and if they were 
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exerting a positive effect on RGL proliferation, I would be able to see some dividing, 
rescued RGLs. Quantification of the percentage of RGLs that is Ki67+ in P64 
animals showed that there are no stem cells dividing even at this early time point in 
Ascl1neocKO mice (WT versus Ascl1neocKO, 1.8% ± 0.2% versus 0% Ki67+ RGLs; 
Figures 3-11B and 3-11C). This suggests that the effect that we see in RGLs is cell 
autonomous and not a secondary consequence derived from the IPCs.  
 
Figure 3-11 Short-term block of RGL proliferation in Ascl1neocKO mice  
(A) Administration of TAM to P60 animals and analysis straight after the last of five injections results 
in an environment where recombined RGLs in Ascl1neocKO mice are surrounded by non-recombined 
IPCs and neuroblasts. This is shown by immunolabeling for the IPC marker Tbr2, the neuroblast 
marker DCX and the reporter YFP, which are present in both WT and Ascl1neocKO animals (B and C) 
Immunolabeling for GFAP, Ki67 and YFP and quantification of the percentage of Ki67-expressing 
cells in the GFAP+ YFP+ radial population show that despite the presence of WT progeny, RGLs in 
Ascl1neocKO do not proliferate shortly after Ascl1 deletion. * p<0.05. Scale bars = 20μm (A, B). 
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3.6.2 Ascl1-deleted cells do not proliferate in the presence of progeny 
To further validate the cell-autonomy of Ascl1 on RGLs, I carried out a mosaic 
deletion of Ascl1, where I administered only one TAM injection as opposed to the 
five that I normally administer. In this way only a proportion of the stem cells will 
undergo recombination, while the rest would still be able to generate progeny (Figure 
3-12A). Following the logic of the experiment above, if proliferating progeny were 
required for RGLs to divide, this set up would allow me to see any rescued RGLs. 
Quantification of Ki67+ RGLs that are either YFP- or YFP+ in WT and Ascl1neocKO 
mice showed that this is not the case. While in WT animals I was able to find both 
YFP- and YFP+ dividing RGLs, no YFP+ RGL was positive for Ki67 in Ascl1neocKO 
mice (YFP- versus YFP+, 81.5 ± 18.5 versus 161 ± 37.1 cells in WT; 47.6 ± 14.0 
versus 0 cells in Ascl1neocKO; Figures 3-12B and 3-12C). This effect was 
independent of the recombination efficiency (Figure 3-12D). 
I next performed the same mosaic analysis in Ascl1cKO mice to discard any 
possible experimental confound due to different backgrounds between the WT and 
Ascl1neocKO mice. Quantification of the percentage of Ki67+ or MCM2+ RGLs that 
are either YFP+ or YFP- showed that Ascl1-deficient stem cells are unable to divide 
regardless of the context (YFP- versus YFP+, 0.4% ± 0.2% versus 0.07% ± 0.07% 
Ki67+ RGLs; 0.7% ± 0.4% versus 0% MCM2+ RGLs; Figures 3-12E and 3-12F). 
Here we also note the probable presence of uncoupled recombination, with a small 
proportion of YFP+ RGLs being Ki67+ (Figure 3-12E). Altogether these results 
indicate that Ascl1 acts cell-autonomously to promote RGL proliferation in the DG 
of adult mice. 
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Figure 3-12 Cell autonomous function of Ascl1 in RGLs after mosaic deletion (legend 
next page) 
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Figure 3-12 Cell autonomous function of Ascl1 in RGLs after mosaic deletion 
(A) Only one injection of TAM at P60 results in a mosaic Ascl1 deletion with just a proportion of 
RGLs recombined. Immunolabeling for YFP and the neuroblast marker DCX illustrate this mosaic 
deletion and show that non-deleted precursors giving rise to progeny are still present in Ascl1neocKO 
mice. (B) Staining for the RGL marker GFAP, the proliferation marker Ki67 and YFP to visualise the 
active stem cell population show that while YFP- (non-recombined) RGLs can still proliferate in 
Ascl1neocKO mice (white arrow, bottom panel), RGLs that have deleted Ascl1 (recombined, YFP+) do 
not proliferate. (C) Quantification of the number of Ki67-expressing GFAP+ radial cells in WT and 
Ascl1neocKO mice confirms that in a WT background both YFP+ and YFP- RGLs exist, but in 
Ascl1neocKO animals, only YFP- Ki67+ cells are found. (D) The loss of proliferation in Ascl1neocKO 
RGLs does not depend on the recombination efficiency. This is shown by plotting the total number of 
Ki67+ RGLs (vertical axis) against the recombination efficiency as the ratio of YFP+ RGLs to total 
RGLs (horizontal axis). Each WT and Ascl1neocKO mouse studied is plotted separately and the number 
of recombined (YFP+) and non-recombined (YFP-) RGLs for each mouse is linked by a vertical line. 
(E and F) Quantification of the percentage of Ki67 or MCM2-expressing GFAP+ radial cells in 
Ascl1cKO mice in recombined (YFP+) and non-recombined (YFP-) RGLs. In animals that have 
undergone recombination to delete the PGK promoter-neo cassette the same result is observed; YFP+ 
cells divide. Recombination efficiency in the RGL population for these experiments was between 12% 
and 40%. Note that expression of Ki67 in one YFP+ RGL in (E) is likely due to the uncoupling of 
recombination between Ascl1 and the Rosa26 YFP reporter alleles. n = 3 (C, D) for WT, 6 (C, D) for 
Ascl1neocKO; 4 (E, F) for Ascl1cKO. ** p<0.01. Scale bars = 20μm (B), 40μm (A). 
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Data so far has demonstrated that Ascl1-deficient RGLs are unable to divide and that 
this is a cell-autonomous effect. Next, I set out to determine the consequences of a 
loss of proliferation in RGLs in the DG. If stem cells do not proliferate then I 
hypothesise they do not generate any progeny, so first I analysed the neurogenic and 
astrogliogenic output of Ascl1-deleted cells. In this chapter I will also describe the 
fate of RGLs after Ascl1 deletion: is Ascl1 involved in maintaining the stem cell 
properties of RGLs, or does it exclusively affect their ability to proliferate? And 
finally, as an extension of these two sections, in this chapter I will go on to determine 
what is the long-term effect of Ascl1 deletion. 
4.1 Ascl1 deletion results in a block of neurogenesis 
One obvious question to ask having completely blocked RGL divisions by the 
deletion of Ascl1 is whether any new neurons are still being generated. To answer 
this question I deleted Ascl1 in two-month old mice by administering TAM for 5 
days, and looked for the expression of markers characteristic of more committed 
cells in the neurogenic lineage one month later. This time frame is enough to allow 
cells generated at P60 to differentiate into neurons. 
The lack of a proliferating population shown in the previous chapter suggests 
that there is indeed an absence of IPCs. To confirm this I performed immunolabeling 
for the IPC marker Tbr2, and I assuredly found no Tbr2+ cells in Ascl1neocKO mice. 
Interestingly, I saw no difference in the number of Tbr2+ cells between WT and 
Ascl1neoflox mice (WT versus Ascl1neoflox versus Ascl1neocKO, 1169 ± 202 versus 1089 
± 262 versus 30.0 ± 22.9 cells; Figures 4-1A and 4-1B). This is surprising 
considering that I found a significant reduction in the number of both Ki67+ and 
MCM2+ cells, as well as in the number of BrdU-incorporating cells in these mice 
(see Figure 3-6). This raises the question of whether this result is accurate or a 
technical artefact, which might be possible taking into account the knowledge of the 
variable nature of the Tbr2 immunostaining. 
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Figure 4-1 Block of neurogenesis after Ascl1 deletion (legend next page) 
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Figure 4-1 Block of neurogenesis after Ascl1 deletion 
(A and B) Immunostaining for the IPC marker Tbr2 and YFP and quantification of the total number 
of Tbr2+ YFP+ cells in the DG show that IPCs are absent in Ascl1neocKO mice. (C and D) Similarly, 
staining for the immature neuronal marker DCX and YFP and quantification of the total number of 
DCX+ YFP+ cells in the DG show that no new neurons are generated in Ascl1neocKO mice. Ascl1neoflox 
mice, which have reduced levels of Ascl1 expression, also show a reduction in the number of DCX+ 
cells in the DG. (E) That no new neurons are born in Ascl1neocKO mice can be observed by labelling 
for YFP and the mature neuronal marker NeuN. In WT animals, new-born YFP+ neurons can be seen 
in the GL of the DG, and these express NeuN. No YFP+ neurons can be found in in the GL of 
Ascl1neocKO mice. n = 3 (B, D) for all genotypes. * p<0.05, ** p<0.01. Scale bars = 20μm (A, E) and 
40μm (C). 
Next, I performed immunostaining for the late IPC or immature neuron 
marker DCX, and after quantification I found these cells also to be lost after Ascl1 
deletion. In WT mice it is possible to find DCX+ YFP+ cells in the SGZ and GL of 
the DG, indicating that new cells were generated between TAM administration and 
analysis, while none of these cells are found in Ascl1neocKO mice (Figures 4-1C and 
4-1D). I also observed, differently from the Tbr2 data, a significantly lower number 
of DCX+ cells in Ascl1neoflox animals, indicating that neuron generation is also 
affected by the level of Ascl1 expression (WT versus Ascl1neoflox versus Ascl1neocKO, 
17600 ± 2058 versus 5262 ± 1238 versus 0 cells; Figure 4-1D). Finally, both YFP 
expression in the GL and colocalisation with the mature neuronal marker NeuN 
confirm that no new neurons are generated and therefore neurogenesis is absolutely 
blocked after Ascl1 is deleted (Figure 4-1E). 
4.2 Effect of Ascl1 deletion on astrogliogenesis 
Stem cells in the DG of the hippocampus not only generate neurons, but are known 
to also give rise to astrocytes (Bonaguidi et al., 2011, Encinas et al., 2011). Two 
independent routes for generating astrocytes in the adult DG have been proposed. 
The first one involves astrogliogenic asymmetric RGL divisions. The second one, on 
the other hand, involves direct differentiation via transition astroglia or transition 
astrocytes (TA; Bonaguidi et al., 2011). Because GLAST is expressed not only by 
RGLs but also by mature astrocytes, it means that recombination using Glast-
CreERT2 animals occurs in both populations. This does not cause interference when 
studying the neurogenic lineage, since we find no expression of Ascl1 in astrocytes. 
However, by using this cre deleter line and following YFP+ cells, I am unable to 
determine whether deletion of Ascl1, as well as blocking neurogenesis, affects the 
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generation of astrocytes. In order to circumvent this obstacle, I crossed Ascl1neoflox; 
R26-floxed stop-YFP mice with mice carrying a Nestin-CreERT2 allele instead of 
Glast-CreERT2. Nestin is expressed in RGLs, and recombination in astrocytes is not 
observed in animals carrying cre under this promoter (Encinas et al., 2011). In this 
way, by following the fate of YFP+ cells one month after TAM administration I 
would be able to determine if astrocytes are generated after Ascl1 loss (Figure 4-2A).  
I first attempted to resolve this question by observing the morphology of 
YFP+ cells in WT and Ascl1neocKO mice crossed with Nestin-CreERT2 mice (see 
also Figures 4-3A and 4-3B for more on cellular phenotypes). Astrocytes exhibit 
numerous branching processes and are, consequently, often described as “bushy”. I 
found no significant difference in the percentage of astrocyte-like cells among the 
total YFP+ population between WT and Ascl1neocKO mice (WT versus Ascl1neocKO, 
2.7% ± 1.7% versus 1.6% ± 1.4% astrocyte-like cells; Figure 4-2A). However, to 
discard the possibility of biasing the findings by focusing on morphology, and 
because the validity of this result depends on the total number of YFP+ cells being 
equal between the two genotypes, I went on to specifically quantify those cells that 
were positive both for YFP and the mature astrocytic marker S100β. This analysis 
showed that, even though not significantly different, there are more double positive 
cells in Ascl1neocKO animals compared to WT (WT versus Ascl1neocKO, 274 ± 274 
versus 3200 ± 1319 cells; Figure 4-2B). This analysis also revealed that while 
S100β+ YFP+ cells were all found in the CA region in WT mice, 30% of these cells in 
Ascl1neocKO animals were in the SGL/GL area of the DG, and they resembled the 
TAs that had been previously described by others (Bonaguidi et al., 2011; see also 
Figure 4-3B). This data might suggest that Ascl1-deficient RGLs are more likely to 
directly differentiate into astrocytes compared to WT RGLs. To address this, I 
quantified the number of TAs present in each of these genotypes using the Glast-
CreERT2 deleter line, which shows a more efficient recombination. I considered TAs 
those cells that were both GFAP and Nestin positive but that did not qualify as an 
RGL, namely, they were either in the GL as opposed to the SGZ, or had more than 
one process. This quantification did not convey a definite answer. There were more 
TAs in Ascl1neocKO mice compared to WT mice, but this was not a significant 
difference (WT versus Ascl1neocKO, 798 ± 99.1 versus 1105 ± 107 cells; Figure 4-
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2C). Altogether, these results, even though not conclusive, point to a small increase 
in the direct differentiation of RGLs to astrocytes.	  
 
Figure 4-2 Effect of Ascl1 deletion on astrogliogenesis 
(A) Deletion of Ascl1 using a Nestin-CreERT2 deleter to study the fate of RGLs one month after 
TAM administration. Quantification of the percentage of YFP+ cells showing astrocytic morphology 
(cell body with numerous branching processes) among all YFP+ cells shows no apparent difference in 
the generation of astrocytes between WT and Ascl1neocKO mice. (B) Quantification of the total 
number of YFP+ cells that are also S100β+ in the hippocampus of WT and Ascl1neocKO mice shows 
that more astrocytes are found in Ascl1neocKO animals. Whether these are generated by direct 
differentiation from RGLs or through a proliferation step we cannot ascertain with this data. However, 
having in mind the complete lack of proliferation in Ascl1neocKO mice it appears likely that a small 
proportion of stem cells terminally differentiates into an astrocytic fate without going through a 
proliferative step. (C) Quantification of the total number of transition astrocytes (TAs, GFAP+ Nestin+ 
non-RGL) in the DG of WT and Ascl1neocKO animals shows a slight, but not significant, increase in 
TAs in Ascl1-deficient mice. n = 5 (A), 7 (B) and 2 (C) for WT; 7 (A), 9 (B) and 2 (C) for 
Ascl1neocKO. 
4.3 Stem cells retain their characteristics after Ascl1 deletion 
4.3.1 RGLs are maintained after Ascl1 deletion 
Results so far show that neurogenesis is blocked after Ascl1 deletion. What happens, 
however, to RGLs? Can they maintain their characteristic properties after losing their 
ability to self-renew and generate new progeny? To answer these questions I first 
made use of Nestin-CreERT2 animals again crossed with our Ascl1neoflox mice. 
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Recombination efficiency in this cre line is very much reduced when compared to 
that of Glast-CreERT2, which makes it easier to follow cells and rely on morphology 
for analysis (Figures 4-3A and 4-3B). Moreover, quantification of RGL’s progeny 
one month after Ascl1 deletion showed results consistent with those previously 
obtained with the Glast-CreERT2 line (Figure 4-3C). I found a proportion of YFP+ 
cells in WT mice that resemble type 2 cells (or IPCs, 13.71% ± 5.53%), with the 
majority of them being MCM2+ (57.65% ± 21.85%). No cells exhibiting type 2 
morphology were found in Ascl1neocKO mice. Similarly, a big proportion of the 
YFP+ cells present one month after recombination in WT mice had already 
differentiated into immature or mature neurons (40.32% ± 9.00%), as opposed to a 
small proportion of them in Ascl1neocKO mice (6.66% ±	  2.60%). These cells most 
likely represent events of uncoupled recombination (where the RYFP locus 
undergoes recombination of at least one of its alleles, but Ascl1 does not, see section 
3.3.3), since I do not find such population of YFP+ neurons using the Glast-CreERT2 
deleter line. 
Next, I moved on to quantify the proportion of RGLs that are maintained one 
month after TAM administration. This analysis revealed that, in Ascl1neocKO mice, a 
majority of the cells that had undergone recombination had the characteristic radial 
morphology and had therefore been maintained as RGLs (35.59% ± 3.96% in WT 
and 76.48% ± 6.69% in Ascl1neocKO; Figures 4-3B and 4-3C). All together, these 
results suggest that Ascl1 deletion leads to a block of neurogenesis but a maintenance 
of RGLs.  
4.3.2 RGLs do not differentiate into the astrocytic lineage 
Evidence so far suggests that stem cells are maintained despite their failure to divide, 
and does not point towards their aberrant differentiation. I, nonetheless, investigated 
the possibility of RGLs terminally differentiating into astrocytes. Analysis with the 
low-recombination Nestin-CreERT2 mice already suggests that this might be the case 
for a very small proportion of the RGLs, but further quantification of YFP+ S100β+ 
cells in the DG of Glast-CreERT2 Ascl1 WT and Ascl1neocKO mice shows that the 
number of double positive cells remains the same (WT versus Ascl1neocKO, 974 ± 
361 versus 1110 ± 173 cells; Figures 4-4A and 4-4B). Therefore, despite the 
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possibility of an increase in the number of TAs in the DG of Ascl1neocKO mice there 
is not an increase in the number of S100β+ cells, and therefore provide more evidence 
that RGLs retain their stem cell characteristics after Ascl1 deletion. 
 
Figure 4-3 Ascl1-deficient cells retain their RGL morphology and are maintained in the 
adult DG (legend next page) 
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Figure 4-3 Ascl1-deficient cells retain their RGL morphology and are maintained in the 
adult DG 
(A) The Nestin-CreERT2 deleter line was crossed to Ascl1neoflox mice to study the fate of Ascl1-deleted 
cells. TAM was administered at P60 and morphology of YFP+ (recombined) cells in the DG (and CA 
in the case of astrocytes) of both WT and Ascl1neocKO mice was examined one month later. Note the 
limited recombination efficiency obtained using the Nestin-CreERT2 deleter line, which eases the 
study of cellular morphology. (B) Examples of the different type of cells recognised in the DG 
neurogenic lineage. Type 1 cells (RGLs) have their cell body in the SGZ and they have a radial 
process that extends along the GL. Type 2 cells (IPCs, three of them shown here) have small cell 
bodies positioned around the SGZ region and they possess small horizontal processes. Type 3/4 cells 
represent all neuroblasts (NB) and neurons. They have round cell bodies in the GL or SGZ and they 
have long thin processes extending towards the CA region. Two types of astrocyte-like cell types are 
recognised. Cells that resemble RGLs (but cannot be considered RGLs for not being positioned in the 
SGZ or having multiple processes) are called here transition astrocytes (TA), and highly ramified or 
“bushy” cells I called astrocytes. Characterisation of the cellular phenotype was assisted by 
immunostaining for the stem cell marker GFAP (not shown). (C) Quantification of the percentage of 
each of these cells found in WT and Ascl1neocKO mice among all YFP+ cells confirms that no new 
neurons are generated from cells that have lost Ascl1, and also shows that RGLs are maintained in this 
instance. The percentage of type 1 cells that remain one month after recombination is doubled in 
Ascl1neocKO mice compared to WT. A proportion of type 2 cells is found in WT but not Ascl1neocKO 
mice. Also, a big proportion of type 3/4 cells are found in WT animals, and only few of them are 
found in Ascl1-deficient mice. These type 3/4 cells in Ascl1neocKO animals likely represent uncoupled 
recombination events. There is no difference in the percentage of astrocytes found. TA astrocytes are 
included in the “other” category, which also includes any cell that did not fit into the rest of 
categories. n = 5 for WT and 7 for Ascl1neocKO. Scale bars = 20μm (B), 40μm (A). 
During embryonic development, activation of Notch signalling has been 
reported to induce gliogenesis (Morrison et al., 2000, Wang and Barres, 2000). 
Therefore, one possibility for why RGLs are maintained in favour of terminal 
differentiation towards the astrogliogenic lineage, which could be expected in the 
absence of proliferation, is that there are reduced levels of Notch in RGLs. Notch 
ligands presented by IPCs (Lavado and Oliver, 2014) are indeed absent in this 
scenario, since IPCs are all depleted one month after Ascl1 deletion. In order to 
determine if lower Notch activity might be responsible for the maintenance of RGLs, 
we measured expression of the Notch effectors Hes1 and Hes5 in laser capture-
microdissected SGZ tissue. We found Notch activity to be indeed much reduced in 
Ascl1neocKO animals (Figure 4-4C), albeit not completely absent. The remaining 
Notch activity could be provided by other ligand-presenting cells (e.g. blood vessel 
endothelial cells), although this remains to be determined. These results point to a 
possible mechanism for the block of astrocytic differentiation of RGLs in 
Ascl1neocKO animals. 
Results 4 
 
 105 
 
Figure 4-4 Stem cells do not express markers of mature astrocytes 
(A and B) Labelling for the astrocytic mature marker S100β and YFP and quantification of the total 
number of S100β+ YFP+ cells shows that there is no difference in the number of astrocytes in the DG 
between WT and Ascl1neocKO mice, and that therefore RGLs do not express mature astrocytic markers 
and retain their undifferentiated stem cell character. (C) Quantitative RT-PCR analysis of LCM tissue 
for the Notch transcriptional effectors Hes1 and Hes5 show that Notch signalling activity is reduced in 
the SGZ of Ascl1neocKO mice. Expression levels are normalized to Gapdh. (C) Performed by Ayako 
Ito. n = 2 (B) and 4 (C) for both genotypes. Scale bar = 40µm (A). 
4.3.3 RGLs do not differentiate into the oligodendrocytic lineage 
Next, we went on to confirm Ascl1-deficient cells do not take on an aberrant fate and 
differentiate into cells of the oligodendrocytic lineage. Retrovirus-mediated 
overexpression of Ascl1 in the DG has been shown to result in the exclusive 
generation of cells of the oligodendrocytic lineage (Jessberger et al., 2008). 
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Quantification of YFP+ Olig2+ cells one month after TAM administration revealed 
that: 1) very few oligodendrocyte cells are generated in the DG, and that 2) there was 
no difference in the number of those generated between WT and Ascl1neocKO mice 
(WT versus Ascl1neocKO, 192 ± 192 versus 128 ± 64 cells; Figures 4-5A and 4-5B). 
These results suggest that no aberrant differentiation of RGLs after Ascl1 deletion is 
taking place. 
 
Figure 4-5 Stem cells do not aberrantly differentiate into the oligodendrocytic lineage 
(A and B) Labelling for the oligodendrocyte marker Olig2 and YFP and quantification of the total 
number of Olig2+ YFP+ cells shows that there are very few oligodendrocytes generated in the DG of 
adult mice and that there is no difference in this number between WT and Ascl1neocKO mice. n = 3 
(B). Scale bar = 40µm (A). 
4.3.4 RGLs do not become senescent 
Ascl1-deleted RGLs are in a quiescence-like state, since I have shown they do not 
produce progeny and do not aberrantly differentiate into other lineages. Another 
possibility to explore was that of these cells having become senescent. Senescence is 
a permanent retirement out of the cell cycle, and it is generally induced by stimuli 
that put a cell at risk, the most common being DNA damage (Blomen and Boonstra, 
2007). Ascl1 deletion could be driving RGLs into a non-proliferative senescent state. 
To test this possibility we performed expression analysis by RT-qPCR for the 
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senescence-associated cyclin-dependent kinase inhibitor p16INK4a (Molofsky et al., 
2006) in SGZ tissue obtained with LCM. Both WT and Ascl1neocKO mice show very 
low levels for p16INK4a, and there is no difference in expression between the two 
genotypes (Figure 4-6), thus suggesting that RGLs that have deleted Ascl1 are not 
senescent. 
 
Figure 4-6 Ascl1-deficient cells do not become senescent 
Quantitative RT-PCR analysis for the cyclin-dependent kinase inhibitor p16INK4a/Cdkn2a in LCM 
SGZ tissue shows that expression of this marker is scarcely detected in the DG of P90 mice and it is 
not increased in Ascl1neocKO animals compared to WT animals. Expression levels are normalized to 
Gapdh (also shown here as a scale). Performed by Ayako Ito. n = 3 for both genotypes. 
4.3.5 RGLs retain stem cell characteristics 
Finally, I performed immunohistochemical analysis of known stem cell markers to 
verify that RGL characteristics are indeed maintained in Ascl1-deleted animals. As 
mentioned in the previous section, RGLs in these mice retain their characteristic 
radial morphology. Importantly, the radial processes in these cells express both 
GFAP and Nestin (Figure 4-7A). In the case of Ascl1-deficient cells, the level of 
Nestin expression was in occasion lower or barely detectable when compared to WT 
cells, and this is translated into a significant lower proportion of GFAP+ cells that 
express Nestin in Ascl1neocKO animals (Figure 4-7B). This is consistent with reports 
indicating that quiescent cells express lower levels or no Nestin (Codega et al., 2014, 
DeCarolis et al., 2013). 
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Figure 4-7 RGLs retain stem cell characteristics after Ascl1 deletion 
(A and B) Administration of TAM at P60 and immunostaining analysis one month later reveals that 
Ascl1-deficient RGLs still express GFAP and Nestin, two markers characteristic of the stem cell 
phenotype. Quantification of the percentage GFAP radial cells that are also Nestin+ shows that in WT 
animals almost all RGLs express both markers. In Ascl1neocKO animals, the vast majority of GFAP+ 
cells also express Nestin. The level of expression in these animals, however, is slightly lower than that 
in WT mice (not shown), and this is reflected in a significant difference in the percentage of cells 
expressing both markers between them. (C and D) Immunohistochemistry for YFP and the precursor 
marker Sox2 shows that Ascl1-deleted RGLs retain expression of this marker, and quantification of 
the total number of Sox2+ YFP+ cells in the DG shows no difference between WT and Ascl1neocKO 
animals. (E) Ascl1-deficient RGLs also retain the expression of the quiescence marker p57, shown by 
immunolabeling for p57, GFAP and YFP. (F) Quantification of the intensity of the nuclear p57 
staining in RGLs in WT and Ascl1neocKO animals shows that stem cells that have lost Ascl1 retain 
levels of this marker that are comparable to those levels in WT cells. n = 2 (F) and 3 (B, D) for WT; 2 
(B, D, F) for Ascl1neocKO. * p<0.05. Scale bars = 40μm (A, C and E). 
In a similar manner, I did not find any difference in the expression of the 
stem cell marker Sox2. The number of YFP+ Sox2+ cells was comparable in WT and 
Ascl1neocKO mice, with all RGLs expressing this marker (Figures 4-7C and 4-7D). 
The cyclin-dependent kinase inhibitor p57 has been described to be expressed in 
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RGLs and to contribute to the regulation of RGL quiescence (Furutachi et al., 2013). 
Immunolabeling for p57 showed that Ascl1-deficient RGLs do not lose the 
expression of this marker (Figure 4-7E), and that the intensity of its expression is 
comparable to that of WT mice (Figure 4-7F). Therefore, Ascl1 loss does not disrupt 
stem cell maintenance or quiescence.   
4.4 Long-term effect of Ascl1 deletion  
4.4.1 RGLs remain quiescent long-term 
Stem cells in Ascl1neocKO mice appear to be quiescent one month after Ascl1 
deletion. I next went on to examine whether this state was stable over a longer period 
of time. For this, two-month old mice received TAM over five consecutive days as 
before and analysis was carried out 5 months after at P210 (Figure 4-8). In WT mice 
we can observe the number of GL-positioned YFP+ neurons that were generated over 
this period (Figure 4-8, upper panel). We can also find a proportion of RGLs that is 
Ki67+ and therefore dividing (Figure 4-8, upper inset panel). In Ascl1neocKO mice, 
on the other hand, we can see that no new neurons were generated during this time 
(Figure 4-8, bottom panel). Nevertheless, RGLs still retained their characteristic 
radial morphology and expressed stem cell markers like GFAP, Nestin and Sox2 
(Figure 4-8 and not shown). These cells were also negative for the proliferation 
marker Ki67+ (Figure 4-8A, bottom inset panel), indicating that Ascl1-deficient 
RGLs remain inactive and quiescent long-term. 
 
 
Figure 4-8 Ascl1-deficient RGLs remain non-proliferative long-term 
Administration of TAM over five consecutive days and analysis five months later to study the effect 
of Ascl1 deletion long-term. Immunolabeling for YFP shows that, while in WT animals a big number 
of neurons were generated in this time (rounded YFP+ cells in GL), no new neurons were generated in 
Ascl1neocKO mice. In addition, staining for Ki67 and GFAP show that stem cells in the DG of 
Ascl1neocKO mice not only remain non-proliferative (Ki67-), but they also retain their characteristic 
radial morphology. RGLs in WT animals still retain their proliferative ability (see Ki67+ GFAP+ YFP+ 
RGL in inset, white square). Scale bars = 40μm and 10μm in enlargement. 
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Figure 4-8 Ascl1-deficient RGLs remain non-proliferative long-term (legend previous 
page) 
4.4.2 Ascl1 deletion prevents RGL exhaustion 
Hippocampal neurogenesis is reduced with age, and this reduction is attributed, in 
part, to non-self-renewing RGL divisions (Bonaguidi et al., 2012, Encinas and Sierra, 
2012; see also section 1.3.4.1). Quantification of the total number of stem cells over 
time in WT animals showed that indeed, this number significantly decreases between 
P64 and P90 and that it decreases further at P210 (Figure 4-9). The same 
quantification in Ascl1neocKO mice showed, however, that the total number of RGLs 
does not change between P64 and P90, and only slightly but not significantly 
decreases at P210 (WT versus Ascl1neocKO, 22116 ± 1681 versus 24533 ± 1399 
RGLs at P64; 14453 ± 1021 versus 26098 ± 1913 RGLs at P90; 12516 ± 1603 versus 
20764 ± 395 at P210; Figure 4-9). This data supports the finding that RGLs in 
Ascl1neocKO mice do not divide, and suggests that Ascl1 deletion prevents the 
attrition of the RGL pool. 
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Figure 4-9 Hippocampal stem cell attrition is prevented by Ascl1 deletion 
Quantification of the total number of stem cells (GFAP+ Nestin+ radial cells) at P64, P90 and P210 in 
WT and Ascl1neocKO mice that received TAM at P60. WT animals show a reduction in total stem cell 
numbers from P64 to P90 and a further decrease at P210. In Ascl1neocKO mice, the number of stem 
cells remains constant from P64 to P90, and only slightly and not significantly decreases at P210. n = 
3 for both genotypes. * p<0.05. 
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Deletion of Ascl1 results in a block of neurogenesis due to the inability of stem cells 
to enter the cell cycle and proliferate. The role of RGLs in the adult hippocampus is 
that of sensors, in that they need to be able to sense and integrate the different stimuli 
present in the environment to then generate appropriate responses. In this way stem 
cells in the DG mediate the response to changing physiological demands, as well as 
to pathological insults. In this chapter I will be exploring the response of Ascl1 to 
neurogenic and anti-neurogenic stimuli. Not much is known at the moment as to how 
RGLs are able to respond to their environment in response to stimuli. The expression 
of Ascl1 and what we know of its function so far highlight it as a possible candidate 
to fulfil this role.  
5.1 Ascl1 expression is regulated in response to neurogenic and anti-
neurogenic stimuli 
5.1.1 Voluntary running does not affect stem cell activity 
I started by examining the effect of neurogenic stimuli on stem cell activity and 
Ascl1 expression. If Ascl1 is to be an important factor in the response to stimuli, then 
its expression should be upregulated in RGLs upon their activation. Exercise is a 
potent neurogenic stimulus. Its impact on RGL activity has been much debated. 
Some groups have reported an effect of running on the stem cell population (Lugert 
et al., 2010), while others claim that this effect is restricted to the IPC population 
(Kronenberg et al., 2003). Exposure to a running wheel for 12 days resulted in an 
overall increase of proliferation in WT mice (Figure 5-1). Quantification of the 
proportion of GFAP+ radial cells that express MCM2 showed, however, that, at least 
with the procedure that we followed, RGL activity is not affected by voluntary 
running (Control versus RUN, 4.4% ± 0.5% versus 3.2% ± 1.0% MCM2+ RGLs; 
Figure 5-2A). Correspondingly, Ascl1 expression is unchanged in RGLs after 12 
days of voluntary exercise (Control versus RUN, 1.4% ± 0.3% versus 1.3% ± 0.6% 
MCM2+ RGLs; Figure 5-2B).  
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Figure 5-1 Voluntary running increases total proliferation in the DG 
Voluntary running for 12 days in adult WT mice increases the number of active cells in the DG, 
illustrated here by immunostaining for MCM2. n = 4. Scale bar = 40μm 
 
Figure 5-2 Voluntary running does not affect hippocampal stem cell activation (legend 
next page) 
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Figure 5-2 Voluntary running does not affect hippocampal stem cell activation 
(A) Quantification of the percentage of GFAP+ radial stem cells that are positive for MCM2 revealed 
that the increase of MCM2+ cells does not correspond with an increase in activated RGLs; there is no 
difference in the proportion of MCM2+ RGLs between control animals and runners. (C) Similarly, no 
difference in the percentage of Ascl1+ RGLs is observed between control and RUN animals. n = 4 (B) 
and 6 (C) for control; 7 (B) and 9 (C) for RUN.  
5.1.2 Social isolation negatively regulates Ascl1 expression 
Another known stimulus that regulates stem cell activity is acute stress (Dong et al., 
2004). Social isolation and transfer of mice from a grouped-cage to a singled-cage 
environment elicits a stress response in mice, and consequently negatively regulates 
stem cell activity. Isolation of two-month-old WT animals and analysis one or two 
days later revealed that this negative stimulus modulates Ascl1 expression in RGLs 
(Ctrl 0 versus Isol D1 versus Isol D2, 3.4% ± 0.9% versus 4.5% ± 0.4% versus 1.8% 
± 0.8% Ascl1+ RGLs; Figure 5-3B). A reduction in the number of Ascl1+ RGLs two 
days after isolation is translated into a slight decrease in the number of MCM2+ 
RGLs (Ctrl 0 versus Isol D1 versus Isol D2, 4.5% ± 1.9% versus 6.2 ± 1.1% versus 
3.9% ± 0.9% MCM2+ RGLs; Figure 5-3A). Ascl1 expression is, therefore, 
modulated in RGLs upon the reception of anti-neurogenic stimuli. 
 
Figure 5-3 Social isolation is an anti-neurogenic stimulus that negatively regulates 
Ascl1 in RGLs (legend next page) 
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Figure 5-3 Social isolation is an anti-neurogenic stimulus that negatively regulates 
Ascl1 in RGLs 
(A) Social isolation paradigm to test the effect of an anti-neurogenic stimulus on Ascl1 expression and 
stem cell activity. Before the start of the experiment WT mice were kept in a large cage with 4-8 
littermates (Group caged). On day 0, animals were placed on small cages on their own (Ctrl 0) and 
analysis was carried out one or two days later (Isol D1 or Isol D2, respectively) by performing 
immunohistochemistry for MCM2 and Ascl1. Quantification of the percentage of MCM2-expressing 
GFAP+ radial cells shows that stem cell activation is slightly reduced on the second day of isolation 
(Isol D2). (B) The reduction in MCM2+ RGLs at Isol D2 corresponds with a significant decrease in 
the percentage of Ascl1+ RGLs. n = 4 (A, B) for Isol D1and Isol D2; 5 for Ctrl 0. * p<0.05. 
5.1.3 Ascl1 is upregulated after removal of an anti-neurogenic stimulus 
I next made use of a genetic approach to further study Ascl1 regulation in RGLs of 
the DG after the removal of an anti-neurogenic stimulus. Notch signalling is an 
important regulator of stem cell maintenance, and deletion of the Notch pathway 
component RBPJκ induces the activation of RGLs (Ehm et al., 2010). TAM 
administration in 3 month-old mice carrying an inducible RBPJκ-mutant allele as 
well as the Glast-CreERT2 deleter and examination of stem cell activity 7 days later 
revealed a dramatic increase in the number of MCM2+ RGLs as expected (WT versus 
RBPJκ cKO, 1.6% ± 0.6% versus 17.7 ± 3.4 MCM2+ Ascl1- RGLs; Figures 5-4A and 
5-4B). More strikingly, I saw a similarly dramatic induction of Ascl1 expression in 
RGLs after loss of Notch signalling compared to control mice. I also found an 
increased proportion of RGLs expressing Ascl1 but not MCM2, a population of cells 
that was almost negligible in normal conditions (WT versus RBPJκ cKO, 1.5% ± 
0.7% versus 26.7% ± 1.1% MCM2+ Ascl1+ RGLs; 0.2% ± 0.2% versus 3.6% ± 1.5% 
MCM2- Ascl1+ RGLs; Figure 5-4B).  
The induction of Ascl1 was specific and not a general response of proneural 
factors to the loss of Notch, as shown by in situ hybridisation (ISH) for both Ascl1 
and Neurog2 (Figures 5-5A and 5-5B). Ascl1 is upregulated after RBPJκ deletion, 
but this is not the case for Neurog2, whose expression in the adult DG appears 
undetectable by ISH (see Figure 5-5C showing an ISH for Neurog2 in the E14.5 
mouse telencephalon as a control). Together, these data demonstrate that anti-
neurogenic signals like Notch supress Ascl1 expression. 
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Figure 5-4 Ascl1 upregulation in hippocampal stem cells after the removal of an anti-
neurogenic stimulus 
(A and B) Conditional deletion of RBPJκ after TAM administration in P90 animals and analysis five 
days after the last injection. Labelling for Ascl1, MCM2 and GFAP and quantification of the 
percentage of Ascl1+ and/or MCM2+ GFAP+ radial cells reveals that the loss of Notch signalling 
results in a dramatic activation of stem cells in the DG, with an increase in the proportion of MCM2+ 
RGLs (light and dark orange bars, B; white arrow, A). This activation is accompanied by an increase 
in the percentage of Ascl1+ RGLs (dark orange and black bars; white arrow, A), and by an increase of 
Ascl1+ MCM2- stem cells (black bars). n = 5 for WT; 7 for RBPJκ cKO. p values, MCM2+ RGLs in 
WT versus RBPJκ cKO < 0.0001; Ascl1+ RGLs in WT versus RBPJκ cKO < 0.0001; Ascl1+ MCM2- 
RGLs in WT versus RBPJκ cKO = 0.0911. Scale bars = 20µm in main panel and 10µm in enlarged 
panel. 
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Figure 5-5 Ascl1 upregulation after Notch signalling inactivation is specific 
(A) In situ hybridisation (ISH) for Ascl1 shows that the upregulation of Ascl1 protein observed after 
RBPJκ deletion is, at least in part, due to an upregulation in Ascl1 transcription. RBPJκ cKO mice, 
which received TAM for five days at P90 and were sacrificed for analysis seven days after, present a 
great increase of Ascl1 signal in the SGZ (black box, inset) when compared to WT animals. (B) This 
upregulation of Ascl1 transcription is not general for all proneural factors, but specific to Ascl1. ISH 
for Neurog2 in WT and RBPJκ cKO mice shows no difference in Neurog2 transcription in the DG, 
with very low or undetectable levels for both genotypes. (C) ISH for Neurog2 in the E14.5 embryonic 
mouse brain as a positive control showing signal in the dorsal telencephalon. 
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5.1.4 Ascl1 is upregulated early in response to seizures 
Finally, in order to study Ascl1 expression in response to a stimulus in more detail, I 
made use of kainic acid (KA), a potent pharmacological stimulus that is known to 
activate stem cells (Steiner et al., 2008). I used two month-old WT mice and 
administered a sub-seizure dose of KA (19 mg/kg) that was enough to have an effect 
on RGL activity (Figure 5-6A). Measuring stem cell activation by quantifying the 
proportion of MCM2+ RGLs 1, 2, 4 and 7 days after KA injection, I found that by the 
second day there is an upregulation of the percentage of active RGLs when 
compared to animals that received saline. This increase becomes significant 4 days 
after KA administration (Saline versus KA, 4.1% ± 0.9% versus 3.4% ± 1.0% at Day 
1; 2.0% ± 1.2% versus 9.6% ± 2.5% at Day 2; 2.7% ± 0.5% versus 13.9% ± 1.1% at 
Day 4; 4.2% ± 0.6% versus 7.1% ± 1.0% MCM2+ RGLs; Figure 5-6B). The 
activation in response to KA appears to be a transient event, since 7 days after the 
injection the proportion of RGLs that was MCM2+ was already reduced.  
Interestingly, when examining the expression of Ascl1 in RGLs, I found that 
Ascl1 is upregulated already one day after KA administration (Saline versus KA, 
3.7% ± 0.5% versus 8.6% ± 2.7% at Day 1; 0.5% ± 0.5% versus 6.4% ± 1.5% at Day 
2; 1.6% ± 0.02% versus 6.4% ± 1.1% at Day 4; 3.4% ± 1.0% versus 3.5% ± 0.9% 
Ascl1+ RGLs; Figure 5-6C), and the upregulation is maintained for 4 days, after 
which Ascl1 expression in RGLs returns to baseline levels. This data highlights that 
a significant fraction of RGLs that are positive for Ascl1 at 24 hours after injection 
are negative for MCM2 (Saline versus KA, 1.4% ± 0.9% versus 7.8% ± 1.3% at Day 
1; 0% versus 0.4% ± 0.4% at Day 2; 0.5% ± 0.5% versus 0.6% ± 0.3% at Day 4; 
0.4% ± 0.4% versus 0.6% ± 0.3% at Day 7; Figure 5-6D), and thus indicates that 
Ascl1 induction precedes RGL activation. Altogether, this data shows that 
neurogenic stimuli rapidly induce Ascl1 expression and subsequently quiescence exit 
in RGLs. 
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Figure 5-6 Early Ascl1 upregulation in response to neurogenic stimuli 
(A) Administration of saline or kainic acid (KA) by i.p. injection to adult WT mice and analysis one 
(Day 1), two (Day 2), four (Day 4) or seven (Day 7) days later to study stem cell activity. Labelling 
for Ascl1, MCM2 and GFAP show that KA induces stem cell activation and Ascl1 upregulation from 
Day 1. (B) Quantification of the percentage of active RGLs (MCM2+) among all GFAP+ radial cells 
shows that KA induces MCM2 expression from Day 2. This induction is maintained at four days but 
is  downregulated to levels  almost  comparable to saline by Day 7 (legend continued in next page). 
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(C) Quantification of Ascl1+ RGLs in saline and KA-injected mice revealed that KA administration 
induces Ascl1 upregulation after only one day (yellow arrowheads and inset in white box, A), 
indicating that stem cells upregulate Ascl1 and only after express MCM2. Ascl1 upregulation in KA-
injected mice is maintained up to Day 4, and by Day 7 its expression is back to baseline levels. (D) 
That Ascl1 is upregulated from Day 1 and MCM2 is not indicates that, as shown here as the 
percentage of Ascl1+ MCM2- RGLs, one day after KA injection there is a population of cells that 
express Ascl1 but do not express MCM2, showing that stem cells express Ascl1 and only after exit 
quiescence. n = 3 (B, C, D) for Saline Day 2, Day 4 and Day 7, and for KA Day 7; 4 (B, C, D) for 
Saline Day 1, and for KA Day 2 and Day 4; 5 (B, C, D) for KA Day 1. * p<0.05, ** p<0.01, *** 
p<0.001. Scale	  bars	  =	  20μm in main panel and 10μm in enlarged panel. 
5.2 Ascl1-deficient RGLs do not respond to neurogenic stimuli 
The results above show that Ascl1 is regulated in RGLs in response to stimuli. The 
next question to ask was whether this regulation was required for the response of 
RGLs to the stimuli. To answer this question I made use of Ascl1neoflox animals to 
delete Ascl1 at P60 and investigate their response to KA after 4 days of injection (see 
Figure 5-7A for injection timings). In WT animals KA strongly induced 
neurogenesis, and this is shown by the quantification of the number of MCM2+ cells 
(Figures 5-7A and 5-7B). In contrast, KA entirely failed to activate RGLs in 
Ascl1neocKO mice and to consequently induce neurogenesis (KA WT versus 
Ascl1neocKO, 16974 ± 2719 versus 505 ± 128 cells; Figures 5-7A and 5-7B). The 
transcription factor Ascl1 is therefore required for RGLs in the adult DG to respond 
to neurogenic stimuli, and its loss renders RGLs inactive and unable to respond to 
their environment. 
 
Figure 5-7 RGLs do not respond to neurogenic stimuli after Ascl1 deletion (legend next 
page) 
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Figure 5-6 RGLs do not respond to neurogenic stimuli after Ascl1 deletion  
(A and B) Kainic acid (KA) administration to WT and Ascl1neocKO mice that had received TAM at 
P60 and analysis 4 days later to study the response of RGLs after Ascl1 inactivation. Immunostaining 
for MCM2 and YFP show that KA greatly induces precursor activation in the DG of WT mice, but it 
has no effect on Ascl1-deficient cells. Quantification of the total number of MCM2+ cells in the DG of 
WT and Ascl1neocKO mice four days after either saline or KA injection illustrates the lack of a 
neurogenic response in Ascl1neocKO animals. n = 3 (B) for Saline in both genotypes, and KA in WT; 2 
(B) for KA in Ascl1neocKO. * p<0.05, ** p<0.01. Scale bar = 40μm (A). 
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Ascl1 is required for the response of stem cells to their environment: reception of a 
signal modulates Ascl1 expression to generate a response, which in this case will 
mean either to enter the cell cycle to divide or not. One important question that 
remains to be addressed is what mediates this role, i.e. what are the targets of Ascl1 
in adult hippocampal stem cells. To understand this we started by examining the 
genome-wide binding of Ascl1 in hippocampal stem cells and established possible 
genes that could be performing this role. From here I was then able to select a 
number of genes to validate in vivo, that I will be describing next.  
6.1 Genome-wide investigation of Ascl1-bound genes 
In order to identify possible target genes mediating the proliferative role of Ascl1 in 
hippocampal stem cells, we performed chromatin immunoprecipitation-sequencing 
(ChIP-seq). With this approach we were able to identify, in a genome-wide manner, 
Ascl1 binding sites in neural stem cells derived from the adult hippocampus (AH-
NSCs). Next, using the Genomic Regions Enrichment of Annotations Tool 
(GREAT), we established a list of genes associated with an Ascl1 binding peak to be 
able to search for target candidates (see Table A1 1). Appendix 1 contains the 
information and data regarding the ChIP-seq analysis, which was performed by Ben 
Martynoga (see also Andersen et al., 2014).  
Because we had an extensive list of genes bound by Ascl1, we decided to 
intersect these with differentially expressed genes in quiescent versus active adult-
like stem cells of already published data sets. First, I intersected Ascl1-bound genes 
with genes that were downregulated during quiescence in Martynoga et al., 2013. 
Martynoga and colleagues characterised a cell culture model of NSC quiescence, 
where exposure of embryonic stem cell-derived NSC cultures to BMP4 leads to their 
acquisition of a quiescent state. Quiescence is a fundamental characteristic of stem 
cells in adult tissues. Since Ascl1 regulates the exit of these cells from their dormant 
state, we reasoned that those genes that were downregulated after BMP4 treatment in 
NSC cells would be some of the genes important during stem cell proliferation and, 
therefore, possible Ascl1 targets. Of the 4079 Ascl1-bound genes, 500 of them were 
common to the total 1957 genes down in quiescence NSCs (Figure 6-1A; see Table 
A1 2 in Appendix 1 for a list of overlapping  genes). Among the  genes  that are both  
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Figure 6-1 Investigation of Ascl1-bound genes in AH-NSCs  
(A) Venn diagram showing the overlap (purple) between genes bound by Ascl1 in adult hippocampus-
derived NSCs (AH-NSCs, blue) and genes that are downregulated in quiescent NSCs (quies NSC, 
pink) after BMP4 treatment from Martynoga et al., 2013. (B) Gene ontology (GO) analysis of the 500 
genes common for both sets of genes from (A) reveals that the terms most enriched are those related 
to kinase activity and cell cycle regulation, among others. (C) Venn diagram showing the overlap 
(purple) of genes that were bound by Ascl1 in AH-NSCs (blue) and those that were enriched in 
activated NSCs (aNSCs, pink) from Codega et al., 2014. (D) GO analysis of the 250 genes common 
for both sets of genes from (C) reveals that the terms most enriched are those related to cell cycle 
processes. See also Appendix 1 for the full lists of genes in (B, D). (B and D) The X-axis values 
correspond to DAVID p-values. All terms reported have a false discovery rate (FDR) <5%. The total 
number of genes in each term is shown in brackets. 
bound by Ascl1 and downregulated in quiescence there are known Ascl1 targets such 
as Dll1 and Dll3 (Castro et al., 2011). In addition, Gene Ontology (GO) analysis 
using DAVID showed these genes were mainly involved in the regulation of 
phosphorylation and kinase activity, as well as, importantly, the regulation of the cell 
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cycle (Figure 6-1B). Some of the cell cycle-related genes include Ccnd1, Cdc6, 
Ccna1 and E2f1 (see Table A1 3 in Appendix 1 for a full list of genes included in 
each term). 
Next, I intersected the list of Ascl1-bound genes with a recently published list 
of SVZ genes enriched in activated NSCs (aNSCs) compared with quiescent NSCs 
(qNSCs; Codega et al., 2014). Fiona Doetsch’s group isolated stem cells from the 
adult SVZ and used GFAP, prominin and the presence or absence of EGFR to 
distinguish active versus quiescent NSCs, respectively. From this analysis, I found 
250 genes to be present in both lists (Figure 6-1C, and see Table A1 4 in Appendix 1 
for a list of overlapping genes). GO analysis of these 250 common genes between 
Ascl1-bound and aNSCs from Codega et al., 2014 showed cell cycle-related 
processes to be the most represented terms (e.g. GO terms “DNA replication”, “Cell 
cycle”, “mRNA processing” and “DNA metabolic process”, Figure 6-1D). Cell cycle 
regulators included in these terms are Cdc6, Rrm2, E2f1, Skp2, Ccnd1 and Ccnd2 
(see Table A1 5 in Appendix 1 for a full list of genes included in each term). 
Intersection of the three lists (Ascl1-bound, down in quies NSC and aNSC 
signature genes) resulted in 95 common genes and revealed that cell cycle processes 
are also the ones predominantly enriched (see Tables A1 6 and A1 7 in Appendix 1 
for a full list of genes and GO terms). Our in vivo studies described in previous 
chapters demonstrated that Ascl1 is required for stem cell proliferation, and the 
meta-analysis described here does but highlight the central role of Ascl1 during this 
process. 
6.2 Validation of Ascl1 targets 
Cultured cells, in contrast to cells in vivo, are exposed to high concentrations of 
mitogens, thus biasing transcriptional annotations towards cell cycle-related terms. 
To establish whether cell cycle-related genes were among the direct targets of Ascl1 
in adult hippocampal stem cells, and validate the analysis described above, we used 
FACS sorting to isolate YFP+ cells from the DG of WT and Ascl1neocKO mice. We 
administered TAM for 5 consecutive days to 2 month-old mice carrying the Glast-
CreERT2  deleter as before, and dissected and dissociated their  DG ready for  FACS  
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Figure 6-2 Validation of Ascl1 targets in the adult hippocampus 
(A) Fluorescent-activated cell sorting (FACS) to isolate hippocampal RGLs was performed four days 
after the last of five TAM injections that started at P60. Representative FACS plot showing gating 
strategy. The X-axis represents the side scatter (SSC) and Y-axis represents the intensity of FITC 
(YFP expression). Red dots in P5 represent sorted cells (YFP+). (B) Quantitative RT-PCR analysis of 
FACS-sorted YFP+ RGLs from the hippocampus of WT and Ascl1neocKO mice shows that Ascl1 
expression, as well as expression of two Ascl1-bound cell cycle-related genes, Ccnd2 and Rrm2, are 
strongly reduced in Ascl1neocKO cells. The expression of other Ascl1-bound cell cycle-related genes 
like Ccnd1 and Skp2 is not significantly reduced, and the expression of Fbl is unchanged. Expression 
levels are normalized to Gapdh and Ppia and are relative to WT expression. n = 4 (B) for Rrm2 and 
Fbl for both genotypes; 6 (B) for Ascl1, Ccnd2, Ccnd1, Skp2 for both genotypes. ** p<0.01. 
purification 4 days after the last injection (Figure 6-2A). By then analysing gene 
expression by qPCR in FACS-sorted YFP+ RGLs, we were able to determine if our 
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candidate genes were, as well as being bound by Ascl1, mis-regulated in 
Ascl1neocKO, and therefore possible direct targets.  
Some of the genes tested were not detectable by qPCR (eg. Cdc6, Ccna1 and 
E2f1, not shown), but of the ones detected, I found the cyclin Ccnd2 and the 
ribonucleotide reductase M2 Rrm2 to be significantly downregulated in Ascl1-
deleted cells (Figure 6-2B). Expression of other cell cycle genes like Ccnd1 and Skp2 
was reduced, albeit not significantly, and the expression of some non-cell cycle 
genes tested like Fbl was unchanged (Figure 6-2B). Together, this data demonstrates 
that Ascl1 controls the proliferation of hippocampal stem cells by directly activating 
the expression of cell cycle genes. 
6.3 Cyclins as Ascl1 targets 
Both cyclins Ccnd1 and Ccnd2 are bound by Ascl1, and appeared to be both 
downregulated in quiescence in NSCs (Ccnd1), and enriched in aNSCs (both Ccnd1 
and Ccnd2). Interestingly, their importance in the self-renewing population of cells 
in the hippocampus has been previously established (Kowalczyk et al., 2004). I went 
on to further describe their expression in the RGLs of the DG. Ccnd2 is indeed 
expressed by radial progenitors in the DG (Figure 6-3, white arrow in top panel), and 
it is also expressed by non-radial IPCs (Figure 6-3, yellow arrowhead in top panel). 
Deletion of Ascl1 by TAM administration at P60 showed that Ccnd2 is completely 
lost from recombined cells one month later, as expected from the mRNA expression 
data. 
Similarly, immunolabeling for Ccnd1 showed this protein to be highly 
expressed in RGLs in the SGZ (Figure 6-4A, white arrows in top panel). The 
proportion of Ccnd1+ RGLs was surprisingly higher when compared to any of the 
other markers of proliferation used so far (10-15% compared to less than 5% for 
MCM2, Figure 6-4B). A complete loss of Ccnd1 expression is, nevertheless, seen 
after Ascl1 deletion (WT versus Ascl1neocKO, 11.2% ± 4.8% versus 0% Ccnd1+ 
RGLs; Figures 6-4A and 6-4B). This is different from what I observed after FACS-
sorting analysis of Ascl1neocKO RGLs, where no significant difference in mRNA 
expression was observed between WT and Ascl1-deleted cells (see Figure 6-2B).  
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Figure 6-3 Ccnd2 expression in the adult DG 
Labelling for Ccnd2, GFAP and YFP in the hippocampus of P90 WT and Ascl1neocKO mice that had 
received TAM at P60 shows that Ccnd2 is expressed in the SGZ of WT, but not Ascl1-deficient mice. 
In WT animals, Ccnd2 is expressed both by RGLs (white arrow, top panel) and IPCs (yellow 
arrowhead, top panel). In Ascl1neocKO mice, Ccnd2 expression is absent in YFP+ cells, indicating that 
Ccnd2 is a target of Ascl1 in the adult hippocampus. Note the presence of Ccnd2+ cells that are not 
part of the neurogenic lineage in the SGZ and therefore YFP- (white arrowhead, bottom panel). Scale 
bar = 20μm. 
Ccnd1 is bound by Ascl1 and its expression is lost in RGLs after Ascl1 
deletion, highlighting it as a likely direct target of this transcription factor. I 
previously showed Ascl1 to be expressed in RGLs early on, and before the activation 
marker MCM2, in response to the neurogenic stimulus KA. I hypothesised direct 
targets of Ascl1 to also be upregulated early on in response to neurogenic stimuli. To 
test this, I performed immunostaining for Ccnd1 24 hours after a single injection of 
KA in WT mice. This is the time when Ascl1 has already been induced, but MCM2 
has not. Indeed, KA administration results in a dramatic induction of Ccnd1 just 24 
hours after injection, following the pattern of induction seen for Ascl1 (Saline versus 
KA, 15.1% ± 2.2% versus 55.4% ± 4.1% Ccnd1+ RGLs; Figure 6-4C). These results 
show that Ascl1 controls stem cell activation by regulating expression of Ccnd1 and 
Ccnd2, among other cell cycle-related genes. 
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Figure 6-4 Ccnd1 expression in the adult DG (legend next page) 
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Figure 6-4 Ccnd1 expression in the adult DG 
(A) Administration of TAM to WT and Ascl1neoflox mice at P60 and immunohistochemical analysis one 
month later shows that Ccnd1 is expressed in a big proportion of WT RGLs (white arrows, top panel) 
but is absent in Ascl1neocKO cells, which have inactivated Ascl1 (bottom panel). Note the presence of 
Ccnd1+ cells that are not part of the neurogenic lineage in the SGZ and therefore YFP- (white 
arrowhead, top and bottom panels). (B) Quantification of the percentage of all GFAP+ radial cells that 
are Ccnd1+ shows that expression of this marker is completely absent in Ascl1-deficient stem cells. 
(C) Administration of kainic acid (KA) to WT animals and analysis of Ccnd1 expression in GFAP+ 
radial cells by immunohistochemistry revealed that the percentage of Ccnd1+ RGLs is drastically 
increased only one day after injection compared to saline-injected controls. n = 2 (C) for both 
treatments and (B) for Ascl1neocKO; 3 (B) for WT. * p<0.05. Scale bar = 20μm (A). 
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Although initially thought to be mainly confined to IPCs, Ascl1 expression is also 
observed in a third of the active radial GFAP-positive stem cells in the SGZ. This 
seemingly minor expression in steady physiological conditions is rapidly and 
significantly increased or decreased in response to neurogenic or anti-neurogenic 
stimuli, respectively. This dynamic pattern of expression together with results 
showing that loss of Ascl1 completely blocks stem cell activation and subsequent 
neurogenesis suggest a model whereby signals from the surrounding environment 
converge on Ascl1 expression to modulate stem cell activity and consequently 
maintain tissue homeostasis under both physiological and pathological conditions.  
In this chapter I will be discussing our results and putting them into context 
with what we know both within the hippocampal neurogenesis niche and within 
other adult stem cell niches. I have divided the body of the discussion into three main 
parts, which I believe correspond to the three fundamental aspects of this work. First 
I will be commenting on the signalling aspect of the work: the integration of external 
signals by stem cells and how this might converge onto Ascl1. Then I will discuss the 
molecular mechanism by which Ascl1 controls stem cell proliferation with a focus 
on cyclin proteins. Next, I aim to step back and consider the bigger picture, to 
explore the biological significance of this work and of Ascl1 function. I will end the 
chapter by postulating a few remaining questions and how they might be resolved 
and, finally, by drawing the general conclusions from the work presented. 
7.1 Neurogenic and anti-neurogenic signals converge onto Ascl1 expression 
7.1.1 Ascl1 as a switch for activation 
Our results show that Ascl1 expression is rapidly modulated in hippocampal stem 
cells upon reception of environmental signals (Figure 7-1). This is a significant 
result, since it makes Ascl1 the first transcription factor found to integrate external 
stimuli and cell cycle regulation in the adult brain. What signals lie upstream of 
Ascl1 and how they control its regulation is, however, not yet known. A number of 
signalling pathways, nonetheless, are known to regulate stem cell activity and, the 
absolute phenotype we uncovered in Ascl1 mutant mice, suggests that most of these 
known pathways act, ultimately, by regulating Ascl1 expression. By analogy with 
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other systems we might speculate how these signals interact with Ascl1 to regulate 
its activity (see Figure 7-2 for a schematic representation of how these signals might 
come together).  
 
Figure 7-1 Ascl1 expression is regulated by extracellular stimuli 
Ascl1 is rapidly modulated in hippocampal stem cells upon reception of neurogenic and anti-
neurogenic stimuli to control the balance between quiescence and activation (see text for details). 
Administration of a sub-seizure dose of KA resulted in a robust and 
consistent induction of Ascl1 expression in stem cells. KA is an agonist for the 
kainate type of glutamate receptors, and although it is widely used as a seizure-
inducing agent and is known to activate stem cells in the adult brain, how it exerts its 
neurogenic function it is not clear. Presumably, KA, by over-exciting the 
hippocampal neuronal circuits is able to activate stem cells that were otherwise 
quiescent. A few years back, Karl Deisseroth and colleagues (Deisseroth et al., 
2004), in view of the observation that a number of interventions affecting adult 
neurogenesis are also likely to modulate neuronal activity, went on to establish a 
possible link between excitatory neural activity and neurogenesis. By using adult rat 
hippocampal neural progenitor cell (NPC) cultures, they showed that excitation is 
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coupled to neurogenesis directly via Ca2+ channels and NMDA receptors present on 
the proliferative progenitor population. Moreover, they were able to show that 
excitation mediates neurogenesis by inhibiting the expression of the transcription 
factors Hes1 and Id2, and in turn by promoting the expression of NeuroD1. Both 
Hes1 and Id2 are negative regulators of Ascl1 (see below), but little difference in 
Ascl1 expression was seen after excitation in this system. NPCs in culture are 
exposed to high concentrations of mitogens and are thus found to be actively 
dividing, making them more similar to IPCs in vivo. It remains to be determined 
whether quiescent RGLs in vivo respond to neuronal activity in a similar way that 
these neuronal progenitors in vitro do, and whether Ascl1 might be upregulated in 
such case.  
An alternative hypothesis to explain the effect of KA on stem cells is the 
release of growth factors upon KA administration that in turn stimulate stem cell 
activation. VEGF mRNA, for example, has been shown to increase two hours after 
electroconvulsive seizures (ECS) in the rat hippocampus (Newton et al., 2003); and 
this VEGF induction was found to be necessary and sufficient for activation of 
quiescent stem cells of the rat DG (Segi-Nishida et al., 2008). Along these lines, 
deletion of VEGF in the adult mouse hippocampus using a Nestin-CreERT2; 
VEGFfl/fl line resulted in a reduction of RGL proliferation (Kirby et al., 2014 Sfn 
poster presentation). In both cases VEGF, which could be acting both in a paracrine 
manner via endothelial cells, or in an autocrine manner as VEGF-C was shown to do 
in the SVZ (Calvo et al., 2011), appeared to be signalling through VEGFR-2 (Flk-1). 
Together, this evidence suggests an appealing model, where release of VEGF in 
response to KA acts on hippocampal stem cells to regulate Ascl1 expression via an 
as yet unknown intracellular signalling cascade. 
Another well studied signalling pathway known to positively regulate 
neurogenesis in the adult brain and linked to neuronal activity is the Wnt/β-catenin 
pathway.	  Wnt ligands secreted by hippocampal astrocytes or, following an autocrine 
fashion, by neuronal progenitors themselves, are able to regulate progenitor 
proliferation and later differentiation (reviewed in Varela-Nallar and Inestrosa, 
2013). Two recent publications suggest that both physiological and pathological 
stimuli, namely neuronal activity and ageing, modulate stem cell activity by 
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regulating Wnt signalling, through the expression of the two Wnt inhibitors sFRP3 
and Dkk1, respectively (Jang et al., 2013, Seib et al., 2013). In crypt intestinal stem 
cells, Ascl2, a transcription factor paralog to Ascl1, is a master regulator of crypt 
stemness (van der Flier et al., 2009) and is under direct regulation of Wnt signalling 
(Schuijers et al., 2015). An intriguing possibility is that of Ascl1 being a target of 
Wnt in stem cells of the hippocampus. However, the expression pattern of the Wnt 
receptor Frizzled 1 (Fzd1) in the adult DG suggests that Wnt acts mainly on IPCs 
(Varela-Nallar et al., 2014 Sfn poster presentation). Moreover, cre-mediated deletion 
or short hairpin RNA (shRNA)-induced silencing of β-catenin in Sox2+ cells, 
suggests that disruption of Wnt signalling in the DG blocks neuronal differentiation 
without affecting the GFAP+ Sox2+ stem/progenitor cell compartment (Kuwabara et 
al., 2009). Examination of Wnt-responsive cells in the SGZ of the adult DG will shed 
light on the role of this signalling pathway in the RGL population. 
While the mechanism by which KA induces Ascl1 is still unclear, the 
mechanism by which loss of Notch signalling results in an increase of Ascl1 
expression can be inferred from studies in the embryonic brain. Notch signalling 
induces the expression of Hes factors, and these directly repress Ascl1 transcription 
(reviewed in Imayoshi and Kageyama, 2014). RBPJκ is part of the transcriptional 
activator complex responsible for Hes expression, and its deletion renders the Notch 
pathway non-functional, and hence leads to stem cells being rapidly activated, since 
Notch is required for stem cell maintenance (Ehm et al., 2010). This activation, 
prompted by the removal of an anti-neurogenic signal, is most likely brought about 
by the release of Ascl1 inhibition. Deletion of Ascl1 in RBPJκ mutant mice would 
establish whether the stem cell activation seen in the latter is, as expected, Ascl1-
dependent. In our experiment, as it was the case for the KA experiment, we found 
Ascl1 to be induced before stem cells express MCM2 and exit quiescence, with an 
increase in the presence of Ascl1-only positive stem cells, supporting the idea that 
stem cell activation is Ascl1-dependent. 
Anti-neurogenic signals can, not only target and inhibit Ascl1 transcription, 
but they can also target Ascl1 protein and prevent it from executing its role. BMPs 
are important for the maintenance of quiescent RGLs (Martynoga et al., 2013, Mira 
et al., 2010), and by inducing expression of Id proteins, which can physically interact 
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with Ascl1 DNA-binding partners, the E-proteins, they repress Ascl1 activity (Jen et 
al., 1992, Bertrand et al., 2002). In the SVZ, Id1 expression characterises the 
quiescent B1 stem cells (Nam and Benezra, 2009), and deletion of all three Id genes 
results in an inability of stem cells to retain their stemness (Niola et al., 2012). 
Presumably, this phenotype could be linked to the loss of inhibition of Ascl1 activity. 
 
Figure 7-2 Extrinsic and intrinsic signals converge to regulate Ascl1 expression 
Diagram illustrating the different signalling pathways known to regulate stem cell activity and how 
some of them might converge onto Ascl1 activity, both at the mRNA and protein levels (see text for 
details). 
No doubt, more signals affecting stem cell activity will be identified in the 
near future. However, the knowledge we possess so far represents a good starting 
point for further studies (Figure 7-2). Moreover, it will be of interest to investigate 
whether strong pathological insults to the niche can induce the activation of an 
alternative mechanism of stem cell activity that is Ascl1-independent. Preliminary 
data from one of our collaborators, Juan Manuel Encinas, suggests that this might be 
the case. In a model of temporal lobe epilepsy (MTLE), intrahippocampal injection 
of KA, a procedure that delivers high concentrations of KA directly to the DG, 
results in a very significant activation of quiescent RGLs in WT mice three days after 
injection. This activation, in accordance with an activation-dependent deforestation 
hypothesis (Encinas and Sierra, 2012), results in an accelerated depletion of the stem 
cell pool. In Ascl1neocKO mice, there was a significant reduction in the percentage of 
dividing RGLs after KA injection in the SGZ, a result that would lead to a partial 
Discussion 
 
 138 
preservation of the RGL population. However, in contrast to what we observed after 
an i.p. injection of KA at a concentration that does not induce observable seizures, 
our collaborator found a considerable proportion of stem cells that were able to 
proliferate (BrdU+ radial NSCs: 45% in WT mice versus 15% in Ascl1neocKO mice; 
Encinas J.M., personal communication). This might suggest that an alternative 
mechanism for stem cell activation exists but it only comes into play after strong 
insults to the brain. 
Once inside the cell, a few transcription factors are known to be involved in 
mediating the response to dormancy or activation signals. One of the transcription 
factors thought to mediate the activity of extracellular signals is FoxO3, which is 
inactivated in response to the insulin/IGF-1 signalling pathway. FoxO3 acts in the 
NSC pool to induce a transcriptional programme that promotes quiescence (Renault 
et al., 2009). Genome-wide analysis of FoxO3 and Ascl1 targets in cultures of adult 
neural progenitor cells revealed that these two transcription factors share common 
targets, and that binding of FoxO3 to these targets in quiescent cells antagonises 
Ascl1’s activity (Webb et al., 2013), suggesting a mechanism by which a balance of 
quiescence versus activation transcription factors might regulate NSC homeostasis. 
In contrast, and as an example of another factor, as Ascl1, responsible for 
positively regulating stem cell function, we know of the orphan nuclear receptor 
TLX, which has been shown to promote proliferation of RGLs of the adult 
hippocampus. This action was shown to be mediated extrinsically by Wnt7a in an 
autocrine/paracrine fashion, and intrinsically by p21 in a p53-dependent manner (Niu 
et al., 2011, Qu et al., 2010). How and if TLX is regulated by neurogenic stimuli is, 
however, not yet known. Interestingly, though, TLX was shown to activate Ascl1 and 
induce neuronal lineage commitment in cultured adult rat hippocampus-derived 
progenitors (Elmi et al., 2010). Whether TLX is acting upstream of Ascl1 in vivo to 
promote stem cell proliferation will remain an important question to address in the 
future. 
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7.1.2 Fine-tune of the neurogenic output by Ascl1 regulation 
Considering our results together with the above analysis, a model emerges where 
Ascl1 expression is controlled both at the mRNA and protein levels to modulate the 
rate of hippocampal neurogenesis. Our results obtained with mice carrying the 
hypomorphic allele Ascl1neoflox, as well as those carrying a copy of the Ascl1 null 
allele (Ascl1 Δ) support such a model. Reducing levels of Ascl1 transcripts is 
translated into a reduction of the fraction of RGLs that divide in the adult DG, and 
the extent of the reduction appears to be strongly correlated with Ascl1 expression 
levels. Moreover, decreasing the proliferating portion of RGLs is directly correlated 
with the neurogenic output, as shown by the considerable loss of DCX+ immature 
neurons in Ascl1neoflox mice. 
The above model is also supported by the phenotype observed in RGLs in 
animals where Ascl1 is regulated at the protein level. A current member of our 
laboratory has created a line where the E3 ubiquitin-protein ligase Huwe1 is 
conditionally deleted in RGLs in adult mice. Huwe1 interacts with Ascl1 protein to 
target it for proteasomal degradation and, therefore, control its stability. When 
Huwe1 is deleted in hippocampal stem cells, we observe an increase in Ascl1 
positive RGLs and, consequently, an increase in the fraction of active stem cells 
(Urbán N., manuscript in preparation). In the embryonic brain, differential levels of 
Ascl1 are also involved in mediating the response to extracellular signals. Ascl1 
protein stability is regulated by the PDK1/Akt signalling pathway, which, in itself is 
being regulated by the extrinsic growth factor IGF-1, to control the production of 
neocortical GABAergic neurons (Oishi et al., 2009). Altogether, these results 
strongly support the idea that tight regulation of the levels of Ascl1 is important for 
maintaining an adequate balance of quiescence and activation in stem cells of the 
adult hippocampus and for ensuring that the adequate number of neurons is 
generated. 
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7.2 Ascl1 has a crucial role in hippocampal stem cell proliferation 
7.2.1 Ascl1 acts in a cell-autonomous manner in hippocampal stem cells  
The results obtained with the mouse models of Ascl1 deletion point to a central role 
of this proneural protein during the cell cycle exit and proliferation of adult 
hippocampal stem cells. But because we have shown Ascl1 to be expressed in both 
early progenitors and activated type 1 cells, it was important to elucidate where 
Ascl1 was acting. Ascl1 could be cell autonomously controlling stem cell 
proliferation, leading to the rest of the phenotype in the lineage, or Ascl1 could be 
controlling RGL activity in a non-cell autonomous way as a secondary consequence 
of the loss of IPCs.  
Two possible scenarios can be envisaged for the latter idea of IPCs being the 
primary cause and loss of active RGLs being a secondary consequence in the 
phenotype we observe. In the first scenario, IPCs could, in normal conditions, be 
exerting a positive effect on RGLs by, for example, secreting growth factors that 
affect their activity. Loss of this positive feedback, through loss of IPCs, could lead 
to a block of RGL proliferation. A recent publication reported Ascl1 to be critical for 
the maintenance and tumorigenicity of glioblastoma cancer stem cells (GBM CSCs), 
and highlighted a possible mechanism by which Ascl1 could control proliferation in 
a non-cell autonomous way. By binding to and repressing the Wnt negative regulator 
Dkk1, Ascl1 activates Wnt signalling, which in turn promotes proliferation 
(Rheinbay et al., 2013). In the zebrafish injured retina, induction of Ascl1a and 
inhibition of Dkk1-mediated Wnt repression is also a mechanism utilised for 
successful regeneration (Ramachandran et al., 2011).  
We examined the possibility of Ascl1 controlling hippocampal stem cell 
proliferation by modulation of Wnt signalling by interrogating the genes bound by 
Ascl1 in AH-NSCs. Only a small fraction of these genes overlapped with those genes 
bound by Ascl1 in GBM CSCs. Well-characterised Ascl1 targets like Dll1, for 
example, were common sites in the two cell types. However, many more sites were 
found only in AH-NSCs, including those of cell cycle regulators like E2f1, Ccnd2, 
Ccna1 and Skp2. And importantly, we found no Ascl1 binding site near the Wnt 
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regulator gene Dkk1 in AH-NSCs (see Figure A1 2 in Appendix 1). This suggests 
that Ascl1 does not control stem cell proliferation in the hippocampus by regulating 
Wnt signalling. 
We next went further and investigated the possibility of an as yet unknown 
positive feedback signal from IPCs to RGLs being disrupted and therefore affecting 
stem cell activity with two different analyses: deletion at an early time-point and 
mosaic deletion. In both cases the progeny of WT cells was present and could thus 
still provide any required stimulation. In no case we found Ascl1 mutant cells being 
rescued by the neighbouring progeny and dividing. The possibility of the 
hypothetical positive feedback signal being below a certain necessary threshold is 
unlikely since we found the absence of dividing RGLs to be independent of the 
recombination efficiency in the mosaic analysis (see Figure 3-12D). 
In the second scenario of a non-cell autonomous effect of Ascl1, IPCs could 
be part of a negative feedback loop to maintain RGLs in a quiescent state. A number 
of recent reports have provided evidence that IPCs, by activating Notch signalling 
through Notch ligands expressed on their surface promote stem cell quiescence 
(Hodge et al., 2012, Lavado et al., 2010, Kawaguchi et al., 2013, Lavado and Oliver, 
2014). In this case, and because the loss of IPCs will result in an activation of RGLs, 
we would expect to find dividing RGLs in situations where IPCs are totally absent. 
Our analysis at P90, one month after Ascl1 deletion, shows that the progeny is 
already completely absent but no proliferation is taking place. When analysing the 
hippocampus of Ascl1neocKO mice five months after deletion, we still find RGLs to 
be in a quiescent-like state, with no proliferation and no exhaustion of the stem cell 
population, which has been reported for those mutant mice lines where stem cell 
maintenance is disrupted (Mira et al., 2010, Ehm et al., 2010, Andreu et al., 2015, 
Ables et al., 2010). What’s more, at no time point do we observe formation of new 
neurons or an increase of GFP-expressing cells, which we would expect if there was 
a rise in proliferation immediately after TAM administration. All together, these 
results show that Ascl1 controls stem cell proliferation in a cell-autonomous manner. 
One separate and important aspect to discuss concerning the function of 
Ascl1 in stem cell proliferation is the idea that the cre recombinase could be having 
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an effect on proliferation on its own, as suggested by the experiments with Ascl1flox 
animals. Total proliferation was significantly reduced in Ascl1 WT mice compared to 
Ascl1flox mice. Similarly, proliferation in RGLs in these mice was highly, but not 
significantly reduced (see Figures 3-9 and 3-10). Since the animals analysed were 
littermates, the only difference between them was the presence (WT) or absence 
(Ascl1flox) of the GlastCre-ERT2 deleter, suggesting that indeed cre is the responsible 
for the differences observed. Despite the reduction of proliferation having been 
already described in mammalian cells in the presence of cre recombinase (Loonstra 
et al., 2001), this was an unexpected result for us. Our main phenotype is one 
affecting proliferation, and it is therefore important to understand the implications of 
this idea. 
Ascl1neocKO animals carry the cre recombinase, and it might be argued that 
the difference in proliferation observed between these animals and their Ascl1neoflox 
cre-less counterparts is in fact a consequence of this presence rather than the loss of 
Ascl1 in Ascl1neocKO animals. There are a number of arguments against this idea. 
Firstly, we know that loss of Ascl1 significantly affects proliferation in a cre-
independent manner because disruption of Ascl1 transcription by the presence of the 
PGK promoter-neo cassette results in a strong block in proliferation in Ascl1neoflox 
animals that is restored when the cassette in the Ascl1 locus is removed. Similarly, 
both total and RGL proliferation are significantly different between Ascl1 WT and 
Ascl1cKO animals, both of which carry the cre recombinase. Finally, and following a 
similar trend of thought, when both Ascl1 WT and Ascl1neocKO animals receive KA 
injections, only Ascl1 WT stem cells are able to respond, while cells that have deleted 
Ascl1 remain unresponsive to the stimulus. All together, our results, even though 
they point to a cre-dependent proliferation effect in the DG, they show that Ascl1 is 
able to regulate proliferation independently of any cre effect. 
7.2.2 Ascl1 regulates cyclin D genes in hippocampal stem cells  
Our gene expression analysis in FACS-isolated WT and Ascl1 mutant cells, together 
with protein expression analysis, indicate that Ascl1 promotes the cell cycle 
progression of RGLs by directly regulating, among other cell cycle-related genes, the 
cyclins Ccnd1 and Ccnd2 (Figure 7-3). D-type cyclins are essential proteins for the 
Discussion 
 
 143 
progression through the G1 phase of the cell cycle. In early G1, D cyclins activate 
cyclin-dependent kinases 4 and/or 6 (CDK4/6) to initiate the phosphorylation of the 
retinoblastoma (Rb) family of proteins (Rb, p107, p130). Rb is a central component 
of a transcriptional repressor complex that, by inhibiting the binding of E2F 
transcription factors to their target genes, inhibits the promotion of the cell cycle. 
Phosphorylation of Rb leads to the release of E2Fs and the activation of the genes 
required for G1 progression (reviewed in Coqueret, 2002, Satyanarayana and Kaldis, 
2009). 
 
Figure 7-3 Ascl1 directly regulates cell cycle genes to control hippocampal stem cell 
proliferation 
Ascl1 binds to and activates cyclin D genes as well as the ribonucleoside reductase M2 (Rrm2) gene 
to control hippocampal stem cell activity (see text for details). 
While CDK levels remain constant through the cell cycle, expression of 
cyclins varies throughout. In particular, the expression of D-type cyclins is largely 
dependent on extracellular signals. Stimulation by mitogens is coupled with rapid 
cyclin D transcriptional induction, making these proteins a fundamental link between 
extracellular stimuli and cell cycle progression (Coqueret, 2002). We found both 
Ascl1 and Ccnd1 to be upregulated early upon induction of neurogenic stimuli, and 
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both do so before the induction of proliferation. Our results, therefore, are consistent 
with the mitogen-sensing role of cyclins. 
The activity of CDK/cyclin complexes is also regulated by cyclin-dependent 
kinase inhibitors (CKIs), which are responsible for inhibiting CDK/cyclin complexes 
and induce cell cycle arrest. Two families of CKIs exist: the INK4 and the Cip/Kip 
families (Blomen and Boonstra, 2007). During quiescence, one of the Cip/Kip family 
members, p27Kip, appears to be highly expressed and its levels decrease as cells 
progress through G1. p27Kip inhibits the formation of CDK2/cyclin E complexes, 
which are required for further Rb phosphorylation and progression through the G1 
restriction point (R) into S phase. Activation of CDK4/6-cyclin D complexes by 
mitogen stimulation can result in the sequestering of p27Kip to release CDK2-cyclin 
E inhibition and promote proliferation (Blomen and Boonstra, 2007). Ccnd2 has 
been proposed to play a central role in the down-regulation of p27Kip at the G0-G1 
transition in a number of cell types by directly translocating p27Kip from the nucleus 
to the cytoplasm for its degradation (Susaki et al., 2007). Very interestingly, a recent 
report has shown p27Kip to be an important regulator of stem cell quiescence in the 
adult DG (Andreu et al., 2015). These observations, together with our results, point 
to the intriguing idea of the Ascl1 - cyclin D - p27Kip axis as a possible mechanism 
for the induction of cell division in quiescent stem cells of the adult hippocampus.  
 Another member of the Cip/Kip family of CKIs, p57Kip2, has been shown to 
play a role in the control of DG stem cell quiescence. p57Kip2 inhibits the formation 
of CDK2/cyclin E complexes, as its partner p27Kip does. Quiescent RGLs in the DG, 
but not IPCs, express p57Kip2, and conditional deletion of this CKI using a Nestin-
driven CreERT2 line, resulted in a transient expansion of the radial NSC pool due to 
the activation of the quiescent subpopulation (Furutachi et al., 2013). In the 
hematopoietic system, deletion of p57Kip2 leads to a compensatory upregulation of 
p27Kip (Matsumoto et al., 2011), suggesting that these two factors may have 
overlapping roles. How they interact in the hippocampus to regulate RGL quiescence 
remains unknown. 
Interestingly, mice mutant for Ccnd2, but not Ccnd1, showed severe defects 
in adult neurogenesis in the DG (Kowalczyk et al., 2004). While D-type cyclins are 
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in general able to compensate for the loss of one of their siblings, slight differences 
in the timing of expression in certain cell types can render them unable to perform 
functional compensation (Satyanarayana and Kaldis, 2009). This idea is illustrated 
by an elegant experiment where Ccnd2, when expressed in place of Ccnd1, is able to 
drive nearly normal development, suggesting that it is mostly the tissue-specific 
pattern of expression that drives the differences between these two cyclins (Carthon 
et al., 2005). In the case of the adult hippocampus, Ccnd2 appears to be able to 
compensate for Ccnd1 upon Ccnd1 loss, but the opposite appears to not be the case. 
Another example where Ccnd1 is unable to compensate for Ccnd2 function is in 
ovarian granulosa cells, which show defective proliferation resulting in sterility in 
Ccnd2 null mice (Sicinski et al., 1996). In the DG, this might be due to Ccnd1 being 
more broadly expressed than Ccnd2. 
One disconcerting result that we observed is the discrepancy between Ccnd1 
mRNA expression in sorted stem cells and protein expression in the DG in situ. 
While Ccnd1 protein was absent when examined by immunohistochemistry, there 
was no significant down-regulation of Ccnd1 transcript numbers by qPCR. Ccnd1 
levels can be regulated transcriptionally and post-transcriptionally by many different 
factors (Musgrove, 2006). One possibility is that the discrepancy we observe is due 
to differential regulation of the Ccnd1 gene in different cell types. We performed 
RGL isolation by FACS three days after the last TAM injection in order to avoid 
collecting any YFP+ progeny in WT samples; however, it is likely that some IPCs 
were sorted together with RGLs. If this was the case, we can envisage a scenario 
where Ccnd1 expression in IPCs, regulated by other signalling cascades, is acting in 
an Ascl1-independent manner to induce neurogenesis, and that this is what we detect 
by qPCR. A number of signalling cascades are known to regulate Ccnd1 expression, 
with Wnt/β-catenin being one of the better studied ones (Clevers, 2006). Wnt 
signalling plays an important role in both the proliferation and differentiation of IPCs 
in the adult DG (Varela-Nallar and Inestrosa, 2013). 
Deletion of Ascl1 in hippocampal stem cells also led to a significant down-
regulation of ribonucleoside reductase M2 (Rrm2) expression (Figure 7-3). Rrm2 is 
regulated in a cell cycle-dependent fashion, and has been shown to inhibit Wnt 
signalling in HEK293 cells (Tang et al., 2007). It can be speculated, that if also true 
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for hippocampal stem cells, inhibition of the Wnt signalling pathway could be an 
important negative feedback mechanism to prevent stem cell over-proliferation. No 
studies have examined Rrm2 expression or function in the adult DG. 
It is very likely that Ascl1 regulates other cell cycle-related genes that we did 
not identify here. Our ChIP-seq analysis shows that Ascl1 binds to a significant 
number of genes involved in the cell cycle. However, we were not able to validate 
many of these due to limited starting material. Further expression analysis in WT and 
Ascl1-deficient RGLs, as well as studies with more mutant mouse lines, will shed 
light on the regulation of cell cycle progression in adult DG stem cells. One study, 
for example, has reported impaired hippocampal neurogenesis in mice lacking the 
transcription factor E2f1, a target of Ascl1 in AH-NSCs (Cooper-Kuhn et al., 2002). 
Whether E2f1 is under the control of Ascl1 regulation in RGLs in vivo we do not 
know. 
7.2.3 Diverse roles of Ascl1 during embryonic and adult neurogenesis 
Neurogenesis in the embryonic brain is regulated primarily by proneural 
transcription factors, including Ascl1 and Neurog2. These factors play key roles in 
promoting neural progenitor cell cycle exit and neuronal differentiation (Bertrand et 
al., 2002). However, a more recent genome-wide characterisation analysis of the 
transcriptional targets of Ascl1 in the embryonic brain and in NSC cultures from our 
laboratory unravelled a novel function for this proneural gene. Ascl1 was shown to 
control the expression of a large number of positive cell cycle regulators, and to be 
required for normal progenitor divisions (Castro et al., 2011). The work described 
here illustrates another instance where Ascl1 is important for cell cycle progression. 
The comparison, nevertheless, brings about a number of topics worth discussing. 
Of note is the differential proliferation dynamics in stem cells of the 
embryonic and adult brains. NPCs in the embryo are responsible for generating the 
diverse types of neurons and glia that build the entirety of the nervous system, and 
therefore need to continuously and rapidly proliferate. Stem cells in the adult 
hippocampus, on the other hand, are found primarily in a quiescent state, with only a 
small fraction of them dividing at one time (Urban and Guillemot, 2014). Therefore, 
Discussion 
 
 147 
while we talk about proliferation in NPCs of the embryo, it would appear more 
accurate to refer to activation in hippocampal RGLs, since stem cells here need to be 
“awaken” before they proceed to proliferation. Here we show that, upon reception of 
extrinsic stimuli, quiescent RGLs induce Ascl1 and MCM2 expression. MCM2 is 
part of a pre-replication complex that marks not only cycling cells, but also activated 
cells that have not yet re-entered the cell cycle (Torres-Rendon et al., 2009, Stoeber 
et al., 2001). Deletion of Ascl1 results in a loss of MCM2 expression, which suggests 
that RGLs are unable to become activated and therefore remain in a quiescent state. 
Whether activation and proliferation are coupled processes and are both regulated by 
Ascl1 in these cells it is not possible to determine, since we see a defect in the first 
one of them. Considering the phenotype observed in the embryonic brain after Ascl1 
loss, as well as the evidence presented showing that Ascl1 regulates cell cycle genes, 
we may assume it to be likely for Ascl1 to control both processes. 
Similarly, having lost RGL proliferation and therefore IPC generation, it is 
not possible to determine what role Ascl1 plays in these cells. Because of their rapid 
proliferation dynamics, these cells resemble more embryonic NPCs, and therefore it 
may also be speculated that Ascl1 is important here. The use of an IPC-specific cre 
line would help establish whether this is the case. Ascl1 colocalises with Tbr2 in late 
IPCs, thereby the use of a Tbr2-CreERT2 line crossed to Ascl1cKO mice, though not 
optimal, might be useful for this purpose. 
During development, Ascl1 in NPCs is required for the process of 
neurogenesis in the ventral telencephalon (Casarosa et al., 1999). In the adult 
hippocampus, Ascl1 expression is downregulated before the onset of neuronal 
differentiation, and we see no colocalisation between this factor and markers of 
immature neurons like DCX. It is therefore unlikely that Ascl1, in the adult DG, 
plays a direct role in activating the programme of neurogenesis. In contrast, data 
obtained with Huwe1 conditional mutant mice by another member of the laboratory 
show that Ascl1 needs to be downregulated in IPCs before the neurogenic 
programme can progress. Stabilization of Ascl1 protein by deletion of Huwe1 
resulted in a significant increase in the number of dividing RGLs in the DG, which is 
consistent with the idea of Ascl1 promoting the progression of the cell cycle. More 
interestingly, stabilization of Ascl1 protein also resulted in a block of neurogenesis, 
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indicating that Ascl1 protein needs to be downregulated for neurogenesis to proceed 
normally (Urbán N., manuscript in preparation). Therefore, Ascl1 might be playing 
other roles in the adult DG that we are not able to observe with our mouse model. 
Next, and related to Ascl1 levels, we consider the relevance of the dynamic 
expression of Ascl1. The multipotent state of embryonic NPCs has been shown to 
correlate with the oscillatory expression of a number of fate determination factors, 
including Hes1, Ascl1 and Olig2. On the other hand, accumulation of Ascl1 during 
G1 phase is a decisive sign for neuronal determination (Imayoshi et al., 2013). 
Whether oscillatory behaviour of proneural genes is also characteristic of adult stem 
cells it now under investigation (Kageyama R., personal communication). Our work 
shows that deletion of Ascl1 leads to a complete block of proliferation, but Ascl1 
protein expression is only observed in a third of active RGLs. Similarly, Ccnd1 is 
expressed in a much larger proportion of RGLs than those expressing Ascl1. These 
patterns could be an indication that Ascl1 expression also oscillates in adult 
hippocampal stem cells.  
Given the crucial role of Ascl1 during embryogenesis, it was important to 
evaluate the possibility that the phenotype we observed in adult Ascl1neocKO animals 
was not brought about by developmental defects. The first argument against this idea 
is that DG of adult Ascl1neocKO animals looks normal. If Ascl1 were required during 
development for hippocampal granule cell generation, we would expect a smaller 
and undeveloped DG to be formed, as it is the case for the DG in animals that have 
lost the bHLH factor Neurog2 (Galichet et al., 2008). This initial piece of evidence 
suggests that Ascl1 function might be dispensable during early hippocampal 
development. Moreover, we not only observe the same phenotype in our Ascl1cKO 
animals, but we were also able to show that there is a switch in the requirement of 
Ascl1 from early postnatal to adult stages. When Ascl1 was deleted at P7, RGLs 
continued to proliferate three days later (Andersen et al., 2014). These results nicely 
fit with observations made in Ccnd2 mutant mice, where DG cell proliferation 
appears to be dependent on Ccnd2 only after the first few weeks of life (Ansorg et 
al., 2012).  Ccnd1 appears to be able to partially compensate for Ccnd2 loss for at 
least the first two weeks of life, when the reduction in proliferation in the SGZ is 
only about 60%. After this time, between P14 and P28, however, there appears to be 
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a switch with Ccnd2 becoming an essential requirement for on-going neurogenesis. 
Therefore, it appears likely that a switch in the control of RGL proliferation takes 
place during early postnatal stages, with the activation of a mitogenic pathway 
involving Ascl1 and Ccnd2: from embryonic control to adult mitogenic regulation 
(see section 1.3.4 for definitions of control and regulation). 
7.2.4 Transcriptional regulation by Ascl1 
Our results show that Ascl1 controls stem cell activation in the adult hippocampus by 
regulating expression of cell cycle-related genes. The mechanism by which Ascl1 
regulates transcription is, however, not yet completely understood. Gene expression 
is regulated through the combined activity of many regulatory elements, including 
promoters, which are normally found near the transcriptional start sites (TSS) of 
genes, and elements that are located at a greater distance from the TSS, such as 
enhancers.  
Enhancers are non-coding sequences that activate, and can greatly increase, 
promoter-mediated transcription of their target genes. Enhancers are similar to 
proximal promoter regions in that they are organized as a series of cis-acting 
elements that are bound by trans-acting regulatory proteins. They can be 
distinguished from promoter elements, however, by their ability to act at a distance 
and to do so either upstream or downstream from the promoter they control. Upon 
binding of specific transcription factors, recruitment of transcriptional coactivators 
and chromatin remodelling proteins occur on the enhancers. Here, the protein 
complexes are thought to facilitate DNA looping, bringing enhancer protein 
complexes into close physical proximity to those on the promoter, and allowing 
promoter-mediated gene activation.  
Enhancers and their transcription factors have, therefore, prominent roles in 
the initiation of transcriptional regulation of gene expression. Importantly, 
combinatorial transcription factor occupancy can lead to diverse types of 
transcriptional output, resulting in discrete and precise patterns of transcriptional 
activity at different developmental stages or different cell types (Spitz and Furlong, 
2012). 
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The generation of genome-wide maps of specific chromatin marks has 
allowed the successful identification of enhancers and other regulatory elements in 
the genome. The use of ChIP-seq techniques, for example, has provided a tool for the 
identification of genome-wide binding profiles of both DNA-binding proteins and 
chromatin remodelling complexes that are enriched at specific regulatory elements. 
For instance, histone 3 lysine 4 monomethylation (H3Kme1) was found to mark 
enhancers, and distinguish them from promoters, which are marked by trimethylation 
at this site (H3K4me3). Similarly, histone 3 lysine 27 acetylation (H3K27ac) has 
been associated with enhancers, and has been shown to discriminate active from 
poised enhancers, which contain H3K4me1 alone.  Another element that has been 
used for enhancer identification is the acetyltransferase and transcriptional 
coactivator p300, which is a protein associated to enhancers. Therefore, a 
combination of histone mark identity and presence of p300 have been previously 
used to identify and predict the activity of transcriptional enhancers throughout the 
genome (Rada-Iglesias et al., 2011, Heintzman et al., 2009, Creyghton et al., 2010). 
In our work we have used ChIP-seq to identify Ascl1-binding sites in the 
genome of AH-NSCs. Analysis of these binding events showed that most Ascl1-
binding sites are located between 5kb and 500kb away from a TSS (see Figure S7 in 
Andersen et al., 2014), suggesting that Ascl1 binds mainly distal enhancers in AH-
NSCs. Indeed, we show that a large fraction of Ascl1-binding sites overlap enhancers 
present in proliferating NSCs (from Martynoga et al., 2013), while almost half of 
enhancers present in proliferating NSCs are bound by Ascl1. In agreement with this 
data, Raposo et al. (2015) showed that Ascl1 binds predominantly distal enhancer 
regions in differentiating NSCs.  
The study by Raposo and colleagues (2015) also shed light on the possible 
mechanism of action of Ascl1 activity. They showed that Ascl1 acts as a pioneer 
transcription factor when regulating gene expression in its native context. In a 
previous study, Wapinski et al. (2013) had uncovered that, during fibroblast 
reprogramming, Ascl1 displays pioneer activity by accessing and binding 
nucleosomal DNA as a single factor. Ascl1 is then able to actively recruit other 
transcription factors to many of its targets. Following on this, the study published in 
2015 showed that Ascl1 functions also by promoting chromatin accessibility in its 
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native context, neurogenesis. Altogether, these studies give us clues as to how Ascl1 
regulates its targets genes during adult neurogenesis in the hippocampus. Differential 
enhancer binding as well as differential transcription factor recruitment by Ascl1 are 
likely to regulate gene expression in the many Ascl1-dependent processes. 
7.3 Biological significance of Ascl1 function 
Stem cells are a long-lived population of cells that are uniquely able to both self-
renew and give rise to multiple cell types (Weissman, 2000). A number of adult 
tissues in the body, including the adult nervous system, retain the ability to 
regenerate cells lost to turnover, injury and/or disease throughout life thanks to the 
presence of populations of tissue-specific stem cells. Our work shows that Ascl1 is 
crucial for the normal functioning of stem cells in the adult hippocampus.  
In thinking about the role of Ascl1 in the bigger picture, it is necessary to 
reflect on the function of neurogenesis in the adult brain. One aspect of this question 
relies on thinking about the role that the newly generated neurons play in 
hippocampal circuits; but maybe more relevant is to think how does stem cell 
activity and neurogenesis contribute to the general homeostasis of the adult brain. 
Within this topic, there are two main things to explore, and these are two sides of the 
same coin: how does the balance between self-renewal and quiescence confer such a 
unique status to tissues stem cells, and how their misregulation leads to aberrant 
phenotypes and disease. In this section I will very briefly discuss each of these topics 
and point out how the present work may fit within the broader framework of tissue 
stem cell biology. 
7.3.1 Ascl1 controls the balance between quiescence and self-renewal 
Two central features define adult or tissue stem cells: they are able to self-renew and 
they give rise to differentiated progeny in response to the needs of the organism. 
Importantly, a number of tissues do this while being mostly in a dormant or 
quiescent state. From these features, two important points can be drawn: 1) it is the 
balance between stem cell self-renewal and quiescence that is responsible for tissue 
homeostasis, and 2) adult stem cells, not only rely on intrinsic control, but are also 
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able to listen to and, are therefore under, the control of their cellular environments 
(Nakada et al., 2011).  
A number of models exist that aim to explain how the balance between 
quiescence and activation of stem cells in adult niches is regulated. Li and Clevers 
(2010), for example, propose the coexistence of distinct but adjoining pools of 
quiescent and active stem cells. In this “zoned” model of stem cell maintenance and 
self-renewal, which is opposed to a model where a single population of stem cells 
exists, quiescent stem cells function as a reserve population that is activated to 
replenish the active stem cells, or to regenerate tissue that has been lost or damaged. 
In the hematopoietic system, for example, a population of dormant hematopoietic 
stem cells (HSCs) reversibly switches from a quiescent to a self-renewing state at the 
interface between homeostasis and repair (Wilson et al., 2008). Rezza and colleagues 
(2014), on the other hand, propose that while rapidly renewing tissues like the bone 
marrow, the small intestine and the hair follicles in the skin have distinct stem cell 
populations as explained in the zoned model above, organs that undergo slow rates of 
cell turnover like the brain, muscle and liver, contain only relatively-quiescent or 
slow-dividing stem cells. These also maintain tissue homeostasis and can be 
activated upon injury, but they exist as a single population. 
In the DG of the adult brain, due to a lack of stem cell markers, it is still 
unclear how many stem cell populations exist. Stem cells in the DG, as opposed to 
other stem cell niches where active and quiescent cells are differentially located 
facilitating the reception of distinct signals, do not show any apparent divergence in 
localisation that would allow them to form separate pools. Nonetheless, some 
evidence, like differential proliferative and neurogenic potentials observed with 
different cre lines (Bonaguidi et al., 2011, Bonaguidi et al., 2014 Sfn poster 
presentation), support the possibility that active and quiescent hippocampal stem 
cells also represent distinct pools and that the transition between the two is limited to 
very specific scenarios, like injury and/or disease (reviewed in Giachino and Taylor, 
2014). This would be consistent with the observation that, while IPCs and 
neuroblasts are under constant external regulation, RGLs are rarely modulated by 
their environment (see section 1.3.4). The few examples that exist so far are epileptic 
seizures and acute social stress. 
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Interestingly, some of our results might also support the existence of separate 
populations of RGLs in the DG. For example, we find a much bigger proportion of 
stem cells expressing the early G1 marker Ccnd1 compared to any other proliferation 
marker. Can this be marking a population of stem cells that are primed to be able to 
respond to proliferative signals, and therefore a different population from the deeply 
quiescent stem cells? Moreover, deletion of RBPJκ	   in the adult DG resulted in the 
initial activation of only approximately 40% of the stem cells. But what about the 
other 60% of stem cells? Can these represent the population that Li and Clevers 
(2010) consider to be deeply quiescent and therefore a back-up pool that only 
becomes activated after the loss of the active pool? These questions will certainly be 
addressed in the future by examining the fate and expression pattern of these putative 
populations in the long-term. 
In any case, it is generally accepted that it is the niche that is responsible for 
inducing a quiescent versus active state in stem cells. In that way, quiescent and 
active stem cell populations will respond to corresponding inhibitory and stimulatory 
signals (Li and Clevers, 2010, Orford and Scadden, 2008, Rezza et al., 2014). These 
signals in the DG are, generally speaking, but with the exception of neuronal activity, 
which is not only unique but also very important in the adult brain, the same when 
compared to other adult stem cell niches (Rezza et al., 2014). Wnt, for example, is a 
potent mitogenic factor across a number of different tissues. On the other hand, BMP 
is well known to actively inhibit proliferation and induce quiescence. And as an 
added mechanism of control, the progeny of stem cells in many adult organs is 
thought to participate in a negative feedback involving Notch signalling to modulate 
the balance between self-renewal and quiescence.  
It seems almost impossible that only one factor has such a central role in any 
process. The finding that Ascl1 is also key in the proliferation of RGLs in the SVZ in 
the adult brain only reinforces this conundrum (Andersen et al., 2014). It is also of 
interest the apparent conclusion that most of the signals described above act by 
regulating Ascl1 expression, either at the mRNA or protein level. In the future, it will 
be important to determine whether there is a factor playing such a central role in the 
control of stem cell activity in other adult tissues as Ascl1 does in the adult brain, or 
if this niche is somehow unique. There is one factor whose role is reminiscent of that 
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of Ascl1 and that is MyoD in muscle satellite cells. MyoD controls the transition of 
quiescence to activation in adult myogenic stem cells by regulating Cdc6, a 
component of the pre-replication complex (Zhang et al., 2010). Interestingly Cdc6 
was found to be a target of Ascl1 by ChIP-seq (see Table A1 1 in Appendix 1), but 
mRNA levels were found to be too low for its validation (not shown). 
Going back to thinking about the bigger picture we ask ourselves, what does 
Ascl1’s role in the adult brain tells us about the homeostatic control of hippocampal 
neurogenesis? In the first place, it tells us that regulation is key for correct 
neurogenesis to take place. But it might also reveal some information regarding the 
evolution of this process. With having only one factor responsible for overseeing the 
huge task of generating enough neurons to be incorporated into the appropriate 
circuits of the hippocampus one might ask if this might not be a relatively new 
adaptation or late-evolved trait of mammals that confers adaptability to new 
challenging environments as suggested by Gerd Kempermann (Kempermann, 2012; 
see also section 1.1.4). Would the same principle be true for humans? Or is it 
possible that, as already discussed in previous sections, an alternative mechanism 
exists, and we just have not uncovered it? These are all interesting questions, and 
their answers may come in due course.  
7.3.2 Misregulation of Ascl1 may lead to disease 
The importance of Ascl1 in the neurogenic process in the adult brain comes into 
focus when we think of the consequences of tilting the balance to either side. Loss of 
the self-renewal capacity and/or increased stem cell quiescence underlie both the 
natural process of ageing as well as some neurological disorders. On the other hand, 
over-proliferation of the stem cell compartment predisposes the tissue for cell 
overgrowth and cancer. There is, therefore, a constant need for evaluating the 
requirements of the tissue against the potential harms. 
Our mouse model highlights the importance of maintaining a relatively 
quiescent population of cells in order to preserve the self-renewal and regenerative 
potential of the brain over time. A number of reports across the stem cell field now 
suggest that proliferation, and non self-renewing stem cell divisions, can lead to the 
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exhaustion of the stem cell pool (Encinas et al., 2011, Encinas and Sierra, 2012, 
Orford and Scadden, 2008). And this process, in part, underlies the age-related 
decline in adult hippocampal neurogenesis. Analysis of Ascl1-mutant mice five 
months after deletion revealed that the number of stem cells remains constant if no 
proliferation takes place, which is expected if the model above is correct (see section 
1.3.4.1 for a discussion of ageing and neurogenesis). 
The ageing process, nevertheless, seems to not only rely on an exhaustion of 
the stem cell population, but also on an increased quiescence of the remaining stem 
cells, which is mediated by both intrinsic and extrinsic mechanisms. An increase in 
the cyclin-dependent kinase inhibitor p16INK4a in neural progenitors in the SVZ 
during ageing corresponded with decreased neurogenesis (Molofsky et al., 2006). At 
the same time, increasing levels of quiescence-inducing factors with age negatively 
regulate stem cell activity. For example, accumulation of the Wnt antagonist Dkk1 in 
the DG during old age is suggested to be in part responsible for the reduction of 
neurogenesis and the decline in cognitive function in mice (Seib et al., 2013). This 
modulation of quiescence with increasing age could in principle be also mediated by 
regulation of Ascl1 expression. We indeed observe a reduction in the number of cells 
expressing Ascl1 over time (not shown). Quantification of these numbers, as well as 
of the levels of Ascl1 expression per cell will shed light on the process of age-related 
decline of neurogenesis observed in the DG. 
 On the other side of the balance, we find the role of Ascl1 in stem cell 
function to also have implications in the cancer field. High levels of Ascl1 
expression were found in a number of neuro-endocrine tumours, including small cell 
lung carcinoma and prostate tumours (Ball, 2004, Vias et al., 2008, Augustyn et al., 
2014), as well as several types of gliomas (Phillips et al., 2006, Somasundaram et al., 
2005). In glioblastoma cancer stem cells, Ascl1 was also found to be important for 
the maintenance of tumorigenicity (Rheinbay et al., 2013). The finding that Ascl1 
controls a number of cell cycle-related genes together with evidence of Ascl1 
expression in tumours might suggest that these are causally related. Dysregulation of 
genes or pathways involved in important aspects of normal development, like 
growth, cell division and differentiation, is a way for precancerous cells to progress 
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to full tumorigenicity, and upregulation of Ascl1 appears to be one common 
mechanism by which tumours reach their state. 
Put together, this evidence highlights the relevance of our results in the field 
of stem cell biology, since it is on this light that Ascl1 becomes key to the process of 
neurogenesis and that understanding how it is regulated becomes a central target for 
future treatments.  
7.4 Future directions 
Our work has addressed an important question in the field of adult neurogenesis: 
how do stem cells in the hippocampus integrate signals from the environment? 
However, many questions still remain unanswered. I have pointed out some of these 
throughout the text above, and I have provided an insight of possible directions to 
take when appropriate. There are, nonetheless, a few points that I believe deserve a 
more comprehensive discussion, and I aim to explain them below. 
 The first obvious question to ask is: how is Ascl1 regulated? In the first part 
of this chapter I discussed at length how different signals and transcription factors 
might interact with Ascl1 to modulate its expression at both the transcriptional and 
post-transcriptional levels. Most of these interpretations, however, are made by 
analogy with other systems. The lack of stem cell-specific markers, as well as the 
sensitivity of the system to change and regulation, make this topic a difficult one to 
tackle. An alternative to studying how Ascl1 and stem cell activity are regulated in 
vivo is the use of hippocampus-derived stem cell cultures. Isabelle Blomfield, a PhD 
student in the laboratory has taken this approach. She is using AH-NSCs and 
exposing them to BMP4, which is able to induce a quiescent-like state in them 
(Martynoga et al., 2013). In this way she can study the action of a number of signals 
normally present in the hippocampal neurogenic niche and how they function to fine-
tune the quiescence versus activation balance. With this approach it will also be 
possible to assess Ascl1 expression and how it is affected under these different 
conditions.  
Discussion 
 
 157 
 We have focused our target analysis in genes related to the cell cycle. This 
was a decision based on the phenotype we observed and on the roles that we know 
Ascl1 plays in the ventral telencephalon. With this knowledge, however, the question 
of whether Ascl1 might not be playing other cell cycle-independent roles in 
hippocampal stem cells arises. The transition from quiescence to activation involves 
many cellular changes, like changes in lipid and oxygen metabolism, and changes in 
cell adhesion. These are possible cellular functions where Ascl1 could be important. 
In support of this idea, GO terms not related to the cell cycle are found as some of 
the top hits among the Ascl1-bound genes (see Figure 6-1). A short qPCR screen of 
transcripts of some of these genes in WT and Ascl1neocKO FACS-isolated 
hippocampal stem cells showed no significant differences between them (see Figure 
A1 4 in Appendix 1). In the future, it will be of interest to perform an unbiased 
transcriptomic analysis using RNA-Seq. In this way it will be possible to ascertain 
whether other genes that are bound by Ascl1 in AH-NSCs, are also misregulated in 
Ascl1neocKO mice, and are therefore direct targets, and ultimately establish whether 
Ascl1 is involved in regulating genes outside of the cell cycle.  
 A topic that has come up throughout the discussion of this work is the 
possible existence of heterogeneity among the total pool of stem cells. Within this 
topic, a few clarifications are needed. Mainly, what kind of heterogeneity are we 
talking about? In the “zoned” model of stem cell maintenance and self-renewal 
proposed by Li and Clevers (2010) the two separate populations are differentiated by 
their being located in either activation- or quiescent-inducing environments within 
the niche. In such case, the two populations do not need to be developmentally 
different; their properties are induced by the signals they are exposed to, and their 
roles could potentially be swapped. Another scenario can be envisaged where the 
active and quiescent populations are different due to intrinsic differences that arise 
from, for instance, them developing from different progenitor pools. This idea could 
correspond with the proposal of the existence of a deeply quiescent pool of stem 
cells, which would be less responsive to external stimulation and would only become 
activated after an insult to the brain or after disease.  
 Yet, within this foundation, further subpopulations of stem cells might be 
described. And these distinctions can be on the basis of how primed they are for 
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activation or how neurogenic they are. All of these are active areas of research in the 
field at the moment. Our results, together with results from Noelia Urbán in the 
laboratory, point to the possibility that different populations of stem cells in the 
hippocampus do exist. Further characterisation of these cells and their behaviour 
over time will be required in the future to answer these questions. Moreover, Stefania 
Vaga, another postdoctoral fellow in the laboratory, will be taking on the challenge 
of carrying out single-cell RNA-Seq analysis of RGLs isolated from the adult 
hippocampus, an approach that will shed light on their potential heterogeneity. 
 Finally, and now moving into a systems perspective, I would like to discuss 
the implications of our results and our mouse model in the future of DG functional 
studies. The study of the role of new-born neurons in the adult hippocampus in 
cognitive performance has relied, on its most part, on several methods of ablation of 
neurogenesis. Such methods have included, among others, the administration of anti-
mitotic drugs and irradiation (Deng et al., 2010). These approaches, however, have 
severe side effects in animals and the consequences of these on hippocampal 
function are not normally taken into consideration. Conditional Ascl1 mutant mice 
could now be used as an alternative approach to these methods of neurogenesis 
ablation. Our animals show a complete block of neurogenesis, and even though not 
directly quantified, cell death does not appear to be a major event. Behavioural 
studies using both Ascl1neocKO and Ascl1cKO mice will provide important insights 
on the relevance of new neurons in the adult hippocampal circuit. We are currently 
collaborating with Nora Abrous, at the Neurocentre Magendie in Bordeaux, to 
perform these experiments. 
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7.5 Conclusions  
Our study of the function of the proneural factor Ascl1 in the neurogenic lineage of 
the adult hippocampus has revealed a fundamental player in the control of stem cell 
activity. Ascl1 was exposed as an intermediate factor in stem cells connecting the 
outside world with the inner operative system of the cells to regulate neurogenic 
output and, ultimately, homeostasis (Figure 7-4).  
 Neurogenesis in the adult hippocampus is an extremely intricate and delicate 
process, with every step being influenced by innumerable extrinsic and intrinsic 
factors. Importantly, this regulation observed along the neurogenic lineage, was also 
shown to affect cognitive performance. We have provided evidence that Ascl1 is up- 
or downregulated in stem cells upon the reception of neurogenic or anti-neurogenic 
stimuli, respectively. Ascl1 directly regulates a number of cell cycle genes, among 
which the cyclin D factors are of huge importance, to control the activation of stem 
cells. Loss of Ascl1 completely abolishes precursor proliferation and, therefore, 
neurogenesis.  
 Our results are significant because this is the first transcription factor shown 
to act as an integrator of extrinsic signals in the adult brain. Our results are also 
partly unexpected. It is not common in nature to find only one factor having such a 
central role in one process. Even reduced levels of expression of Ascl1 have an 
impact on the total neurogenic yield, emphasising the importance of correct Ascl1 
regulation at both the protein and RNA levels to take place. 
 Recent years have seen a growth in the interest for exploiting the brain’s 
endogenous reservoir of stem cells as a potential therapeutic strategy for tackling 
neurological disorders. In order for this to be possible it is necessary to understand 
what it is that enables stem cells to proliferate, and what mechanisms can be 
employed to extrinsically stimulate their proliferation and neuronal differentiation 
(Taylor et al., 2013). Our work has majorly contributed to the basic understanding of 
stem cell activation and proliferation, and on this basis will, hopefully, contribute to 
future therapies.   
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Figure 7-4 Model of Ascl1 function in adult hippocampal stem cells 
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Figure A1 1 Genome-wide investigation of Ascl1 binding in AH-NSCs 
(A) Diagram illustrating the derivation of adult hippocampus-derived NSC (AH-NSC) cultures to 
perform chromatin immunoprecipitation-sequencing (ChIP-seq). (B) Heat map representation of the 
density of ChIP-seq reads for Ascl1 in AH-NSCs and p300 marking enhancers in proliferating NSCs 
at the same genomic locations (from Martynoga et al., 2013) shows that a large part of Ascl1-binding 
sites are located in enhancers present in proliferating NSCs. (C) Similarly, the distribution of Ascl1-
binding sites among different types of enhancers (from Martynoga et al., 2013) shows that a majority 
of Ascl1-binding sites map to enhancers previously identified in NSCs and that a big proportion of 
them are active-specific. (D) And, in a reciprocal manner, a large fraction of active-specific enhancers 
in NSCs are bound by Ascl1. quies-specific and active-specific are enhancers that are specific for 
quiescent or active NSCs, respectively. pan-specific enhancers are those that are present in both 
quiescent and active NSCs. For more information see Andersen et al., 2014 and Martynoga et al., 
2013. Analysis performed by Ben Martynoga. 
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Figure A1 2 Comparison of Ascl1-bound genes in AH-NSCs and GBM CSCs 
(A) Venn diagrams showing (left) the overlap between Ascl1 ChIP-seq peaks found in AH-NSCs 
(blue) and those found in glioblastoma cancer stem cells (GBM CSCs, pink, from Rheinbay et al., 
2013), and (right) the overlap between Ascl1-bound genes in these two data sets. The overlap between 
these two data sets is not big. (B) Examples of ChIP-seq signals for Ascl1 in both AH-NSCs and 
GBM-CSCs. A binding peak is found for both cell types in the known Ascl1 target Dll1. For other 
genes, like E2f1, a peak is observed only in AH-NSCs; and yet for others, like Dkk1, a peak is found 
only in GBM-CSCs, suggesting that Ascl1 regulates different genes in different cell types. Analysis 
performed by Ben Martynoga. 
Appendix 1 
 
 184 
 
Figure A1 3 Cell cycle genes feature Ascl1-binding events 
Examples of cell cycle-related genes that are bound by Ascl1 in AH-NSCs. For each gene the signal 
for Ascl1, and the enhancer marks for p300 and H3K27ac are shown (from Martynoga et al., 2013). 
Significant binding peaks are highlighted with a green box. The direction of transcription is indicated 
with an arrow. Analysis performed by Ben Martynoga. 
 
Appendix 1 
 
 185 
 
Figure A1 4 Non-cell cycle genes might also be regulated by Ascl1 
Short screen to test whether other genes that are bound by Ascl1 but are not cell cycle-related are also 
misregulated in Ascl1neocKO mice. Cdh4 is a cell-cell adhesion glycoprotein that is important in 
neuronal outgrowth; Iqgap1 interacts with components of the cytoskeleton and with cell adhesion 
molecules to regulate cell morphology; Dhx15 is a pre-mRNA processing factor involved in the 
disassembly of spliceosomes after the release of mature mRNA; Rpia is important in carbohydrate 
metabolism. In this case none of the genes are downregulated after Ascl1 deletion. In the future, 
however, it will be of interest to examine this possibility more closely. 
Table A1 1 
 
 186 
Table A1 1 Ascl1-bound genes in AH-NSCs 
Gene name 
0610007P08Rik Ckmt2 Gpr126 Noxa1 Sipa1l3 
0610007P14Rik Clasp2 Gpr146 Npas3 Sis 
0610010O12Rik Clasrp Gpr149 Npc2 Six2 
0610011L14Rik Cldn11 Gpr15 Npepl1 Skap2 
0610012H03Rik Cldn23 Gpr153 Npff Ski 
1110002B05Rik Cldn4 Gpr155 Npffr1 Skor1 
1110012J17Rik Clec14a Gpr156 Npffr2 Skp2 
1110021J02Rik Clec2d Gpr22 Npl Slc10a4 
1110028C15Rik Clec2i Gpr26 Nppa Slc10a7 
1110032A04Rik Clec3b Gpr3 Nptx1 Slc12a2 
1110034B05Rik Clec9a Gpr30 Npvf Slc12a3 
1110038F14Rik Clic1 Gpr50 Nqo1 Slc12a8 
1110051M20Rik Clic4 Gpr52 Nr1d1 Slc13a3 
1110065P20Rik Clic5 Gpr56 Nr2c1 Slc13a4 
1110067D22Rik Clic6 Gpr6 Nr2c2 Slc14a1 
1190002N15Rik Clip1 Gpr61 Nr2c2ap Slc14a2 
1300002K09Rik Clip2 Gpr63 Nr2f1 Slc16a1 
1500001M20Rik Clip3 Gpr82 Nr2f2 Slc16a7 
1500009L16Rik Clip4 Gpr83 Nr2f6 Slc16a9 
1500012F01Rik Clmn Gpr88 Nr3c1 Slc19a3 
1500015O10Rik Cln8 Gprc5b Nr3c2 Slc1a1 
1600012P17Rik Clpb Gprin2 Nr4a3 Slc1a2 
1600014K23Rik Clrn1 Gpsm1 Nr6a1 Slc1a3 
1700001O22Rik Clrn3 Gpt2 Nrbf2 Slc1a4 
1700003F12Rik Clvs1 Gramd1b Nrcam Slc1a6 
1700008A04Rik Cml2 Gramd2 Nrk Slc22a12 
1700010I14Rik Cmpk2 Gramd3 Nrn1l Slc22a16 
1700010M22Rik Cmtm5 Gramd4 Nrp1 Slc22a2 
1700011E24Rik Cmtm6 Grasp Nrp2 Slc22a23 
1700011H14Rik Cngb1 Grb10 Nrsn1 Slc22a3 
1700011I03Rik Cnih4 Grb14 Nrxn1 Slc24a1 
1700012B07Rik Cnksr3 Grb2 Nrxn2 Slc24a2 
1700016C15Rik Cnn3 Greb1 Nrxn3 Slc24a3 
1700016D06Rik Cnnm3 Grem2 Nsg2 Slc24a5 
1700017B05Rik Cno Grhl1 Nsmaf Slc25a13 
1700019G17Rik Cnot2 Grhl2 Nsmce2 Slc25a18 
1700019O17Rik Cnot6l Gria2 Nsun3 Slc25a24 
1700020L24Rik Cnp Gria4 Nsun7 Slc25a29 
1700023I07Rik Cntn1 Grid2 Nt5dc3 Slc25a31 
1700024P04Rik Cntn4 Grik1 Ntm Slc25a34 
1700025G04Rik Cntn5 Grin2b Ntn1 Slc25a36 
1700029H14Rik Cntn6 Grin3a Ntng1 Slc25a4 
1700034H14Rik Cntnap1 Grinl1a Ntrk2 Slc25a40 
1700034J05Rik Cntnap4 Grip1 Ntrk3 Slc25a42 
1700057G04Rik Cntrob Grk5 Ntsr2 Slc25a43 
1700057K13Rik Cobll1 Grlf1 Nuak1 Slc25a5 
1700061J05Rik Cog6 Grm1 Nuak2 Slc27a1 
1700066M21Rik Col12a1 Grm3 Nudt18 Slc27a6 
1700090G07Rik Col15a1 Grm4 Nudt2 Slc29a4 
1700094C09Rik Col18a1 Grm5 Nudt4 Slc2a10 
1700102P08Rik Col1a1 Grtp1 Nudt7 Slc30a10 
1700106J16Rik Col27a1 Grxcr1 Nudt9 Slc30a5 
1700108M19Rik Col2a1 Gsdmc Nuf2 Slc30a8 
1700110M21Rik Col3a1 Gse1 Nup214 Slc31a2 
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1700112E06Rik Col4a1 Gsg1l Nup35 Slc35b1 
1700129C05Rik Col4a3 Gstm1 Nusap1 Slc35c2 
1810011O10Rik Col4a4 Gsto2 Nwd1 Slc35f1 
1810020D17Rik Col5a1 Gstt4 Nxnl2 Slc35f3 
1810041L15Rik Col5a3 Gstz1 Nxph1 Slc37a2 
1810046K07Rik Col8a1 Gsx1 Nynrin Slc38a1 
1810074P20Rik Col9a1 Gtdc1 Nyx Slc38a10 
2010111I01Rik Col9a3 Gtf2a1 ORF63 Slc38a3 
2010317E24Rik Colq Gtf2i Oaz2-ps Slc38a6 
2210009G21Rik Commd9 Gtf3c4 Ociad1 Slc38a9 
2210021J22Rik Cops8 Gtpbp2 Odam Slc39a11 
2310035K24Rik Coq2 Guca2a Odc1 Slc39a12 
2310046A06Rik Corin Gucy1b2 Odf3l1 Slc41a2 
2310061N02Rik Coro1c Gucy1b3 Odz3 Slc41a3 
2310067B10Rik Coro2b Gxylt1 Odz4 Slc44a1 
2310079G19Rik Cox18 Gypa Ofcc1 Slc45a1 
2410004B18Rik Cox6c H2-M10.1 Ogg1 Slc45a4 
2410004P03Rik Cox8c H2-M10.3 Ola1 Slc48a1 
2410066E13Rik Cp H2-M10.5 Olfm3 Slc4a3 
2410131K14Rik Cpa1 H2afy2 Olfml2a Slc4a4 
2610002I17Rik Cpd H60b Olfml2b Slc4a7 
2610002J02Rik Cpeb2 Haao Olfml3 Slc5a7 
2610021K21Rik Cpeb4 Habp2 Olfr1324 Slc6a1 
2610029G23Rik Cplx2 Hadhb Olfr1331 Slc6a11 
2610039C10Rik Cplx3 Hao1 Olfr1505 Slc6a12 
2610109H07Rik Cpm Hap1 Olfr1513 Slc6a2 
2610528E23Rik Cpn2 Hapln1 Olfr161 Slc6a6 
2700060E02Rik Cpne3 Has2 Olfr24 Slc8a1 
2810405K02Rik Cpne7 Hbegf Olfr412 Slc8a3 
2810428I15Rik Cps1 Hbp1 Olfr71 Slc9a6 
2810474O19Rik Cpxcr1 Hdac4 Olfr854 Slc9a9 
2900010M23Rik Cpxm1 Hdac5 Olig1 Slco1c1 
2900011O08Rik Cpxm2 Hdac7 Olig2 Slco3a1 
2900026A02Rik Crabp1 Hdac9 Olig3 Slit1 
3110001D03Rik Cradd Hddc2 Oma1 Slitrk2 
3110007F17Rik Crb1 Hdgfl1 Opa1 Slitrk3 
3110035E14Rik Crb2 Hectd2 Opa3 Slmo1 
3110056O03Rik Creb3l1 Heg1 Opalin Smad2 
3110079O15Rik Creb3l2 Helb Oplah Smad4 
3300002A11Rik Creb5 Hepacam Oprd1 Smad5 
3830431G21Rik Crebbp Hepacam2 Oprl1 Smad7 
4632415K11Rik Crhr2 Herpud2 Optc Smarca2 
4632428N05Rik Crim1 Hes1 Orai1 Smarca5 
4831426I19Rik Crip1 Hes2 Orm1 Smc2 
4833422F24Rik Crip2 Hes6 Osbp2 Smg1 
4921510H08Rik Crispld2 Hexim1 Osbpl10 Smg6 
4921511C20Rik Crmp1 Hexim2 Osbpl5 Smoc1 
4930402H24Rik Crtam Heyl Osbpl8 Smoc2 
4930403N07Rik Cryab Hfm1 Osbpl9 Smok2a 
4930404H21Rik Cryba4 Hgd Osm Smox 
4930427A07Rik Crybb1 Hhatl Osmr Smtn 
4930449E01Rik Crybb3 Hhipl1 Osr1 Smug1 
4930452B06Rik Crybg3 Hibadh Osr2 Smyd2 
4930453N24Rik Cryz Hic1 Osta Smyd3 
4930455C21Rik Cs Hic2 Otoa Sncaip 
4930467E23Rik Csda Hif1a Otof Snd1 
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4930468A15Rik Csdc2 Hif1an Otol1 Sned1 
4930473A06Rik Csk Hip1 Otos Snrk 
4930474N05Rik Csl Hipk2 Otub1 Snrnp40 
4930503L19Rik Csmd2 Hist1h1b Otud7b Snrpe 
4930506M07Rik Csnk1a1 Hivep3 Otx2 Snta1 
4930525F21Rik Csnk1e Hk1 Oxct1 Sntb1 
4930549C01Rik Csnk1g3 Hlcs Oxr1 Sntn 
4930562C15Rik Csnk2a2 Hlx Oxsm Snx11 
4930596D02Rik Cspg4 Hmbox1 P2rx4 Snx20 
4931440F15Rik Cspg5 Hmcn1 P2ry1 Snx22 
4932438H23Rik Csrnp3 Hmcn2 P2ry12 Snx25 
4933400A11Rik Csrp1 Hmg20a P2ry2 Snx29 
4933403F05Rik Csrp2 Hmga2 P2ry6 Snx30 
4933407C03Rik Cst3 Hmgb1 P4ha1 Snx5 
4933409G03Rik Cst6 Hmgcll1 P4ha2 Snx9 
4933426M11Rik Cst7 Hmgcr Pabpc2 Sobp 
4933427D06Rik Cstad Hnrnpu Pabpc6 Socs3 
4933430I17Rik Ctbp2 Hnrpdl Pacrg Socs7 
4933436I01Rik Ctdp1 Hnrpll Pacs2 Sod3 
5031414D18Rik Ctdspl Homer2 Pacsin1 Sorbs2 
5031439G07Rik Ctgf Hook1 Pacsin2 Sorcs1 
5330437I02Rik Ctnnb1 Hoxa1 Padi2 Sorcs2 
5430435G22Rik Ctnnbl1 Hoxa2 Pafah2 Sorcs3 
5730403B10Rik Ctnnd1 Hpcal1 Pag1 Sord 
5730455O13Rik Ctnnd2 Hrh1 Pak1 Sorl1 
5730508B09Rik Ctrb1 Hrh2 Pak6 Sos2 
5730559C18Rik Ctsc Hrh4 Palm Sox1 
5830405N20Rik Ctsl Hs1bp3 Palmd Sox10 
5830433M19Rik Ctso Hs2st1 Pam Sox11 
6030405A18Rik Cttnbp2 Hs3st3a1 Pamr1 Sox2 
6030419C18Rik Cubn Hs6st1 Pank1 Sox21 
6030446N20Rik Cuedc1 Hsd17b3 Papd7 Sox3 
6030498E09Rik Cux1 Hspa8 Pappa Sox4 
6230409E13Rik Cwc22 Hspb1 Pard3 Sox5 
6330512M04Rik Cx3cl1 Htr2c Pard3b Sox6 
6330527O06Rik Cxadr Htr3a Pard6b Sox8 
6430527G18Rik Cxcl11 Htr6 Park2 Sox9 
6530418L21Rik Cxcl12 Htr7 Parm1 Sp3 
8430427H17Rik Cxcl13 Htra1 Parp11 Sp4 
9030409G11Rik Cxcr4 Htra4 Parp16 Sp5 
9030418K01Rik Cxcr7 Ibtk Parvb Sp8 
9030617O03Rik Cxxc4 Icos Pax1 Spag9 
9030625A04Rik Cxxc5 Id1 Pax7 Sparc 
9230019H11Rik Cybrd1 Id2 Pax8 Sparcl1 
9230109A22Rik Cycs Id3 Pbk Spata13 
9330159F19Rik Cyld Id4 Pbx1 Spata17 
9430020K01Rik Cyp24a1 Idh2 Pbx3 Spata19 
9430031J16Rik Cyp2d22 Ier3 Pcbp1 Spata21 
9530068E07Rik Cyp2j13 Iffo1 Pcca Spata24 
9630014M24Rik Cyp2j9 Iffo2 Pcdh10 Spata3 
9830001H06Rik Cyp7b1 Ifnar1 Pcdh15 Spata6 
9930013L23Rik Cyr61 Ifnar2 Pcdh18 Spats2l 
9930021D14Rik Cysltr2 Ifngr1 Pcdh7 Specc1 
A1bg Cyth1 Ift27 Pcdh9 Speer2 
A3galt2 Cyth4 Igdcc4 Pcgf5 Speer4d 
A4galt Cytip Igf1 Pcnx Spert 
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A530016L24Rik Cytl1 Igf1r Pcsk5 Spesp1 
A530021J07Rik D0H4S114 Igf2r Pcsk6 Spg20 
A630001G21Rik D10Bwg1379e Igfbp1 Pcx Spg7 
A630007B06Rik D14Abb1e Igfbp2 Pdcd1 Sphk1 
A630055G03Rik D15Ertd621e Igfbp3 Pdcd6ip Spns3 
A630091E08Rik D16Ertd472e Igfbp4 Pde10a Spo11 
A730011L01Rik D17Wsu104e Igfbp5 Pde11a Spock2 
A830018L16Rik D17Wsu92e Igfbp7 Pde1a Spon1 
A930005I04Rik D18Ertd653e Igfbpl1 Pde1c Spon2 
A930011G23Rik D19Bwg1357e Igsf11 Pde2a Spp2 
A930018P22Rik D19Ertd737e Igsf21 Pde4b Spred1 
AA408296 D1Pas1 Igsf9b Pde4d Spry1 
AI429214 D430041D05Rik Ikbke Pde5a Spry2 
AI467606 D5Ertd579e Il12a Pde9a Spry4 
AI480653 D6Wsu116e Il13ra2 Pdgfa Spsb4 
AI593442 D8Ertd82e Il17a Pdgfc Spty2d1 
AI606181 D930014E17Rik Il17b Pdgfra Spz1 
AI646023 D930015E06Rik Il17d Pdgfrl Sqle 
AI837181 Daam1 Il17ra Pdk4 Sqrdl 
AK053790 Dab1 Il17rd Pdlim1 Srbd1 
AK085995 Dab2ip Il18bp Pdlim3 Src 
AK132123 Dach1 Il23a Pdlim5 Srcin1 
AK168184 Dact1 Il33 Pdpn Srebf1 
AW146020 Dap Il34 Pdss2 Srgap1 
Aagab Dapk1 Il3ra Pdzd2 Srgap2 
Aak1 Dapk2 Il9 Pdzd8 Srgap3 
Aatk Dapl1 Il9r Pdzk1ip1 Srl 
Abat Dars Impad1 Pdzrn3 Srp14 
Abca1 Dbi Impdh1 Pdzrn4 Srpk2 
Abca13 Dbndd1 Inhbb Pea15a Srpx2 
Abcb9 Dbx1 Ino80c Pecam1 Srsf10 
Abcc12 Dbx2 Ino80d Peci Srsf3 
Abcc3 Dcaf5 Inpp4b Pef1 Srsf5 
Abcc4 Dcakd Inpp5a Peg12 Srsf7 
Abcd2 Dcc Inpp5f Peli2 Srsf9 
Abhd10 Dcdc2c Inpp5k Pemt Ss18 
Abhd2 Dclk1 Inppl1 Penk Ssbp2 
Abi2 Dclk2 Ins1 Pepd Ssbp3 
Abi3bp Dclk3 Insc Pet112l Ssr3 
Abl1 Dclre1b Insig1 Pex5l Sst 
Ablim1 Dclre1c Insig2 Pfkfb3 Sstr4 
Ablim2 Dcn Insm1 Pfn2 Sstr5 
Abra Dcp1b Insr Pga5 St18 
Abtb2 Dcp2 Integrin Alpha-4 Pgap1 St3gal1 
Acaca Dctd Intu Pgf St3gal2 
Acacb Dcx Invs Pgk1 St3gal3 
Acadl Ddc Ip6k3 Pgm5 St3gal4 
Acap2 Ddhd1 Ipo5 Pgpep1l St3gal5 
Acap3 Ddi1 Iqcj-schip1 Pgrmc1 St3gal6 
Accn2 Ddit4 Iqgap1 Pgrmc2 St5 
Accn4 Ddit4l Iqsec1 Pgs1 St6gal2 
Accn5 Ddr1 Ireb2 Phactr2 St6galnac3 
Accsl Ddr2 Irf2 Phc2 St6galnac5 
Acer3 Ddx1 Irf2bp2 Phf12 St7 
Acly Ddx11 Irf4 Phf15 St8sia1 
Acn9 Ddx18 Irf6 Phf17 St8sia2 
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Aco1 Ddx20 Irgm2 Phf20 St8sia3 
Acot11 Ddx26b Irs1 Phf21a Stab2 
Acot12 Ddx3x Irs2 Phlda1 Stag1 
Acox3 Ddx6 Irx1 Phldb1 Stambpl1 
Acoxl Dear1 Irx2 Phldb2 Stard13 
Acpl2 Degs2 Irx3 Phlpp1 Stard3 
Acsl3 Dennd2a Irx5 Phox2b Stard5 
Acss1 Dennd4a Irx6 Phtf1 Stard9 
Acss3 Dennd5a Islr Phtf2 Stat1 
Actb Derl1 Itga11 Phyhd1 Stat3 
Actbl2 Dgkb Itga2 Phyhipl Stat4 
Actc1 Dgkd Itgae Pi4k2a Stat5a 
Actg1 Dgkg Itgav Pick1 Stc1 
Actl7b Dgki Itgb1 Pid1 Steap3 
Actn1 Dgkz Itgb1bp2 Pigc Stim2 
Actn2 Dguok Itgb2l Pigv Stk17b 
Actr3 Dhrs2 Itgb3 Pigy Stk24 
Actr3b Dhrs3 Itgb5 Pigz Stk32a 
Acvr1 Dhx15 Itgb6 Pik3c3 Stk32b 
Acvr2a Dhx30 Itgb8 Pik3ca Stk32c 
Acyp2 Dhx35 Itih5 Pik3cd Stk33 
Ada Dhx36 Itm2b Pik3cg Stk35 
Adam10 Dhx40 Itm2c Pik3r1 Stk38l 
Adam12 Dhx8 Itpkb Pim3 Stmn2 
Adam19 Dhx9 Itpr1 Pin1 Stmn4 
Adam30 Diap1 Itpr2 Pinx1 Stox2 
Adam33 Diap2 Itpripl2 Pion Strap 
Adamts12 Dicer1 Itsn2 Pip4k2a Stt3b 
Adamts14 Dio2 Ivns1abp Pipox Stx8 
Adamts16 Dip2b Iyd Pirt Stxbp1 
Adamts17 Dip2c Jag1 Pitpnb Stxbp3a 
Adamts18 Diras2 Jak2 Pitpnc1 Stxbp4 
Adamts20 Dirc2 Jakmip2 Pitpnm2 Stxbp6 
Adamts4 Dis3l Jam2 Pitrm1 Sucla2 
Adamts5 Dis3l2 Jam3 Pja1 Suclg2 
Adamts6 Disc1 Jarid2 Pkd1 Sulf1 
Adamts7 Disp2 Jazf1 Pkd1l1 Sulf2 
Adamts8 Dkk3 Jdp2 Pkd2l2 Sult5a1 
Adamts9 Dleu7 Jhdm1d Pkhd1 Sun1 
Adamtsl1 Dlg2 Jmjd1c Pkig Susd1 
Adamtsl2 Dlg5 Jmy Pkm2 Sv2b 
Adamtsl3 Dlgap1 Josd2 Pkn2 Sv2c 
Adarb1 Dlgap3 Jph1 Pknox1 Svil 
Adarb2 Dlgap4 Jun Pknox2 Swap70 
Adc Dll1 Jup Pkp4 Syce1l 
Adcy1 Dll3 Kalrn Pla2g16 Sykb 
Adcy7 Dlst Kank1 Pla2g2c Syn2 
Adcyap1r1 Dlx2 Kank2 Pla2g7 Sync 
Add2 Dmp1 Kank4 Plac9 Syne1 
Adhfe1 Dmrt1 Kat2b Plcb1 Syt1 
Adk Dmrtb1 Katnal1 Plcb4 Syt11 
Adm Dnahc10 Kbtbd11 Plcd4 Syt13 
Ado Dnahc14 Kbtbd13 Plce1 Syt3 
Adora1 Dnahc5 Kbtbd8 Plcg1 Syt6 
Adora2b Dnaic2 Kcmf1 Plcl1 Syt8 
Adora3 Dnajb12 Kcna10 Plcl2 Sytl2 
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Adra1a Dnajb5 Kcnab2 Plcxd2 Sytl3 
Adra1b Dnajb8 Kcnc1 Pld1 T 
Adra2c Dnajb9 Kcnc4 Pld6 Tac1 
Adrb1 Dnajc1 Kcnd2 Plekha1 Tacc1 
Adrb2 Dnajc19 Kcnd3 Plekha5 Tacc3 
Adrbk2 Dnajc28 Kcne4 Plekha7 Tacr3 
Adssl1 Dnajc5b Kcnh5 Plekhb1 Tada3 
Aebp2 Dnase1l3 Kcnh7 Plekhf1 Taf12 
Afap1 Dner Kcnip2 Plekhf2 Taf4a 
Afap1l2 Dnlz Kcnip3 Plekhg3 Taf4b 
Aff1 Dnm2 Kcnj10 Plekhg5 Tagln2 
Aff2 Dnmt1 Kcnj12 Plekhh2 Tanc1 
Aff3 Dnmt3b Kcnj13 Plekhh3 Tanc2 
Afm Dntt Kcnj2 Plekho1 Tank 
Agap1 Dock1 Kcnj5 Plg Tarbp1 
Agbl1 Dock10 Kcnj6 Plk1s1 Tas2r119 
Agmat Dock2 Kcnk1 Plk2 Tas2r134 
Agpat3 Dock3 Kcnk13 Plk3 Tatdn1 
Agpat4 Dock4 Kcnk15 Pllp Tax1bp1 
Agr3 Dock7 Kcnk2 Plod2 Tbc1d1 
Agrn Dok5 Kcnk3 Plrg1 Tbc1d10a 
Agtpbp1 Dok7 Kcnma1 Pls3 Tbc1d14 
Agtr1a Dolpp1 Kcnn2 Pltp Tbc1d16 
Ahcy Dopey2 Kcnn3 Plxdc2 Tbc1d22a 
Ahcyl1 Dpf3 Kcnn4 Plxna1 Tbc1d23 
Ahdc1 Dpp10 Kcnq1 Plxna2 Tbc1d30 
Ahi1 Dpp6 Kcnq3 Plxna4 Tbc1d7 
Ahr Dpp8 Kcnq4 Plxnd1 Tbcel 
Ahsg Dpyd Kcnrg Pmaip1 Tbl1x 
Aig1 Dpysl2 Kcns2 Pmepa1 Tbl1xr1 
Aim1l Dpysl3 Kcnt1 Pmp2 Tbx1 
Aim2 Dpysl5 Kctd1 Pmp22 Tbx19 
Aipl1 Dscam Kctd13 Pnlip Tbx2 
Ak2 Dscaml1 Kctd14 Pnma1 Tceal8 
Ak4 Dscr3 Kctd16 Pnmal1 Tcf12 
Akap10 Dst Kctd18 Pnmal2 Tcf20 
Akap13 Dstyk Kctd21 Pnrc1 Tcf21 
Akap17b Dtl Kctd3 Poc1a Tcf4 
Akap2 Dtna Kctd8 Poc1b Tcf7l1 
Akap6 Dtnbp1 Kdelr2 Poc5 Tcf7l2 
Akap7 Dtx4 Kdm2b Pofut2 Tcfap2c 
Akap8l Duox2 Kdm4d Pol Tcp10a 
Akna Duoxa2 Kdm6b Pola2 Tcp11 
Akr1d1 Dupd1 Khdrbs3 Pold3 Tcra 
Akt2 Dusp10 Kif13a Polg Tdrd6 
Akt3 Dusp26 Kif13b Polm Tdrd7 
Alcam Dusp4 Kif14 Polr1a Tead1 
Aldh1a7 Dusp5 Kif16b Polr2i Tead4 
Aldh1l1 Dusp6 Kif1b Polr3b Tecta 
Aldh4a1 Dusp7 Kif20b Polr3h Tek 
Aldh8a1 Duxbl Kif21a Polr3k Tekt1 
Aldoc Dync1i1 Kif21b Pom121 Tekt3 
Alg10b Dync1i2 Kif26a Pon1 Tekt5 
Alox12 Dynlrb2 Kif26b Pop1 Tenc1 
Alpl Dynlt1c Kif3a Pou1f1 Tesc 
Alx4 Dynlt3 Kif5c Pou2af1 Tesk1 
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Amfr Dyrk1a Kifc3 Pou2f1 Tet2 
Amot E030019B06Rik Kirrel3 Pou2f2 Tet3 
Amotl1 E030025P04Rik Kit Pou3f1 Tex14 
Amotl2 E130114P18Rik Kitl Pou3f2 Tex2 
Ampd3 E130203B14Rik Kl Pou3f3 Tfb1m 
Amph E130309F12Rik Klf10 Pou3f4 Tfdp2 
Amz1 E2f1 Klf12 Pou4f1 Tff3 
Anapc1 E2f3 Klf13 Ppap2b Tgfb2 
Anapc16 E2f7 Klf14 Ppapdc1a Tgfb3 
Angpt1 E2f8 Klf15 Ppara Tgfbi 
Angpt2 E330034G19Rik Klf2 Pparg Tgfbr1 
Angpt4 Ear14 Klf3 Ppargc1a Tgfbr2 
Angptl4 Ebf1 Klf4 Ppargc1b Tgfbr3 
Ank Ebna1bp2 Klf6 Ppcdc Tgif1 
Ank2 Ece1 Klf7 Ppef2 Tgif2 
Ank3 Echdc3 Klf9 Ppfia1 Tgif2lx1 
Ankib1 Edar Klhdc5 Ppfibp2 Tgm2 
Ankrd1 Edc3 Klhdc7a Ppif Tgoln2 
Ankrd11 Edem1 Klhl13 Ppil1 Thada 
Ankrd17 Edem3 Klhl23 Ppm1a Thbs2 
Ankrd23 Edil3 Klhl25 Ppm1e Thbs4 
Ankrd26 Edn2 Klhl29 Ppm1f Thoc3 
Ankrd28 Ednrb Klhl32 Ppm1h Thoc7 
Ankrd40 Eea1 Klhl36 Ppm1l Thra 
Ankrd43 Eef1a1 Klhl38 Ppnr Thrsp 
Ankrd45 Eef1g Klhl5 Ppp1cb Thsd4 
Ankrd46 Eef2k Klhl6 Ppp1r10 Thumpd3 
Ankrd55 Eefsec Klhl8 Ppp1r12a Thy1 
Ankrd57 Efcab3 Kndc1 Ppp1r12b Tiam2 
Ankrd58 Efcab4b Krc Ppp1r14b Ticam1 
Ankrd6 Efcab5 Kremen1 Ppp1r14c Tigit 
Ano2 Efhd2 Krt8 Ppp1r16b Timp3 
Ano6 Efnb2 Krtap13-1 Ppp1r2 Timp4 
Anp32a Efr3a Krtap26-1 Ppp1r3b Tinag 
Antxr1 Eftud1 Krtap5-4 Ppp1r3c Tinagl1 
Anxa1 Egfl6 Ky Ppp1r9a Tjp1 
Anxa11 Egfl7 L1td1 Ppp1r9b Tk1 
Anxa2 Egflam L3mbtl3 Ppp2ca Tkt 
Anxa5 Egfr Lama4 Ppp2r1b Tle1 
Anxa6 Egln3 Lama5 Ppp2r2a Tle3 
Aoah Ehbp1 Lamb1 Ppp2r2b Tle4 
Aox1 Ehd2 Lamb3 Ppp2r3a Tll1 
Ap3m1 Ehd4 Lamc1 Ppp2r5a Tln2 
Apaf1 Ehf Lamc2 Ppp2r5c Tlr1 
Apba2 Eid1 Laptm4b Ppp2r5e Tlr5 
Apbb2 Eif1b Laptm5 Ppp5c Tlx3 
Apcdd1 Eif2b3 Lasp1 Ppyr1 Tm2d1 
Apln Eif2d Lass5 Prcp Tm4sf1 
Apoa1 Eif3f Lats2 Prdm10 Tm4sf19 
Apobec2 Eif3h Lbh Prdm11 Tm6sf1 
Apol11b Eif4g3 Lbr Prdm2 Tm9sf4 
Apol6 Elac2 Lcat Prdm5 Tmbim1 
Apol8 Elavl2 Lclat1 Prdx6 Tmbim6 
Aqp1 Elavl4 Lcp2 Prelid2 Tmc1 
Aqp6 Elf2 Ldhal6b Prep Tmc2 
Ar Elf5 Ldlrad3 Prex1 Tmc3 
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Araf Elfn1 Ldoc1l Prf1 Tmc5 
Arap2 Elfn2 Lect1 Prickle1 Tmc6 
Arap3 Elk3 Lef1 Prkag2 Tmcc1 
Areg Ell2 Lemd1 Prkar1a Tmcc2 
Arfgap2 Elmo1 Lemd2 Prkar1b Tmcc3 
Arg1 Eln Lep Prkca Tmco5 
Arhgap12 Elovl4 Lfng Prkcb Tmco7 
Arhgap15 Elovl6 Lgals1 Prkce Tmed10 
Arhgap18 Emid1 Lgals8 Prkd1 Tmeff1 
Arhgap21 Emid2 Lgi1 Prkdc Tmeff2 
Arhgap22 Emilin3 Lgmn Prkg2 Tmem100 
Arhgap23 Eml1 Lgr4 Prl3c1 Tmem104 
Arhgap24 Emp1 Lgr5 Prl5a1 Tmem108 
Arhgap26 Emp3 Lhfp Prlhr Tmem117 
Arhgap27 Emx2 Lhfpl1 Prmt8 Tmem120a 
Arhgap31 Enc1 Lhfpl3 Proca1 Tmem131 
Arhgap32 Enho Lhx2 Prok2 Tmem132e 
Arhgap39 Enox1 Lhx4 Prokr1 Tmem149 
Arhgap42 Enpp1 Lhx8 Prom2 Tmem161b 
Arhgef10l Enpp5 Lif Pros1 Tmem163 
Arhgef18 Entpd1 Lifr Prox1 Tmem164 
Arhgef2 Epb4.1 Lima1 Prpf18 Tmem167 
Arhgef3 Epb4.1l4b Limch1 Prpf19 Tmem17 
Arhgef37 Epha4 Limd1 Prpf4b Tmem171 
Arid1a Epha5 Lime1 Prpsap2 Tmem173 
Arid1b Ephb1 Limk2 Prr15 Tmem174 
Arid2 Ephb2 Lims1 Prr18 Tmem176b 
Arid3a Ephb3 Lin28a Prr5 Tmem177 
Arid3b Ephx1 Lingo1 Prr5l Tmem178 
Arid4a Ephx3 Lingo4 Prrc1 Tmem18 
Arid5a Eps8 Lipc Prrc2b Tmem182 
Arid5b Erc1 Lipg Prss48 Tmem188 
Arl11 Ercc2 Litaf Prss52 Tmem194b 
Arl2bp Ercc4 Lix1 Prtg Tmem196 
Arl4a Erf Lmcd1 Psap Tmem2 
Arl4c Ergic1 Lmf1 Psapl1 Tmem20 
Arl6ip6 Erh Lmln Psat1 Tmem209 
Armc1 Erlin2 Lmna Psd3 Tmem211 
Armc2 Erv3 Lmnb1 Psma4 Tmem215 
Arnt2 Esm1 Lmo1 Psma6 Tmem22 
Arntl Esrrb Lmo2 Psmb1 Tmem220 
Arpp21 Esrrg Lmo3 Psmc1 Tmem229b 
Arrdc3 Esyt3 Lmo4 Psmc6 Tmem231 
Arsb Etaa1 Lmo7 Psmd7 Tmem232 
Arsi Etl4 Lmod3 Psmd9 Tmem38b 
Artn Etnk1 Lmx1b Psmg4 Tmem39b 
Asap1 Ets1 Lnp Pstpip2 Tmem41b 
Asap2 Ets2 Lnx1 Ptar1 Tmem44 
Asap3 Etv1 Loh12cr1 Ptbp2 Tmem51 
Asb4 Etv4 Lonrf1 Ptcd2 Tmem52 
Asb6 Etv5 Lpar4 Ptch1 Tmem55a 
Asb8 Etv6 Lpar6 Ptchd2 Tmem63a 
Ascl1 Evc2 Lpcat1 Pten Tmem64 
Asf1a Evi5 Lpcat2 Pter Tmem66 
Ash1l Evi5l Lpcat4 Ptgds Tmem69 
Asnsd1 Evpl Lphn2 Ptges Tmem72 
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Astn1 Evx1 Lphn3 Ptgfr Tmem86a 
Astn2 Exoc3 Lpin1 Ptgs2 Tmem87b 
Asxl1 Exoc4 Lpl Pth1r Tmem90a 
Atad2b Exoc6b Lpp Pth2r Tmem91 
Ate1 Exog Lrch1 Ptk2 Tmie 
Atf1 Exosc9 Lrfn4 Ptk2b Tmod1 
Atf7 Exph5 Lrguk Ptma Tmod2 
Atg10 Ext1 Lrig1 Ptms Tmpo 
Atg4c Extl3 Lrig3 Ptn Tmprss2 
Atg7 Eya1 Lrp11 Ptp4a3 Tmsb10 
Atl2 Eya2 Lrp12 Ptpdc1 Tmsb4x 
Atoh1 F13a1 Lrp1b Ptplad2 Tmtc2 
Atoh8 F2rl1 Lrp4 Ptpn1 Tmtc4 
Atp10a F2rl2 Lrp5 Ptpn13 Tnc 
Atp11a F3 Lrp6 Ptpn3 Tnfrsf11b 
Atp11b F830045P16Rik Lrp8 Ptpn4 Tnfrsf19 
Atp13a4 Fabp2 Lrpap1 Ptpn5 Tnfrsf21 
Atp1a1 Fabp7 Lrpprc Ptpra Tnfsf11 
Atp1a2 Fadd Lrrc28 Ptprb Tnfsf13b 
Atp1b2 Fads1 Lrrc29 Ptprc Tnfsf15 
Atp1b3 Fah Lrrc3b Ptprd Tnfsf18 
Atp2b1 Fam101a Lrrc4 Ptprg Tnik 
Atp5g2 Fam101b Lrrc40 Ptprj Tnk2 
Atp5g3 Fam102a Lrrc42 Ptprm Tnnt2 
Atp5l Fam102b Lrrc4c Ptprn2 Tnp1 
Atp5o Fam105a Lrrc68 Ptpro Tnr 
Atp6ap1l Fam107a Lrrc8b Ptprs Tnrc6a 
Atp6v0e Fam108c Lrrc8c Ptprt Tnrc6b 
Atp6v1a Fam110a Lrrc8d Ptprz1 Tnrc6c 
Atp6v1e2 Fam114a1 Lrrc9 Ptrf Tns1 
Atp6v1g3 Fam120a Lrrfip1 Pum1 Tns3 
Atp8a1 Fam120b Lrriq3 Purb Tns4 
Atp8b5 Fam122a Lrrn1 Pus7 Tob2 
Atp9a Fam122b Lrrn3 Pvrl1 Tom1l1 
Atrnl1 Fam123a Lrrtm2 Pwwp2a Tom1l2 
Atxn1 Fam124b Lrrtm3 Pwwp2b Tomm20 
Atxn10 Fam125b Lrtm1 Pxdn Tomm40 
Atxn2 Fam131a Lrtm2 Pygl Top1 
Atxn7l1 Fam134b Lsamp Qk Tox 
Atxn7l3b Fam135b Lsm5 Qpct Tox2 
Auh Fam13c Lsm6 Qprt Tox3 
Aurkaip1 Fam154b Lta4h Qrfp Tpcn1 
Auts2 Fam160b1 Ltbp1 Qrsl1 Tpcn2 
Aven Fam167a Ltbp4 Qsox2 Tpd52 
Axin2 Fam173a Ltc4s RP23-125A1.2 Tpd52l1 
Azi2 Fam173b Lxn Rab11a Tpm1 
Azin1 Fam174a Ly6c2 Rab11fip3 Tppp 
B020018G12Rik Fam174b Ly75 Rab11fip4 Tpra1 
B230312A22Rik Fam178b Ly86 Rab11fip5 Tprg 
B3galnt1 Fam180a Lyn Rab14 Tpst2 
B3galt2 Fam181b Lynx1 Rab17 Tpt1 
B3galt5 Fam184b Lypd1 Rab20 Tra2b 
B3gat1 Fam185a Lypd6 Rab32 Traf1 
B3gnt2 Fam186b Lyzl1 Rab3b Traf3 
B4galt1 Fam189a2 Lzts1 Rab3c Traf3ip2 
B4galt3 Fam18a Lzts2 Rab3gap2 Traf3ip3 
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B9d1 Fam192a Mab21l1 Rab4a Traf4 
BC017612 Fam198b Mab21l2 Rab6b Traf5 
BC018507 Fam19a2 Macf1 Rab8b Traf6 
BC023829 Fam19a3 Macrod1 Rabgap1l Trak1 
BC024659 Fam19a4 Mad1l1 Rabggta Tram1 
BC026439 Fam19a5 Mael Racgap1 Tram2 
BC027231 Fam20b Maf Rad51l1 Trap1 
BC030867 Fam20c Maged1 Raet1d Trappc3 
BC031353 Fam38b Magee1 Ralbp1 Trappc9 
BC031781 Fam3b Magi1 Ralgapa2 Trdn 
BC032203 Fam3c Magi3 Ralgds Treh 
BC034090 Fam43a Magoh Ralgps1 Trh 
BC035947 Fam46a Malt1 Raly Trib1 
BC037703 Fam49b Maml2 Ramp1 Trib2 
BC048546 Fam53b Maml3 Ranbp3l Trib3 
BC048562 Fam55b Man1c1 Ranbp6 Tril 
BC052040 Fam55d Man2a1 Rap1a Trim16 
BC057022 Fam58b Manba Rap1gap Trim2 
BC067074 Fam59a Map1lc3b Rap2b Trim26 
BC100451 Fam5b Map2k5 Rap2c Trim29 
BC106179 Fam5c Map2k6 Rapgef1 Trim3 
Bace2 Fam64a Map3k1 Rapgef2 Trim32 
Bach2 Fam65b Map3k13 Rapgef3 Trim33 
Bag1 Fam69a Map3k14 Rapgef4 Trim44 
Bag3 Fam69c Map3k7 Rapgef5 Trim52 
Bag5 Fam70b Map3k9 Rarb Trim55 
Bahcc1 Fam76a Map4k3 Rars Trim62 
Bai2 Fam76b Map4k4 Rasa3 Trim67 
Baiap2 Fam78a Mapk10 Rasal2 Trim71 
Bank1 Fam78b Mapk4 Rasgef1c Trim8 
Banp Fam82a1 Mapk8 Rasgrf2 Trim9 
Barhl1 Fam83a Mapkap1 Rasgrp1 Trio 
Barx2 Fam83f Mapkapk2 Rassf10 Trit1 
Baz2b Fam84b Mapre1 Rassf2 Trmt5 
Bbox1 Fam86 Mapre2 Rassf3 Trmt61a 
Bbs10 Fam89a Mapre3 Rbfox1 Trmu 
Bbx Fam92a Mapt Rbfox2 Trp53i11 
Bcan Fam92b March1 Rbl2 Trpc4ap 
Bcar1 Fam98b March3 Rbm15 Trpm1 
Bcar3 Fancc Marcks Rbm19 Trpm3 
Bcas1 Farp1 Mast2 Rbm20 Trps1 
Bcat1 Fars2 Mast4 Rbm24 Tsc22d1 
Bche Fat1 Matn2 Rbm28 Tsc22d2 
Bckdhb Fat3 Max Rbm47 Tsc22d3 
Bcl11b Fat4 Mb Rbms3 Tsga14 
Bcl2 Fbl Mbnl1 Rbmxl2 Tsga8 
Bcl2l11 Fbln1 Mbnl2 Rbpj Tshr 
Bcl6 Fbln2 Mboat2 Rc3h1 Tshz1 
Bcl7a Fbn2 Mbp Rcbtb2 Tshz2 
Bcl9 Fbp1 Mc2r Rchy1 Tshz3 
Bcor Fbp2 Mc4r Rcor2 Tsn 
Bcr Fbrsl1 Mcc Rd3 Tspan11 
Bdh1 Fbxl17 Mchr1 Reep1 Tspan12 
Bdkrb2 Fbxl2 Mctp1 Reep2 Tspan14 
Bend5 Fbxl4 Mctp2 Reep3 Tspan32 
Bfsp2 Fbxl7 Mdfic Refbp2 Tspan5 
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Bhlha9 Fbxo32 Mdga1 Reln Tspan9 
Bhlhe40 Fbxo47 Mdga2 Repin1 Tspyl1 
Bicd2 Fbxo48 Mecr Reps2 Tssc1 
Bloc1s1 Fbxw11 Med10 Rere Tstd2 
Bmf Fbxw4 Med13l Rerg Ttc1 
Bmp6 Fchsd2 Med14 Ret Ttc12 
Bmp7 Fcnb Med16 Rev1 Ttc17 
Bmper Fermt1 Med27 Rev3l Ttc27 
Bmpr1a Fermt2 Med28 Rfc2 Ttc3 
Bmpr1b Fert2 Med30 Rffl Ttc30a1 
Bmpr2 Fez1 Med31 Rfk Ttc33 
Bnc2 Fezf2 Med4 Rftn2 Ttc37 
Boc Fgd3 Mef2a Rfx2 Ttc39a 
Bod1 Fgd4 Mef2c Rfx3 Ttc39b 
Bod1l Fgf1 Mef2d Rfx7 Ttc39c 
Bpgm Fgf11 Megf10 Rfx8 Ttc7 
Bpi Fgf12 Megf9 Rg9mtd3 Ttc9 
Bptf Fgf18 Meig1 Rgag4 Ttll11 
Brd7 Fgf20 Meis1 Rgl1 Ttll3 
Brsk2 Fgf21 Meis2 Rgma Ttll5 
Bst2 Fgfr1 Memo1 Rgmb Ttll7 
Btaf1 Fgfr4 Meox1 Rgnef Ttpa 
Btbd1 Fgfrl1 Meox2 Rgr Tub 
Btbd11 Fggy Mertk Rgs14 Tuba1a 
Btbd16 Fgl1 Metap2 Rgs16 Tuba1b 
Btbd17 Fgr Mett5d1 Rgs17 Tubb2a 
Btbd3 Fhdc1 Mettl11b Rgs20 Tubb2b 
Btbd9 Fhit Mex3b Rgs22 Tubg1 
Btd Fhl3 Mex3c Rgs3 Tulp1 
Btg1 Fhl4 Mfap3 Rgs7 Tulp3 
Btg2 Fign Mfge8 Rgs7bp Tulp4 
Btla Fkbp11 Mfhas1 Rgs8 Twsg1 
Bzw2 Fli1 Mfsd6 Rhbdd3 Txndc2 
C030046E11Rik Flnb Mgat4a Rhbdl3 Txndc3 
C130022K22Rik Flnc Mgat5 Rhbg Txndc8 
C130039O16Rik Flrt1 Mgat5b Rhcg Txnip 
C1d Flrt2 Mgst1 Rheb Txnl1 
C1ql1 Flrt3 Mgst2 Rhob Txnrd2 
C1qtnf1 Flywch2 Mib1 Rhobtb1 Tyr 
C1qtnf5 Fmn1 Micalcl Rhobtb3 Tyro3 
C1qtnf7 Fmn2 Micall1 Rhof Tyrp1 
C1qtnf9 Fmnl2 Mid1ip1 Rhoh Tyw3 
C230052I12Rik Fmnl3 Midn Rhoq Uaca 
C330007P06Rik Fnbp1 Mif4gd Ric8b Uap1 
C530008M17Rik Fndc1 Minpp1 Rimbp3 Uba5 
C77080 Fndc3b Mitf Rimkla Ubash3b 
C78339 Fos Mki67 Rims1 Ubc 
C8b Foxa2 Mkl2 Rin2 Ube2e1 
C9 Foxc1 Mkln1 Rin3 Ube2e2 
CK137956 Foxd3 Mkrn1 Ripk1 Ube2e3 
Cabin1 Foxf1a Mlf1ip Ripk2 Ube2g2 
Cables1 Foxg1 Mll1 Rit2 Ube2u 
Cabp7 Foxi1 Mll5 Rlbp1 Ube2v1 
Cabyr Foxk1 Mllt3 Rmi1 Ube4b 
CacnB2 Foxl1 Mllt4 Rnase1 Ubl3 
Cacna1a Foxn2 Mlxip Rnase13 Ubl4b 
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Cacna1b Foxo1 Mmaa Rnaseh2b Ubtf 
Cacna1h Foxo6 Mmab Rnd3 Uchl4 
Cacna2d1 Foxp1 Mmadhc Rnf112 Uck2 
Cacna2d4 Foxp2 Mmd2 Rnf114 Ugcg 
Cacnb4 Foxp4 Mme Rnf122 Ulk4 
Cacng1 Frmd4a Mmp15 Rnf144a Umps 
Cacng3 Frmd4b Mmp16 Rnf144b Unc13c 
Cacng4 Frmd6 Mmp28 Rnf150 Unc5c 
Cacng5 Frmd8 Mms19 Rnf152 Ung 
Cadm1 Frmpd1 Mms22l Rnf182 Upb1 
Cadm2 Fry Mn1 Rnf19b Upp2 
Calb2 Fryl Mocs2 Rnf214 Uqcr10 
Calcoco1 Fsbp Mogat2 Rnf216 Urm1 
Calcrl Fscn1 Mon1b Rnf4 Urod 
Calm1 Fsd1l Mon2 Rngtt Ush2a 
Calm2 Fsd2 Morc2a Rnmtl1 Usp10 
Calr4 Fshr Morc3 Robo1 Usp12 
Camk1d Fsip1 Morn3 Robo2 Usp24 
Camk1g Fstl1 Moxd1 Rora Usp25 
Camk2a Fstl4 Mpa2l Rorb Usp3 
Camk2b Fth1 Mpdz Rpa1 Usp31 
Camk2d Ftl2 Mpg Rpe Usp38 
Camk2n1 Fto Mphosph9 Rph3a Usp44 
Camkk2 Fxn Mpp3 Rpia Usp46 
Camsap1l1 Fyn Mpp6 Rpl14 Usp6nl 
Cand1 Fzd1 Mpped1 Rpl15 Ust 
Cap2 Fzd4 Mpped2 Rpl27a Utp18 
Capg Fzd6 Mprip Rpl29 Utp6 
Capn12 Fzd7 Mpzl2 Rpl37a Vac14 
Capn13 Fzd9 Mr1 Rpl38 Vamp3 
Capn5 G0s2 Mras Rplp1 Vangl1 
Capns2 G2e3 Mrc2 Rprd1b Vash1 
Car12 G3bp2 Mreg Rprm Vash2 
Car5a G6pc3 Mro Rps10 Vav2 
Car6 Gab1 Mrpl33 Rps14 Vav3 
Car8 Gab2 Mrpl39 Rps24 Vcl 
Car9 Gabra2 Mrpl48 Rps29 Vdac1 
Card11 Gabrg1 Mrps10 Rps6ka2 Vdac2 
Card9 Gadd45a Mrps18a Rptor Vegfa 
Casc1 Gadd45b Mrps23 Rpusd4 Veph1 
Casp12 Gadd45g Mrps28 Rragc Vgll2 
Casp14 Gadl1 Msh6 Rreb1 Vgll3 
Casp3 Galc Msi2 Rrm2 Vgll4 
Casz1 Galm Msl3l2 Rrp7a Vldlr 
Cat Galnt10 Msrb3 Rsl24d1 Vmn1r3 
Cav2 Galnt2 Msx1 Rtkn Vmn1r4 
Cbara1 Galnt4 Mtap1a Rtkn2 Vmn1r64 
Cbfa2t2 Galnt7 Mtap1b Rtn3 Vmn2r18 
Cbfa2t3 Galntl1 Mtap2 Rtn4 Vps13b 
Cbln1 Galntl2 Mtap4 Rtn4rl1 Vps13c 
Cbln4 Galntl4 Mtap6 Rufy3 Vps37b 
Cbr4 Galntl5 Mtap7 Rundc1 Vps45 
Cbwd1 Galr3 Mtbp Runx1 Vps53 
Cbx4 Gap43 Mtch1 Runx1t1 Vps54 
Cbx5 Gapdh Mthfd1l Rusc2 Vps8 
Cbx7 Gapvd1 Mtmr10 Rxfp2 Vrk1 
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Ccbe1 Garnl3 Mtmr2 Rxra Vstm2a 
Ccdc11 Gas1 Mtmr6 Rxrg Vstm2b 
Ccdc121 Gas2l3 Mtr Rybp Vstm2l 
Ccdc132 Gas6 Mtss1 Ryk Vti1a 
Ccdc134 Gas7 Mtss1l Ryr3 Vwde 
Ccdc136 Gatm Muc20 S100a10 Vwf 
Ccdc141 Gatsl2 Muc3 S100a16 Wac 
Ccdc148 Gbe1 Mudeng S100a4 Was 
Ccdc30 Gbf1 Murc S100a6 Wasf1 
Ccdc41 Gbx2 Mus81 S1pr2 Wasf2 
Ccdc42 Gca Mxra7 Sae1 Wasf3 
Ccdc50 Gch1 Myadm Safb2 Wdfy2 
Ccdc54 Gclc Mybpc1 Sag Wdr20b 
Ccdc6 Gcnt1 Mybph Sall1 Wdr26 
Ccdc69 Gcnt2 Myc Sall3 Wdr27 
Ccdc70 Gcom1 Mycn Samd5 Wdr37 
Ccdc8 Gdf10 Myh14 Samd7 Wdr38 
Ccdc81 Gdf6 Myh7b Sap30l Wdr4 
Ccdc83 Gdi2 Myh9 Sardh Wdr44 
Ccdc85c Gemin8 Myl1 Sars Wdr66 
Ccdc86 Gfod1 Mylk Sash1 Wdr7 
Ccdc88c Gfpt2 Myo10 Satb1 Wdr72 
Ccdc90a Gfra1 Myo16 Scamp5 Wdr95 
Ccdc90b Gfra2 Myo18a Scand1 Wdsub1 
Ccdc91 Gga1 Myo18b Scap Whrn 
Ccin Ggh Myo1e Scarb1 Whsc1l1 
Ccl22 Ggt5 Myo3a Scarb2 Wif1 
Ccl25 Ggta1 Myo3b Sccpdh Wipf3 
Ccl9 Ghrh Myo5a Scel Wisp1 
Ccna1 Gig18 Myo7a Scfd2 Wisp3 
Ccnd1 Gin1 Myog Scg2 Wls 
Ccnd2 Gja8 Myoz3 Scgb1a1 Wnt10a 
Ccnd3 Gjb6 Myrip Scgb1c1 Wnt2b 
Ccnjl Gjc3 Myst4 Scgn Wnt5a 
Ccnl1 Gjd2 Myt1 Scml4 Wnt7a 
Ccr3 Gkn1 Myt1l Scn3b Wnt7b 
Ccr6 Glcci1 Mzt1 Scn5a Wrn 
Ccrn4l Glce N4bp1 Scn8a Wsb1 
Cct6b Gle1 N6amt1 Scrg1 Wscd1 
Cct8l1 Glg1 Naa20 Scrn1 Wt1 
Cd109 Gli2 Nacc2 Scx Wwc1 
Cd164 Gli3 Naif1 Scyl1 Wwox 
Cd180 Glis1 Nalcn Sdc1 Wwp2 
Cd2 Glis3 Nanogpd Sdc2 Wwtr1 
Cd247 Glp1r Nap1l1 Sdc3 X99384 
Cd276 Glrb Nap1l5 Sdccag8 Xkr9 
Cd28 Glrx Napa Sdhaf1 Xpnpep2 
Cd47 Glt25d2 Napepld Sdk1 Xpo4 
Cd69 Glt28d2 Napg Sdk2 Xpo6 
Cd81 Glud1 Narg2 Sdpr Xrcc2 
Cd82 Glul Nat3 Sec14l1 Xrcc4 
Cd83 Gm10391 Nat8 Sec14l4 Xrcc6bp1 
Cd93 Gm1060 Nav1 Sec14l5 Xrn2 
Cd96 Gm11744 Nav2 Sec16b Xylt1 
Cd97 Gm11818 Nav3 Sec22b Yes1 
Cdc25b Gm12695 Nbas Sec24b Ykt6 
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Cdc42ep1 Gm12824 Nbr1 Sec61b Ythdc2 
Cdc42se1 Gm1337 Ncald Sec61g Ywhaq 
Cdc42se2 Gm13695 Ncam1 Sel1l Ywhaz 
Cdc5l Gm14483 Ncam2 Sema3a Zbed3 
Cdc6 Gm15319 Ncf2 Sema3b Zbtb10 
Cdca7 Gm1568 Nck2 Sema3d Zbtb16 
Cdh10 Gm1587 Nckap5 Sema4a Zbtb20 
Cdh11 Gm1631 Nckap5l Sema4b Zbtb43 
Cdh13 Gm16378 Ncoa1 Sema4c Zbtb7c 
Cdh2 Gm17019 Ncoa3 Sema4d Zc3h12c 
Cdh20 Gm1965 Ncor2 Sema5a Zc3h3 
Cdh26 Gm239 Ncs1 Sema5b Zcchc13 
Cdh4 Gm3417 Ncstn Sema6a Zcchc2 
Cdh5 Gm347 Ndfip1 Sema6d Zcchc24 
Cdh6 Gm3646 Ndn Sep15 Zcchc6 
Cdh8 Gm4340 Ndnl2 Sepp1 Zdhhc14 
Cdhr3 Gm4906 Ndrg1 Sepsecs Zdhhc19 
Cdk14 Gm4937 Ndrg3 Sept11 Zdhhc20 
Cdk17 Gm4951 Ndst4 Sept4 Zdhhc21 
Cdk19 Gm4980 Ndufa10 Sept7 Zdhhc25 
Cdk2ap1 Gm5134 Ndufa11 Sept9 Zdhhc7 
Cdk5r1 Gm5136 Ndufa4 Serac1 Zdhhc9 
Cdk5rap2 Gm5148 Ndufb9 Sergef Zeb1 
Cdk6 Gm527 Ndufv3 Serhl Zeb2 
Cdk8 Gm5382 Necab1 Serinc1 Zfand5 
Cdkal1 Gm5415 Nedd4 Serinc5 Zfand6 
Cdkl1 Gm5506 Nedd4l Serp2 Zfat 
Cdkn1a Gm5820 Nedd9 Serpina12 Zfc3h1 
Cdkn1c Gm597 Negr1 Serpina3n Zfhx2 
Cdkn2aipnl Gm628 Neil1 Serpinb5 Zfhx3 
Cdkn2d Gm6588 Nek2 Serpine2 Zfp106 
Cdrt4 Gm672 Nek7 Serpine3 Zfp217 
Cdv3 Gm6724 Nek9 Serpinh1 Zfp238 
Cdyl Gm6772 Nell2 Serpini2 Zfp280b 
Ceacam1 Gm6878 Nenf Sertad2 Zfp281 
Ceacam2 Gm6924 Neo1 Sertad3 Zfp330 
Cebpd Gm7073 Nes Sesn3 Zfp362 
Cebpg Gm71 Neto1 Setd5 Zfp365 
Cecr2 Gm7325 Neu4 Sez6 Zfp366 
Cecr5 Gm766 Neurl1a Sez6l Zfp36l1 
Celf2 Gm813 Neurl1b Sf3b4 Zfp36l2 
Cenpc1 Gm815 Neurod4 Sfi1 Zfp385b 
Cenpo Gm8882 Neurod6 Sfmbt2 Zfp41 
Cep164 Gm9104 Nf2 Sfrp2 Zfp423 
Cep170 Gm973 Nfam1 Sfswap Zfp445 
Cep68 Gm9733 Nfasc Sfxn1 Zfp457 
Cer1 Gm9758 Nfatc2 Sfxn5 Zfp462 
Cerk Gm9880 Nfatc3 Sgcz Zfp474 
Ces5a Gm9920 Nfe2l2 Sgip1 Zfp488 
Cetn3 Gm9934 Nfe2l3 Sgk1 Zfp516 
Cfdp1 Gm9961 Nfia Sgk2 Zfp521 
Cfl2 Gm9992 Nfib Sgms1 Zfp532 
Cga Gmds Nfic Sh2b3 Zfp536 
Cgnl1 Gmpr Nfil3 Sh2d1a Zfp608 
Chac1 Gna12 Nfix Sh2d4a Zfp609 
Chchd3 Gna13 Nfkb2 Sh2d4b Zfp664 
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Chchd8 Gnao1 Nfkbia Sh2d5 Zfp69 
Chd2 Gnaq Nfkbiz Sh2d6 Zfp703 
Chd3 Gnat3 Nfyc Sh2d7 Zfp704 
Chd6 Gnaz Ng23 Sh3bgrl Zfp706 
Chd7 Gnb2 Ngdn Sh3bgrl2 Zfp740 
Chd9 Gne Ngly1 Sh3bp4 Zfp787 
Chgb Gng12 Nhlrc2 Sh3gl2 Zfp804a 
Chic2 Gng13 Nhs Sh3kbp1 Zfp827 
Chit1 Gng2 Nhsl1 Sh3pxd2a Zfp868 
Chl1 Gng4 Nicn1 Sh3pxd2b Zfp945 
Chmp4c Gnpda1 Nin Sh3rf1 Zfp957 
Chmp6 Gnpda2 Ninj1 Sh3rf3 Zfpm1 
Chn2 Golga5 Ninj2 Sh3tc2 Zfpm2 
Chrac1 Golga7b Nipal2 Shb Zfr 
Chrd Golim4 Nipsnap3a Shc4 Zfyve21 
Chrdl1 Golm1 Nkain2 She Zfyve28 
Chrm1 Golph3 Nkain3 Shf Zhx2 
Chrm2 Golph3l Nkd1 Shh Zic1 
Chrm3 Golt1a Nkiras2 Shisa2 Zic4 
Chrm4 Gorasp2 Nkx6-3 Shisa4 Zmiz1 
Chrna4 Gp9 Nlgn1 Shox2 Zmiz2 
Chst1 Gpc1 Nln Shq1 Zmym2 
Chst11 Gpc6 Nmnat2 Shroom3 Zmynd11 
Chst2 Gpcpd1 Nmu Shroom4 Zmynd8 
Chst3 Gpd1 Noc3l Siae Znrf1 
Chst4 Gpd2 Noc4l Siah1a Znrf2 
Chst5 Gphb5 Nol11 Siah3 Znrf3 
Chst7 Gphn Nol9 Siglech Zpld1 
Chst9 Gpm6a Nos1ap Sik1 Zscan2 
Chsy1 Gpm6b Nos2 Sik2 Zswim4 
Chsy3 Gpnmb Nostrin Sik3 Zswim6 
Cidea Gpr101 Notch1 Sil1 Zxdc 
Cirbp Gpr110 Notch2 Sipa1l1 rp9 
Cit Gpr123 Nova1 Sipa1l2 	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Table A1 2 Genes that are bound by Ascl1 and downregulated in quies NSCs (from 
Martynoga et al., 2013) 
Gene name 
1700011E24Rik Csrnp3 Igfbp4 Pdzrn4 Slco1c1 
1700017B05Rik D8Ertd82e Igfbp5 Peg12 Slit1 
1700025G04Rik Dcc Igsf21 Pemt Smad5 
2610002I17Rik Dctd Il17d Pgap1 Smc2 
2610021K21Rik Ddc Impdh1 Phc2 Smtn 
2610039C10Rik Ddr2 Inhbb Pinx1 Smyd2 
2610528E23Rik Ddx11 Insm1 Pion Sncaip 
3110035E14Rik Ddx18 Itgb1bp2 Pkig Snrpe 
3830431G21Rik Dgkd Itpr2 Pld1 Sox11 
4930427A07Rik Dgkg Ivns1abp Pnmal1 Sox3 
5330437I02Rik Dhrs2 Jag1 Poc1a Sox6 
5730559C18Rik Disc1 Josd2 Poc1b Sox8 
6230409E13Rik Dlgap3 Kank1 Pola2 Spata24 
6530418L21Rik Dll1 Kbtbd8 Polg Specc1 
A630055G03Rik Dll3 Kcnab2 Polr1a Spred1 
A730011L01Rik Dmp1 Kcnc1 Polr3k Spry1 
AW146020 Dmrtb1 Kcnip3 Pom121 Spry2 
Abcc12 Dnmt1 Kcnj10 Pop1 Spry4 
Acaca Dnmt3b Kcnj2 Pou3f1 Spsb4 
Acap3 Dock10 Kcnk2 Ppargc1b Srgap2 
Acer3 Dpf3 Kcnma1 Ppp1r14b Srl 
Acly Dpp6 Kdm2b Ppp1r14c Srsf10 
Acss1 Dscam Kif14 Ppp2r5c Srsf3 
Ada Dtl Kif20b Ppp5c Srsf7 
Adam12 Dusp4 Kirrel3 Prdm11 Stard9 
Adam19 Dusp6 Kitl Prep Stc1 
Adamts12 Dusp7 Klf12 Prkcb Stim2 
Adamts17 E2f1 Klhl13 Prkg2 Stk33 
Adamts6 E2f3 Klhl23 Prokr1 Sykb 
Adamts7 E2f7 Klhl5 Prr18 Tacc3 
Amz1 Ebna1bp2 Ky Prr5 Tbc1d16 
Apcdd1 Edil3 Lamb1 Psat1 Tbc1d30 
Apln Ednrb Lbr Pstpip2 Tcf12 
Areg Eefsec Lfng Ptch1 Tcf4 
Arhgap18 Efcab5 Lgr5 Ptgds Tecta 
Arhgap24 Egfl7 Lhx2 Ptprb Tex14 
Arhgap26 Egfr Limd1 Ptprj Tgfbr2 
Arl6ip6 Elac2 Lipg Ptpro Tgif2 
Arpp21 Elavl2 Lmcd1 Ptprs Thrsp 
Ascl1 Elavl4 Lmnb1 Ptprz1 Tk1 
Atp1a2 Elovl6 Lmo1 Rab17 Tle1 
Atp6v1e2 Enpp1 Lmo3 Rab3c Tle4 
Atp9a Epb4.1 Lmo7 Rab8b Tmc6 
Axin2 Eps8 Lnp Racgap1 Tmem149 
B3galt5 Erh Lrrc40 Rad51l1 Tmem173 
B3gat1 Etv1 Lrrc8b Raet1d Tmem182 
BC027231 Etv4 Lrrc9 Raly Tmem209 
BC030867 Etv5 Lrrfip1 Rap1gap Tmem39b 
BC052040 Eya2 Lrrn1 Rapgef3 Tmem44 
Bahcc1 Fabp7 Lsm6 Rasa3 Tmem51 
Bai2 Fam105a Ltbp4 Rassf2 Tmod2 
Bcat1 Fam122b Ly75 Rassf3 Tmpo 
Bcor Fam174b Lyn Rcor2 Tmtc2 
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Bend5 Fam49b Lypd6 Repin1 Tnfsf18 
Bmp7 Fam78a Magi1 Rerg Tox2 
Brsk2 Fbl Map2k6 Rfc2 Tox3 
Btbd17 Fbln1 Map4k4 Rfx3 Tppp 
Btla Fbln2 Mchr1 Rfx8 Tra2b 
Bzw2 Fbp1 Mgat5b Rgs7bp Traf3ip2 
C530008M17Rik Fbxo48 Micalcl Rhoq Traf4 
Calm1 Fgr Mlf1ip Rimbp3 Trib2 
Camk1g Fign Mmd2 Rimkla Trim67 
Camk2a Flrt3 Mmp15 Rlbp1 Trit1 
Camk2b Foxf1a Morc2a Rnaseh2b Trmt61a 
Camkk2 Foxp4 Mphosph9 Rnf122 Trp53i11 
Car8 Frmd4a Mpp3 Rnf144a Tsga14 
Ccdc141 Frmd4b Mpped2 Rpl14 Tspan11 
Ccdc69 Fyn Mtbp Rpl15 Tspan5 
Ccna1 Fzd9 Mthfd1l Rps14 Ttc3 
Ccnd1 G2e3 Myc Rrm2 Ttc37 
Ccnjl Gabrg1 Myh14 Rtkn2 Ttc7 
Cd276 Galnt7 Myo18b Ryr3 Ttpa 
Cd82 Galntl1 Nap1l1 Scarb1 Tyro3 
Cdc25b Gas2l3 Nav3 Scml4 Ubash3b 
Cdc6 Gas7 Ncald Sdpr Umps 
Cdca7 Gfpt2 Nckap5l Sec16b Ung 
Cdh4 Glcci1 Nek2 Sema4b Usp10 
Cdk2ap1 Gm10391 Nes Sema4c Usp3 
Cdk6 Golph3 Neurl1a Sema5a Usp44 
Cdk8 Gpr30 Nfia Sema5b Usp6nl 
Cdkn1c Gpsm1 Nfib Sez6l Utp18 
Cdkn2aipnl Gpt2 Noc4l Sfrp2 Vash1 
Cecr2 Grb10 Nol11 Sfxn1 Vash2 
Chd3 Grip1 Nol9 Sgms1 Vav3 
Chd7 Grm5 Nova1 Sh3bgrl2 Vrk1 
Chn2 H2afy2 Nptx1 Sh3gl2 Wasf1 
Chst7 Hap1 Nrk Shc4 Wdr4 
Chsy1 Hectd2 Ntn1 Shq1 Wdr66 
Cit Hes6 Ntrk2 Skp2 Wipf3 
Clic5 Hfm1 Nuf2 Slc12a2 Wisp3 
Cmpk2 Hip1 Nusap1 Slc14a2 Wnt7a 
Cmtm5 Hipk2 Nwd1 Slc1a1 Wnt7b 
Cntn6 Hlx Ogg1 Slc1a3 Wscd1 
Cntrob Hmga2 Ola1 Slc22a23 Xylt1 
Col9a3 Hmgcr Olig1 Slc25a18 Zbtb10 
Coro1c Hnrpdl Olig2 Slc29a4 Zdhhc21 
Crb1 Hrh1 Otoa Slc38a3 Zeb1 
Crispld2 Iffo1 Pcdh10 Slc4a4 Zfp41 
Csda Igf1r Pcdh18 Slc6a1 Zfyve28 
Cspg5 Igfbp3 Pde4b Slc6a11 Zswim6 
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Table A1 3 Specification of GO terms of genes bound by Ascl1 and downregulated in 
quies NSCs (from Martynoga et al., 2013) 
Term Count % p-value Genes 
Regulation of 
phosphorylation 25 5.07 
7.81E-
07 
HMGCR, TRIB2, SPRY4, 
SPRY2, SPRY1, DGKD, DGKG, 
RAPGEF3, SPRED1, PPP1R14C, 
PPP1R14B, MAP2K6, EGFR, 
VAV3, LYN, TGFBR2, PKIG, 
SYKB, KITL, CDC25B, 
CDKN1C, ZFYVE28, NRK, 
BMP7, IGFBP3 
Phosphate metabolic 
process 44 8.92 
4.71E-
05 
STK33, FGR, NEK2, BRSK2, 
PRKG2, DDR2, D8ERTD82E, 
TRIB2, CAMKK2, IGF1R, 
VRK1, CAMK2B, CAMK2A, 
MAP2K6, PTPRB, PTPRJ, 
EGFR, TYRO3, CAMK1G, LYN, 
PTPRZ1, TGFBR2, CDK8, 
PTPRS, SYKB, CDK6, PTPRO, 
CDC25B, PRKCB, MAP4K4, 
DUSP4, TEX14, CCND1, EYA2, 
FYN, ATP6V1E2, HIPK2, 
NTRK2, NRK, CIT, IGFBP3, 
DUSP7, DUSP6, PPP5C 
Regulation of kinase 
activity 17 3.45 
5.10E-
05 
VAV3, HMGCR, PKIG, 
TGFBR2, SYKB, KITL, SPRY4, 
TRIB2, CDC25B, SPRY2, 
SPRY1, DGKD, DGKG, 
ZFYVE28, NRK, SPRED1, 
MAP2K6 
Protein amino acid 
autophosphorylation 10 2.03 
5.56E-
05 
EGFR, IGF1R, VRK1, LYN, 
FYN, NTRK2, CAMK2B, SYKB, 
CAMK2A, CAMKK2 
Neuron differentiation 26 5.27  
5.97E-
05 
DCC, BRSK2, JAG1, CDH4, 
SEMA5A, SLC1A3, CRB1, 
LHX2, ETV1, OLIG1, OLIG2, 
ETV4, DSCAM, KCNMA1, 
PTPRZ1, DLL1, GAS7, NTN1, 
SLIT1, CDKN1C, ASCL1, 
CLIC5, NTRK2, CIT, BMP7, 
WNT7A 
Cell cycle 34 6.90 7.87E-05 
E2F1, GAS2L3, E2F3, NEK2, 
E2F7, PRR5, DDX11, MTBP, 
CAMK2B, CCNA1, CAMK2A, 
LFNG, CDC6, ERH, NUF2, 
SKP2, NUSAP1, CDK6, 
1700017B05RIK, RACGAP1, 
TACC3, HMGA2, SMC2, 
VASH1, 2610039C10RIK, 
CDC25B, CDKN1C, CCND1, 
CNTROB, RASSF2, KIF20B, 
CDK2AP1, CIT, CALM1 
Sensory perception of 
mechanical stimulus 11 
2.23 
 
1.54E-
04 
KCNMA1, TECTA, SPRY2, 
CHD7, SLC1A3, SLC12A2, 
FYN, CLIC5, PGAP1, MYC, 
OTOA 
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Positive regulation of 
developmental process 17 3.45 
1.82E-
04 
TGFBR2, SMAD5, CD276, 
SYKB, JAG1, CDH4, NTN1, 
VASH2, KITL, ADA, ASCL1, 
WNT7B, HLX, TGIF2, BMP7, 
IGFBP3, WNT7A 
Pattern specification 
process 19 3.85 
5.61E-
04 
PGAP1, SMAD5, TGFBR2, 
DLL3, DLL1, ZEB1, SEMA5A, 
PEG12, ASCL1, FOXF1A, 
SFRP2, LHX2, HIPK2, PTCH1, 
RFX3, BMP7, AXIN2, WNT7A, 
LFNG 
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Table A1 4 Genes that are bound by Ascl1 and enriched in aNSCs (from Codega et al., 
2014) 
Gene name 
2610039C10Rik Cycs Hap1 Nusap1 Slc38a1 
2610109H07Rik D19Bwg1357e Hddc2 Odc1 Slc44a1 
2610528E23Rik D430041D05Rik Hes6 Ola1 Slc4a7 
2700060E02Rik D8Ertd82e Hmgb1 Papd7 Smarca5 
4930427A07Rik Dapk1 Hnrpll Pbx3 Smc2 
4930503L19Rik Dclk2 Ift27 Pcdh18 Smyd2 
A630055G03Rik Dcx Igfbpl1 Pdcd1 Sncaip 
Adam12 Ddx20 Insm1 Peg12 Snd1 
Ahcy Dhx15 Ipo5 Pknox1 Snrnp40 
Akt3 Dhx30 Iqgap1 Plcl2 Snrpe 
Ankrd6 Dleu7 Kcnip3 Plrg1 Snx5 
Apaf1 Dlgap3 Kdm2b Plxna2 Socs3 
Arl4c Dll1 Kitl Pola2 Sox11 
Ascl1 Dll3 Lbr Pold3 Sox4 
Asnsd1 Dlx2 Lima1 Polr3k Spata13 
Asxl1 Dnmt1 Lmnb1 Pou3f4 Srsf3 
Aven Dpysl3 Lmo1 Ppil1 St3gal3 
Bag1 Dscaml1 Lrfn4 Ppp1r14b Stag1 
Btg2 Dtl Lrrfip1 Psmb1 Tacc3 
Bzw2 E2f1 Lsm5 Ptprs Tcf12 
C230052I12Rik E2f3 Lsm6 Rab8b Tcf20 
C530008M17Rik E2f7 Maged1 Racgap1 Tead1 
Casp3 E2f8 Magoh Raly Tfdp2 
Cbx5 Edar Map3k1 Rbm15 Tgif2 
Ccdc86 Edc3 Marcks Rbm24 Thoc7 
Ccnd1 Efhd2 Med14 Rcbtb2 Tk1 
Ccnd2 Egfr Mex3b Rfc2 Tmem2 
Cd276 Eif3f Mn1 Rgs16 Tmpo 
Cdc6 Eif3h Mphosph9 Rhbdl3 Tmsb10 
Cdca7 Elavl2 Mrps10 Rnaseh2b Tmsb4x 
Cdh4 Elavl4 Mrps23 Rnf4 Tnfrsf21 
Cdk2ap1 Enc1 Msh6 Rngtt Tra2b 
Cdk5r1 Epb4.1 Mtap1b Rpa1 Trim33 
Cdk6 Epha4 Mtap2 Rpia Trim67 
Cebpg Ephb2 Mycn Rpl14 Tsn 
Celf2 Erh Myt1 Rpl15 Ttc3 
Cenpc1 Etaa1 Nap1l1 Rpl37a Txnip 
Cenpo Fam108c Ncald Rps10 Ubtf 
Chd3 Fam110a Ncor2 Rps29 Uck2 
Chd7 Fam64a Nedd4l Rrm2 Umps 
Cit Fbl Nek2 Rtkn2 Usp10 
Clic4 Flnb Nell2 Sae1 Vamp3 
Cnih4 Fos Nes Sec61g Vash1 
Cntrob Fscn1 Nfia Sez6 Vps37b 
Coro1c G2e3 Nfib Sh3bgrl Vrk1 
Crmp1 Gab2 Nfix Shf Zc3h12c 
Csda Gng2 Nin Sipa1l1 Zfp238 
Csk Golm1 Noc4l Skp2 Zfp41 
Csnk1e Gse1 Nsg2 Slc25a5 Zfp462 
Ctnnb1 Gsx1 Nuf2 Slc29a4 Zmiz1 
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Table A1 5 Specification of GO terms of genes bound by Ascl1 and enriched in aNSCs 
(from Codega et al., 2014) 
Term Count % p-value Genes 
DNA replication 13 5.24 1.72E-06 
CDC6, DTL, PAPD7, NFIX, 
POLA2, TK1, RPA1, POLD3, 
RFC2, RRM2, A630055G03RIK, 
NFIA, NFIB 
Cell cycle 26 10.48 1.84E-06 
E2F1, E2F3, NEK2, E2F7, E2F8, 
RPA1, TFDP2, STAG1, TXNIP, 
CDC6, ERH, SKP2, PAPD7, 
NUF2, NUSAP1, CDK6, TACC3, 
RACGAP1, SMC2, VASH1, 
2610039C10RIK, CCND1, 
CCND2, CNTROB, CDK2AP1, 
CIT 
mRNA processing 15 6.05 2.26E-05 
RALY, TRA2B, PPIL1, LSM6, 
MAGOH, HNRPLL, RNGTT, 
PLRG1, DHX15, LSM5, CELF2, 
THOC7, SNRNP40, DDX20, 
SNRPE 
Forebrain 
development 12 4.84 2.62E-05 
E2F1, EGFR, ASCL1, DLX2, 
GSX1, POU3F4, 
2610109H07RIK, APAF1, 
TACC3, NCOR2, CTNNB1, 
NFIB 
Regulation of 
transcription 55 22.18 3.15E-05 
E2F1, E2F3, ZFP41, E2F7, E2F8, 
CTNNB1, KCNIP3, CBX5, 
MAGED1, FOS, CDCA7, SND1, 
ZFP238, LRRFIP1, DDX20, 
SOX11, MED14, HES6, CSDA, 
MYCN, ASCL1, KDM2B, 
ZFP462, BTG2, TRIM33, ZMIZ1, 
SMARCA5, TGIF2, HMGB1, 
SOX4, NFIX, MYT1, TCF20, 
CHD7, POU3F4, TFDP2, CHD3, 
TXNIP, POLR3K, CEBPG, 
ASXL1, GSX1, TEAD1, DLX2, 
PKNOX1, RNF4, UBTF, 
DNMT1, TMPO, PBX3, TCF12, 
RBM15, NFIA, NCOR2, NFIB 
Regulation of RNA 
metabolic process 41 16.53 4.93E-05 
E2F1, HMGB1, E2F3, E2F7, 
E2F8, SOX4, NFIX, MYT1, 
HNRPLL, CTNNB1, CBX5, 
KCNIP3, MAGED1, FOS, 
TFDP2, POU3F4, ZFP238, 
DDX20, TXNIP, SOX11, 
CEBPG, GSX1, TEAD1, MED14, 
HES6, CSDA, MYCN, ASCL1, 
DLX2, PKNOX1, ZFP462, 
ZMIZ1, SMARCA5, DNMT1, 
TGIF2, PBX3, RBM15, TCF12, 
NFIA, NCOR2, NFIB 
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Positive regulation of 
nitrogen compound 
metabolic process 
21 8.467 5.98E-05 
E2F1, HMGB1, E2F3, CEBPG, 
SOX11, GSX1, TEAD1, SOX4, 
MED14, NFIX, HNRPLL, 
CTNNB1, FOS, ASCL1, DLX2, 
PKNOX1, ZFP462, ZMIZ1, 
RBM15, NFIA, NFIB 
DNA metabolic 
process 18 7.26 1.06E-04 
CDC6, MSH6, DTL, 
C230052I12RIK, PAPD7, NFIX, 
POLA2, TK1, POLD3, RPA1, 
CASP3, RFC2, RRM2, DNMT1, 
A630055G03RIK, APAF1, NFIA, 
NFIB 
Neuron 
differentiation 17 6.85 1.85E-04 
CDK5R1, MTAP2, GSX1, DLL1, 
CDH4, EPHB2, EPHA4, ASCL1, 
DLX2, BTG2, BAG1, MTAP1B, 
POU3F4, 2610109H07RIK, 
PBX3, CIT, DCX 
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Table A1 6 Genes that are bound by Ascl1, downregulated in quies NSCs (Martynoga 
et al., 2013) and enriched in aNSCs (Codega et al., 2014) 
Gene name 
2610039C10Rik Coro1c Hes6 Nusap1 Smc2 
2610528E23Rik Csda Insm1 Ola1 Smyd2 
4930427A07Rik D8Ertd82e Kcnip3 Pcdh18 Sncaip 
A630055G03Rik Dlgap3 Kdm2b Peg12 Snrpe 
Adam12 Dll1 Kitl Pola2 Sox11 
Ascl1 Dll3 Lbr Polr3k Srsf3 
Bzw2 Dnmt1 Lmnb1 Ppp1r14b Tacc3 
C530008M17Rik Dtl Lmo1 Ptprs Tcf12 
Ccnd1 E2f1 Lrrfip1 Rab8b Tgif2 
Cd276 E2f3 Lsm6 Racgap1 Tk1 
Cdc6 E2f7 Mphosph9 Raly Tmpo 
Cdca7 Egfr Nap1l1 Rfc2 Tra2b 
Cdh4 Elavl2 Ncald Rnaseh2b Trim67 
Cdk2ap1 Elavl4 Nek2 Rpl14 Ttc3 
Cdk6 Epb4.1 Nes Rpl15 Umps 
Chd3 Erh Nfia Rrm2 Usp10 
Chd7 Fbl Nfib Rtkn2 Vash1 
Cit G2e3 Noc4l Skp2 Vrk1 
Cntrob Hap1 Nuf2 Slc29a4 Zfp41 
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Table A1 7 Specification of GO terms of genes bound by Ascl1, downregulated in quies 
NSCs (Martynoga et al., 2013) and enriched in aNSCs (Codega et al., 2014) 
Term Count % p-value Genes 
Cell cycle 19 20.21276596 3.83E-09 
E2F1, CDC6, E2F3, ERH, 
NEK2, E2F7, NUF2, SKP2, 
NUSAP1, CDK6, RACGAP1, 
TACC3, SMC2, VASH1, 
2610039C10RIK, CCND1, 
CNTROB, CDK2AP1, CIT 
Mitosis 7 7.446808511 6.25E-04 
CDC6, NEK2, NUF2, NUSAP1, 
CIT, SMC2, 2610039C10RIK 
Regulation of 
neurogenesis 6 
6.38297872
3 8.03E-04 
ASCL1, DLL1, TGIF2, CIT, 
CDH4, TTC3 
Regulation of cell 
proliferation 10 
10.6382978
7 
0.00274390
4 
EGFR, E2F3, CDCA7, E2F7, 
CD276, RTKN2, DNMT1, 
KITL, VASH1, NFIB 
Cytoskeleton 
organization 7 
7.44680851
1 0.0091606 
CORO1C, EPB4.1, CNTROB, 
NUF2, NUSAP1, RACGAP1, 
TACC3 
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Appendix 2  
Interactions between precursors cells in the DG and components of the neurogenic 
niche have been shown to be of vital importance for the regulation of stem cell self-
renewal and differentiation (Doetsch, 2003). In the SVZ, functional interactions 
between blood vessels and stem cells have been uncovered (Ottone et al., 2014). Less 
is known about the nature of these interactions in the DG. Blood-borne factors are 
known to act on and regulate neuronal precursors (Goldberg and Hirschi, 2009). 
However, whether neuronal proliferation and neurogenesis acts on endothelial cells 
to regulate angiogenesis or blood vessel density is not known. A study by Palmer and 
colleagues (2000) reported precursors in the SGZ of rats to be closely associated 
with blood vessels. Moreover, they showed that 37% of DG BrdU immunoreactive 
cells after a 2-hour pulse were of the endothelial lineage. Together, these results 
suggested the possibility of a functional interaction between neurogenesis and 
angiogenesis in the rodent hippocampus. To test this hypothesis we first performed 
BrdU administration experiments to characterise the angiogenic population in the 
DG (Figure A2 1). Next, we hypothesised that in the case of interactions between 
neural and endothelial precursors taking place in the DG, a disruption in the neural 
precursor pool, would also result in a disruption of angiogenesis, and we tested this 
by examining endothelial cell division in WT and Ascl1neocKO mice (Figure A2 2). 
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Figure A2 1 Only a small proportion of endothelial cells divides in the adult mouse 
hippocampus 
(A) Administration of BrdU in the drinking water (0.2 mg/ml) for two weeks to 8 week-old WT mice 
to characterise the population of dividing endothelial cells in the hippocampus. Note that after a 2-
hour BrdU pulse virtually no dividing endothelial cells were found in the hippocampus (not shown). 
Immunolabeling for BrdU and the endothelial marker CD31 shows that BrdU+ cells are clustered in 
the vicinity of blood vessels, as expected from Palmer et al., 2000. (B) Colocalisation of BrdU and 
CD31 in different regions of the DG. A few CD31+ BrdU+ cells were found after two weeks of BrdU 
administration in the hippocampus, and these were either on the subgranular zone (SGZ), the granule 
layer (GL) or the molecular layer (ML). However, the number of these cells found did not correspond 
with the numbers observed in Palmer et al., 2000. In total, only approximately <1% of BrdU+ cells 
also colocalised with CD31. This is unexpected, and would suggest that angiogenesis is not such a 
widespread phenomenon in the DG as reported before. 
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Figure A2 2 Investigation of functional interactions between neurogenesis and blood 
vessels 
To study a possible functional cross-talk between neuronal precursors and blood vessels we 
administered BrdU in the drinking water (0.2 mg/ml) for two weeks to WT and Ascl1neocKO mice. 
Ascl1neocKO mice inactivate Ascl1 in stem cells after TAM administration at P60. Ascl1 deletion 
results in a block of stem cell proliferation and, consequently, neurogenesis (see Chapters 3 and 4). 
We hypothesised that neuronal precursors might regulate blood vessel density or angiogenesis in the 
DG. Labelling for BrdU, the endothelial marker CD31 and YFP to report recombination does not 
appear to show differences in blood vessel morphology or density between WT animals and animals 
that have lost neurogenesis. Moreover, no difference in angiogenesis was observed. These results, 
however, are not enough to discard functional interactions taking place between the neural and 
vascular systems in the hippocampus. Further characterisation and quantification of blood vessel 
quantity, density and branching will shed more light on this possibility. Scale bar = 40μm.  
 
 
 
